<!DOCTYPE html>

<html lang="en">
<head>
<meta charset="utf-8"/>
<meta content="width=device-width, initial-scale=1.0" name="viewport"/>
<title>META-SPRINT: 40Ïùº ÎßåÏóê Ïã†Î¢∞Ìï† Ïàò ÏûàÎäî Ï¶ùÍ±∞ ÌôïÎ≥¥</title>
<link href="https://fonts.googleapis.com" rel="preconnect"/>
<link crossorigin="" href="https://fonts.gstatic.com" rel="preconnect"/>
<link href="https://fonts.googleapis.com/css2?family=Cormorant+Garamond:ital,wght@0,400;0,600;0,700;1,400;1,600&amp;family=Source+Sans+Pro:wght@300;400;600;700&amp;display=swap" rel="stylesheet"/>
<style>
    :root {
      --navy: #1E2761;
      --deep-navy: #141B3D;
      --gold: #D4AF37;
      --cream: #FAF8F5;
      --light-cream: #FFFFFF;
      --text: #2D3748;
      --light-text: #718096;
      --red: #C53030;
      --green: #22c55e;
      --teal: #0f766e;
      --purple: #7c3aed;
      --orange: #f59e0b;
      --transition: 0.5s cubic-bezier(0.4, 0, 0.2, 1);
    }

    * { margin: 0; padding: 0; box-sizing: border-box; }
    html, body {
      height: 100%;
      font-family: 'Source Sans Pro', sans-serif;
      background: var(--deep-navy);
      color: var(--cream);
    }

    .course-container { display: flex; height: 100vh; overflow: hidden; }

    /* ====== SIDEBAR ====== */
    .sidebar {
      width: 300px;
      background: linear-gradient(180deg, var(--deep-navy) 0%, #0a0f1a 100%);
      border-right: 1px solid rgba(212,175,55,0.2);
      display: flex;
      flex-direction: column;
      flex-shrink: 0;
    }

    .sidebar-header {
      padding: 1.25rem;
      border-bottom: 1px solid rgba(212,175,55,0.2);
      text-align: center;
    }
    .sidebar-header h1 {
      font-family: 'Cormorant Garamond', Georgia, serif;
      font-size: 1.3rem;
      font-weight: 700;
      color: var(--gold);
    }
    .sidebar-header p {
      font-size: 0.75rem;
      color: rgba(255,255,255,0.6);
    }

    /* Gamification Stats Panel */
    .stats-panel {
      padding: 1rem;
      background: rgba(212,175,55,0.1);
      border-bottom: 1px solid rgba(212,175,55,0.2);
    }
    .level-display {
      display: flex;
      align-items: center;
      gap: 0.75rem;
      margin-bottom: 0.75rem;
    }
    .level-badge {
      width: 48px;
      height: 48px;
      background: linear-gradient(135deg, var(--gold), #f0c040);
      border-radius: 50%;
      display: flex;
      align-items: center;
      justify-content: center;
      font-size: 1.5rem;
      box-shadow: 0 2px 8px rgba(212,175,55,0.4);
    }
    .level-info { flex: 1; }
    .level-title { font-weight: 700; font-size: 0.9rem; color: var(--gold); }
    .level-subtitle { font-size: 0.7rem; color: rgba(255,255,255,0.6); }
    .xp-bar {
      height: 8px;
      background: rgba(255,255,255,0.1);
      border-radius: 4px;
      overflow: hidden;
      margin-top: 0.5rem;
    }
    .xp-fill {
      height: 100%;
      background: linear-gradient(90deg, var(--gold), var(--orange));
      border-radius: 4px;
      transition: width 0.5s ease;
    }
    .xp-text {
      font-size: 0.65rem;
      color: rgba(255,255,255,0.5);
      text-align: right;
      margin-top: 0.25rem;
    }
    .quick-stats {
      display: grid;
      grid-template-columns: repeat(3, 1fr);
      gap: 0.5rem;
      margin-top: 0.75rem;
    }
    .quick-stat {
      background: rgba(0,0,0,0.2);
      padding: 0.5rem;
      border-radius: 6px;
      text-align: center;
    }
    .quick-stat-value {
      font-size: 1.1rem;
      font-weight: 700;
      color: var(--gold);
    }
    .quick-stat-label {
      font-size: 0.6rem;
      color: rgba(255,255,255,0.5);
    }

    .module-list { flex: 1; overflow-y: auto; padding: 0.5rem 0; }
    .module-item {
      display: flex;
      align-items: center;
      gap: 0.75rem;
      padding: 0.6rem 1rem;
      cursor: pointer;
      transition: all 0.2s;
      border-left: 3px solid transparent;
    }
    .module-item:hover { background: rgba(212,175,55,0.1); }
    .module-item.active { background: rgba(212,175,55,0.15); border-left-color: var(--gold); }
    .module-item.completed .module-number { background: var(--green); color: white; }
    .module-item.locked { opacity: 0.5; cursor: not-allowed; }
    .module-number {
      width: 26px;
      height: 26px;
      border-radius: 50%;
      background: rgba(255,255,255,0.1);
      display: flex;
      align-items: center;
      justify-content: center;
      font-size: 0.7rem;
      font-weight: 700;
      flex-shrink: 0;
    }
    .module-item.active .module-number { background: var(--gold); color: var(--navy); }
    .module-info { flex: 1; min-width: 0; }
    .module-title { font-size: 0.8rem; font-weight: 600; white-space: nowrap; overflow: hidden; text-overflow: ellipsis; }
    .module-subtitle { font-size: 0.65rem; color: rgba(255,255,255,0.5); }
    .module-xp { font-size: 0.6rem; color: var(--gold); }

    /* Badges Panel */
    .badges-panel {
      padding: 1rem;
      border-top: 1px solid rgba(212,175,55,0.2);
    }
    .badges-title { font-size: 0.75rem; font-weight: 600; color: var(--gold); margin-bottom: 0.5rem; }
    .badges-grid { display: flex; flex-wrap: wrap; gap: 0.35rem; }
    .badge-item {
      width: 32px;
      height: 32px;
      min-width: 44px;
      min-height: 44px;
      background: rgba(255,255,255,0.05);
      border: 2px solid rgba(255,255,255,0.1);
      border-radius: 6px;
      display: flex;
      align-items: center;
      justify-content: center;
      font-size: 0.9rem;
      font-family: inherit;
      color: inherit;
      padding: 0;
      opacity: 0.3;
      transition: all 0.3s;
      cursor: help;
      position: relative;
    }
    .badge-item.earned { opacity: 1; background: rgba(212,175,55,0.2); border-color: var(--gold); }
    .badge-item:hover::after {
      content: attr(data-tooltip);
      position: absolute;
      bottom: 100%;
      left: 50%;
      transform: translateX(-50%);
      background: var(--navy);
      color: white;
      padding: 0.25rem 0.5rem;
      border-radius: 4px;
      font-size: 0.6rem;
      white-space: nowrap;
      z-index: 100;
    }

    /* ====== MAIN CONTENT ====== */
    .main-content { flex: 1; display: flex; flex-direction: column; overflow: hidden; }
    .content-header {
      padding: 0.75rem 1.5rem;
      background: rgba(0,0,0,0.3);
      border-bottom: 1px solid rgba(212,175,55,0.2);
      display: flex;
      align-items: center;
      justify-content: space-between;
    }
    .breadcrumb { font-size: 0.85rem; color: rgba(255,255,255,0.6); }
    .breadcrumb span { color: var(--gold); }
    .header-actions { display: flex; gap: 0.5rem; align-items: center; }
    .streak-display {
      display: flex;
      align-items: center;
      gap: 0.35rem;
      background: rgba(239,68,68,0.2);
      border: 1px solid rgba(239,68,68,0.4);
      padding: 0.35rem 0.75rem;
      border-radius: 20px;
      font-size: 0.8rem;
    }
    .streak-display.active { background: rgba(249,115,22,0.2); border-color: var(--orange); }
    .streak-flame { font-size: 1rem; }
    .streak-count { font-weight: 700; color: var(--orange); }

    .btn {
      padding: 0.5rem 1rem;
      border: 1px solid rgba(212,175,55,0.3);
      border-radius: 6px;
      background: rgba(255,255,255,0.05);
      color: var(--cream);
      font-size: 0.8rem;
      cursor: pointer;
      transition: all 0.2s;
    }
    .btn:hover { background: rgba(212,175,55,0.2); border-color: var(--gold); }
    .btn.primary { background: var(--gold); color: var(--navy); border-color: var(--gold); font-weight: 600; }

    .content-body { flex: 1; overflow: hidden; display: flex; }

    /* ====== SLIDES ====== */
    .slides-container { flex: 1; position: relative; overflow: hidden; touch-action: pan-y pinch-zoom; }
    .module-slides { display: none; width: 100%; height: 100%; }
    .module-slides.active { display: block; }

    .slide {
      position: absolute;
      top: 0; left: 0;
      width: 100%; height: 100%;
      display: flex;
      flex-direction: column;
      justify-content: flex-start;
      align-items: center;
      padding: 2rem 2rem 4rem;
      opacity: 0;
      visibility: hidden;
      transition: opacity var(--transition), visibility var(--transition);
      overflow-y: auto;
    }
    .slide.active { opacity: 1; visibility: visible; }
    .slide.dark { background: var(--deep-navy); }
    .slide.light { background: var(--cream); color: var(--text); }
    .slide.black { background: #000; }
    .slide.red-bg { background: linear-gradient(135deg, #7f1d1d, #450a0a); }
    .slide.green-bg { background: linear-gradient(135deg, #14532d, #052e16); }
    .slide.purple-bg { background: linear-gradient(135deg, #4c1d95, #2e1065); }

    .serif { font-family: 'Cormorant Garamond', Georgia, serif; }
    .title {
      font-family: 'Cormorant Garamond', Georgia, serif;
      font-size: clamp(1.8rem, 4vw, 3rem);
      font-weight: 700;
      margin-bottom: 1rem;
      line-height: 1.2;
      text-align: center;
    }
    .title.gold { color: var(--gold); }
    .title.navy { color: var(--navy); }
    .subtitle {
      font-size: clamp(0.9rem, 2vw, 1.3rem);
      color: rgba(255,255,255,0.7);
      margin-bottom: 1.5rem;
      text-align: center;
    }
    .slide.light .subtitle { color: var(--light-text); }

    .big-number {
      font-family: 'Cormorant Garamond', Georgia, serif;
      font-size: clamp(4rem, 12vw, 8rem);
      font-weight: 700;
      line-height: 1;
    }
    .big-number.gold { color: var(--gold); }
    .big-number.red { color: var(--red); }

    .refrain {
      font-family: 'Cormorant Garamond', Georgia, serif;
      font-size: clamp(1.3rem, 3vw, 2rem);
      font-style: italic;
      color: var(--gold);
      text-align: center;
      max-width: 700px;
    }

    .content { display: flex; flex-direction: column; align-items: center; width: 100%; max-width: 850px; }

    /* Cards */
    .card {
      background: var(--light-cream);
      border: 1px solid var(--gold);
      padding: 1.25rem 1.5rem;
      margin: 0.5rem 0;
      max-width: 750px;
      width: 100%;
      border-radius: 8px;
    }
    .card.navy-bg { background: var(--navy); color: var(--cream); }
    .card.red-border { border: 2px solid var(--red); }
    .card.green-border { border: 2px solid var(--green); }
    .card-label {
      font-size: 0.7rem;
      font-weight: 700;
      color: var(--gold);
      letter-spacing: 0.05em;
      margin-bottom: 0.4rem;
      text-transform: uppercase;
    }
    .card-text { font-size: 0.95rem; line-height: 1.6; }
    .card.navy-bg .card-text { color: var(--cream); }

    /* Story box */
    .story-box {
      background: linear-gradient(135deg, rgba(197,48,48,0.15), rgba(30,39,97,0.2));
      border-left: 4px solid var(--red);
      padding: 1.25rem;
      margin: 0.75rem 0;
      max-width: 750px;
      width: 100%;
      border-radius: 0 8px 8px 0;
    }
    .story-box.success { background: linear-gradient(135deg, rgba(34,197,94,0.15), rgba(30,39,97,0.2)); border-left-color: var(--green); }
    .story-box.warning { background: linear-gradient(135deg, rgba(245,158,11,0.15), rgba(30,39,97,0.2)); border-left-color: var(--orange); }
    .story-label {
      font-size: 0.7rem;
      font-weight: 700;
      letter-spacing: 0.1em;
      color: var(--red);
      margin-bottom: 0.4rem;
      text-transform: uppercase;
    }
    .story-box.success .story-label { color: var(--green); }
    .story-box.warning .story-label { color: var(--orange); }
    .story-text { font-size: 0.95rem; line-height: 1.6; }

    /* Epic Story Box */
    .story-box.epic {
      background: linear-gradient(135deg, rgba(20,27,61,0.95), rgba(0,0,0,0.9));
      border-left: 4px solid var(--gold);
      border-top: 1px solid rgba(212,175,55,0.3);
      border-right: 1px solid rgba(212,175,55,0.2);
      border-bottom: 1px solid rgba(212,175,55,0.2);
      padding: 1.5rem;
      position: relative;
    }
    .story-box.epic::before {
      content: '';
      position: absolute;
      top: 0;
      left: 0;
      right: 0;
      height: 2px;
      background: linear-gradient(90deg, var(--gold), transparent);
    }
    .story-box.epic .story-label { color: var(--gold); font-size: 0.65rem; letter-spacing: 0.15em; }
    .story-box.epic .story-text { font-family: 'Cormorant Garamond', Georgia, serif; font-size: 1.05rem; line-height: 1.7; }
    .story-box.epic .story-moral {
      margin-top: 1rem;
      padding-top: 1rem;
      border-top: 1px solid rgba(212,175,55,0.2);
      font-style: italic;
      color: var(--gold);
      font-size: 0.95rem;
    }

    /* Stats */
    .stats-grid {
      display: flex;
      gap: 0.75rem;
      margin: 1rem 0;
      flex-wrap: wrap;
      justify-content: center;
    }
    .stat-box {
      background: var(--navy);
      color: var(--cream);
      padding: 1rem 1.25rem;
      text-align: center;
      min-width: 120px;
      border-radius: 8px;
    }
    .stat-box.light { background: var(--light-cream); color: var(--navy); border: 1px solid var(--gold); }
    .stat-value {
      font-family: 'Cormorant Garamond', serif;
      font-size: clamp(1.3rem, 2.5vw, 2rem);
      font-weight: 700;
    }
    .stat-value.gold { color: var(--gold); }
    .stat-value.red { color: var(--red); }
    .stat-label { font-size: 0.75rem; opacity: 0.8; margin-top: 0.2rem; }

    /* Timeline */
    .timeline { display: flex; flex-direction: column; gap: 0.4rem; width: 100%; max-width: 650px; }
    .timeline-item {
      display: flex;
      align-items: center;
      gap: 0.75rem;
      padding: 0.6rem 0.75rem;
      background: rgba(255,255,255,0.05);
      border-radius: 6px;
      border-left: 4px solid var(--gold);
    }
    .timeline-item.phase-a { border-left-color: var(--purple); }
    .timeline-item.phase-b { border-left-color: #3b82f6; }
    .timeline-item.phase-c { border-left-color: var(--orange); }
    .timeline-item.phase-d { border-left-color: var(--green); }
    .timeline-item.phase-e { border-left-color: var(--red); }
    .timeline-days { font-weight: 700; font-size: 0.8rem; min-width: 70px; color: var(--gold); }
    .timeline-content { flex: 1; }
    .timeline-title { font-weight: 600; font-size: 0.9rem; }
    .timeline-desc { font-size: 0.75rem; opacity: 0.7; }

    /* Checklist */
    .checklist { display: flex; flex-direction: column; gap: 0.4rem; width: 100%; max-width: 650px; }
    .checklist-item {
      display: flex;
      align-items: flex-start;
      gap: 0.6rem;
      padding: 0.6rem 0.75rem;
      background: rgba(255,255,255,0.05);
      border-radius: 6px;
      border: 1px solid rgba(255,255,255,0.1);
    }
    .check-icon {
      width: 22px;
      height: 22px;
      background: var(--gold);
      color: var(--navy);
      border-radius: 4px;
      display: flex;
      align-items: center;
      justify-content: center;
      font-weight: 700;
      font-size: 0.75rem;
      flex-shrink: 0;
    }
    .checklist-text { font-size: 0.9rem; line-height: 1.4; }

    /* Lessons */
    .lesson-item { display: flex; align-items: flex-start; gap: 0.75rem; margin: 0.5rem 0; max-width: 700px; }
    .lesson-number {
      background: var(--gold);
      color: var(--navy);
      width: 28px;
      height: 28px;
      border-radius: 50%;
      display: flex;
      align-items: center;
      justify-content: center;
      font-weight: 700;
      font-size: 0.85rem;
      flex-shrink: 0;
    }
    .lesson-content h4 { font-size: 1rem; font-weight: 700; margin-bottom: 0.2rem; }
    .lesson-content p { font-size: 0.85rem; opacity: 0.8; }

    /* ====== DECISION TREE ====== */
    .decision-tree {
      width: 100%;
      max-width: 700px;
      background: linear-gradient(135deg, rgba(124,58,237,0.15), rgba(30,39,97,0.25));
      border: 2px solid var(--purple);
      border-radius: 12px;
      padding: 1.5rem;
      margin: 0.75rem 0;
    }
    .decision-header {
      display: flex;
      align-items: center;
      gap: 0.75rem;
      margin-bottom: 1rem;
    }
    .decision-icon {
      width: 40px;
      height: 40px;
      background: var(--purple);
      border-radius: 50%;
      display: flex;
      align-items: center;
      justify-content: center;
      font-size: 1.25rem;
    }
    .decision-title {
      font-family: 'Cormorant Garamond', serif;
      font-size: 1.2rem;
      font-weight: 700;
    }
    .decision-xp {
      margin-left: auto;
      background: rgba(212,175,55,0.2);
      padding: 0.25rem 0.75rem;
      border-radius: 12px;
      font-size: 0.75rem;
      color: var(--gold);
      font-weight: 600;
    }
    .decision-scenario {
      background: rgba(0,0,0,0.2);
      padding: 1rem;
      border-radius: 8px;
      margin-bottom: 1rem;
      font-size: 0.95rem;
      line-height: 1.6;
    }
    .decision-question {
      font-weight: 600;
      color: var(--gold);
      margin-bottom: 0.75rem;
      font-size: 1rem;
    }
    .decision-options { display: flex; flex-direction: column; gap: 0.5rem; }
    .decision-option {
      display: flex;
      align-items: flex-start;
      gap: 0.75rem;
      padding: 0.75rem 1rem;
      background: rgba(255,255,255,0.05);
      border: 2px solid rgba(255,255,255,0.15);
      border-radius: 8px;
      cursor: pointer;
      transition: all 0.2s;
    }
    .decision-option:hover { background: rgba(124,58,237,0.2); border-color: var(--purple); }
    .decision-option.selected { background: rgba(124,58,237,0.3); border-color: var(--purple); }
    .decision-option.correct { background: rgba(34,197,94,0.2); border-color: var(--green); }
    .decision-option.incorrect { background: rgba(239,68,68,0.15); border-color: var(--red); }
    .decision-option.disabled { pointer-events: none; opacity: 0.7; }
    .option-letter {
      width: 24px;
      height: 24px;
      background: rgba(255,255,255,0.1);
      border-radius: 50%;
      display: flex;
      align-items: center;
      justify-content: center;
      font-weight: 700;
      font-size: 0.8rem;
      flex-shrink: 0;
    }
    .decision-option.correct .option-letter { background: var(--green); color: white; }
    .decision-option.incorrect .option-letter { background: var(--red); color: white; }
    .option-text { font-size: 0.9rem; }
    .decision-feedback {
      margin-top: 1rem;
      padding: 1rem;
      border-radius: 8px;
      display: none;
    }
    .decision-feedback.show { display: block; }
    .decision-feedback.correct { background: rgba(34,197,94,0.2); border: 1px solid var(--green); }
    .decision-feedback.incorrect { background: rgba(239,68,68,0.15); border: 1px solid var(--red); }
    .feedback-title { font-weight: 700; margin-bottom: 0.5rem; display: flex; align-items: center; gap: 0.5rem; }
    .feedback-text { font-size: 0.9rem; line-height: 1.5; }

    /* ====== PREDICTION ====== */
    .prediction-panel {
      width: 100%;
      max-width: 700px;
      background: linear-gradient(135deg, rgba(212,175,55,0.15), rgba(30,39,97,0.25));
      border: 2px solid var(--gold);
      border-radius: 12px;
      padding: 1.5rem;
      margin: 0.75rem 0;
      text-align: center;
    }
    .prediction-icon { font-size: 2.5rem; margin-bottom: 0.5rem; }
    .prediction-title {
      font-family: 'Cormorant Garamond', serif;
      font-size: 1.3rem;
      color: var(--gold);
      margin-bottom: 0.5rem;
    }
    .prediction-subtitle { font-size: 0.9rem; opacity: 0.8; margin-bottom: 1rem; }
    .prediction-buttons {
      display: flex;
      flex-direction: column;
      gap: 0.5rem;
    }
    .predict-btn {
      display: flex;
      align-items: center;
      justify-content: center;
      gap: 0.5rem;
      padding: 0.75rem 1rem;
      border: 2px solid;
      border-radius: 8px;
      font-size: 0.9rem;
      font-weight: 600;
      cursor: pointer;
      transition: all 0.2s;
      background: rgba(0,0,0,0.2);
    }
    .predict-btn.benefit { border-color: var(--green); color: var(--green); }
    .predict-btn.benefit:hover { background: rgba(34,197,94,0.2); }
    .predict-btn.neutral { border-color: var(--light-text); color: var(--light-text); }
    .predict-btn.neutral:hover { background: rgba(148,163,184,0.2); }
    .predict-btn.harm { border-color: var(--red); color: var(--red); }
    .predict-btn.harm:hover { background: rgba(239,68,68,0.2); }
    .predict-btn.selected { transform: scale(1.02); box-shadow: 0 0 15px rgba(255,255,255,0.1); }
    .prediction-result {
      margin-top: 1rem;
      padding: 0.75rem;
      border-radius: 8px;
      display: none;
    }
    .prediction-result.show { display: block; }
    .prediction-result.correct { background: rgba(34,197,94,0.2); border: 1px solid var(--green); }
    .prediction-result.incorrect { background: rgba(239,68,68,0.15); border: 1px solid var(--red); }

    /* ====== QUIZ ====== */
    .quiz-container { width: 100%; max-width: 650px; }
    .quiz-question {
      font-family: 'Cormorant Garamond', serif;
      font-size: 1.2rem;
      margin-bottom: 1.25rem;
      text-align: center;
    }
    .quiz-options { display: flex; flex-direction: column; gap: 0.5rem; }
    .quiz-option {
      padding: 0.75rem 1rem;
      background: rgba(255,255,255,0.05);
      border: 2px solid rgba(255,255,255,0.2);
      border-radius: 8px;
      cursor: pointer;
      transition: all 0.2s;
      text-align: left;
      font-size: 0.9rem;
    }
    .quiz-option:hover { background: rgba(212,175,55,0.15); border-color: var(--gold); }
    .quiz-option.correct { background: rgba(34,197,94,0.2); border-color: var(--green); }
    .quiz-option.incorrect { background: rgba(239,68,68,0.15); border-color: var(--red); }
    .quiz-option.disabled { pointer-events: none; }
    .quiz-feedback {
      margin-top: 1rem;
      padding: 1rem;
      border-radius: 8px;
      display: none;
      font-size: 0.9rem;
    }
    .quiz-feedback.show { display: block; }
    .quiz-feedback.correct { background: rgba(34,197,94,0.2); border: 1px solid var(--green); }
    .quiz-feedback.incorrect { background: rgba(239,68,68,0.15); border: 1px solid var(--red); }

    /* Crisis box */
    .crisis-box {
      background: linear-gradient(135deg, rgba(124,58,237,0.2), rgba(30,39,97,0.3));
      border: 2px solid var(--purple);
      border-radius: 12px;
      padding: 1.25rem;
      margin: 0.75rem 0;
      max-width: 750px;
      width: 100%;
    }
    .crisis-header { display: flex; align-items: center; gap: 0.75rem; margin-bottom: 0.75rem; }
    .crisis-number {
      width: 36px;
      height: 36px;
      background: var(--purple);
      color: white;
      border-radius: 50%;
      display: flex;
      align-items: center;
      justify-content: center;
      font-weight: 700;
      font-size: 1.1rem;
    }
    .crisis-title { font-family: 'Cormorant Garamond', serif; font-size: 1.15rem; font-weight: 700; }
    .crisis-day { font-size: 0.75rem; color: var(--purple); }

    /* Animation */
    .slide.active .animate { animation: fadeUp 0.5s ease-out forwards; }
    .slide.active .animate.delay-1 { animation-delay: 0.1s; }
    .slide.active .animate.delay-2 { animation-delay: 0.2s; }
    .slide.active .animate.delay-3 { animation-delay: 0.3s; }
    @keyframes fadeUp {
      from { opacity: 0; transform: translateY(15px); }
      to { opacity: 1; transform: translateY(0); }
    }
    .animate { opacity: 0; }

    /* XP Popup */
    .xp-popup {
      position: fixed;
      top: 50%;
      left: 50%;
      transform: translate(-50%, -50%) scale(0);
      background: linear-gradient(135deg, var(--gold), #f0c040);
      color: var(--navy);
      padding: 1.5rem 2.5rem;
      border-radius: 12px;
      font-family: 'Cormorant Garamond', serif;
      font-size: 2rem;
      font-weight: 700;
      z-index: 1000;
      box-shadow: 0 10px 40px rgba(0,0,0,0.5);
      transition: transform 0.3s ease;
    }
    .xp-popup.show { transform: translate(-50%, -50%) scale(1); }
    .xp-popup .xp-amount { font-size: 3rem; display: block; }

    /* Badge Earned Modal */
    .badge-modal {
      position: fixed;
      top: 0; left: 0; right: 0; bottom: 0;
      background: rgba(0,0,0,0.85);
      display: none;
      justify-content: center;
      align-items: center;
      z-index: 1001;
    }
    .badge-modal.show { display: flex; }
    .badge-modal-content {
      background: linear-gradient(135deg, var(--deep-navy), #0a0f1a);
      border: 2px solid var(--gold);
      border-radius: 16px;
      padding: 2rem;
      text-align: center;
      max-width: 350px;
    }
    .badge-modal-icon { font-size: 4rem; margin-bottom: 1rem; }
    .badge-modal-title {
      font-family: 'Cormorant Garamond', serif;
      font-size: 1.5rem;
      color: var(--gold);
      margin-bottom: 0.5rem;
    }
    .badge-modal-desc { font-size: 0.9rem; opacity: 0.8; margin-bottom: 1rem; }
    .badge-modal-close {
      padding: 0.5rem 1.5rem;
      background: var(--gold);
      color: var(--navy);
      border: none;
      border-radius: 6px;
      font-weight: 600;
      cursor: pointer;
    }

    /* Confetti - respects reduced motion */
    .confetti-container {
      position: fixed;
      top: 0; left: 0;
      width: 100%; height: 100%;
      pointer-events: none;
      z-index: 999;
      overflow: hidden;
    }
    .confetti {
      position: absolute;
      width: 10px; height: 10px;
      opacity: 0;
      animation: confetti-fall 3s ease-out forwards;
    }
    @keyframes confetti-fall {
      0% { transform: translateY(-100px) rotate(0deg); opacity: 1; }
      100% { transform: translateY(100vh) rotate(720deg); opacity: 0; }
    }
    @media (prefers-reduced-motion: reduce) {
      *, *::before, *::after {
        animation-duration: 0.01ms !important;
        animation-iteration-count: 1 !important;
        transition-duration: 0.01ms !important;
      }
      .confetti { display: none; }
    }

    /* Combo Counter */
    .combo-display {
      position: fixed;
      top: 80px;
      right: 20px;
      background: linear-gradient(135deg, var(--orange), #ef4444);
      color: white;
      padding: 0.5rem 1rem;
      border-radius: 20px;
      font-weight: 700;
      font-size: 0.9rem;
      z-index: 500;
      transform: scale(0);
      transition: transform 0.3s ease;
      box-shadow: 0 4px 15px rgba(239,68,68,0.4);
    }
    .combo-display.show { transform: scale(1); }
    .combo-display.big { transform: scale(1.2); }

    /* Key Takeaway Card */
    .takeaway-card {
      background: linear-gradient(135deg, rgba(34,197,94,0.15), rgba(30,39,97,0.2));
      border: 1px solid var(--green);
      border-radius: 8px;
      padding: 1rem 1.25rem;
      margin: 0.75rem 0;
      max-width: 700px;
      width: 100%;
    }
    .takeaway-card .takeaway-icon {
      display: inline-block;
      background: var(--green);
      color: white;
      width: 24px;
      height: 24px;
      border-radius: 50%;
      text-align: center;
      line-height: 24px;
      font-size: 0.8rem;
      margin-right: 0.5rem;
    }
    .takeaway-card .takeaway-label {
      font-size: 0.7rem;
      font-weight: 700;
      color: var(--green);
      text-transform: uppercase;
      letter-spacing: 0.05em;
      margin-bottom: 0.35rem;
    }
    .takeaway-card .takeaway-text {
      font-size: 0.9rem;
      line-height: 1.5;
      font-style: italic;
    }

    /* Module Time Estimate */
    .module-time {
      font-size: 0.55rem;
      color: rgba(255,255,255,0.4);
      display: flex;
      align-items: center;
      gap: 0.25rem;
      margin-top: 0.15rem;
    }

    /* Enhanced Focus States for Keyboard Navigation */
    .decision-option:focus-visible,
    .quiz-option:focus-visible,
    .predict-btn:focus-visible {
      outline: 3px solid var(--gold);
      outline-offset: 2px;
    }
    .nav-btn:focus-visible,
    .btn:focus-visible {
      outline: 3px solid var(--gold);
      outline-offset: 2px;
    }

    /* Progress within module */
    .slide-progress-bar {
      position: absolute;
      top: 0;
      left: 0;
      height: 3px;
      background: linear-gradient(90deg, var(--gold), var(--orange));
      transition: width 0.3s ease;
      z-index: 50;
    }

    /* Citation Link Style */
    .citation-link {
      font-size: 0.7rem;
      color: var(--gold);
      opacity: 0.7;
      text-decoration: none;
      display: inline-flex;
      align-items: center;
      gap: 0.25rem;
      margin-top: 0.5rem;
    }
    .citation-link:hover { opacity: 1; text-decoration: underline; }

    /* Mobile Sidebar Toggle */
    @media (max-width: 768px) {
      .sidebar {
        position: fixed;
        left: -300px;
        top: 0;
        bottom: 0;
        z-index: 1000;
        transition: left 0.3s ease;
      }
      .sidebar.open { left: 0; }
      .sidebar-toggle {
        display: flex;
        position: fixed;
        top: 10px;
        left: 10px;
        z-index: 1001;
        width: 40px;
        height: 40px;
        background: var(--gold);
        color: var(--navy);
        border: none;
        border-radius: 8px;
        align-items: center;
        justify-content: center;
        font-size: 1.2rem;
        cursor: pointer;
      }
      .sidebar-overlay {
        display: none;
        position: fixed;
        top: 0; left: 0; right: 0; bottom: 0;
        background: rgba(0,0,0,0.5);
        z-index: 999;
      }
      .sidebar-overlay.show { display: block; }
    }
    @media (min-width: 769px) {
      .sidebar-toggle { display: none; }
      .sidebar-overlay { display: none !important; }
    }

    /* Nav */
    .slide-nav {
      position: absolute;
      bottom: 0; left: 0; right: 0;
      display: flex;
      justify-content: space-between;
      align-items: flex-end;
      padding: 0.75rem 1rem 1.25rem;
      z-index: 100;
      pointer-events: none;
    }
    .nav-btn {
      background: rgba(0,0,0,0.5);
      border: 1px solid rgba(255,255,255,0.2);
      color: white;
      font-size: 1.1rem;
      cursor: pointer;
      opacity: 0.6;
      transition: all 0.2s;
      padding: 0.4rem 0.6rem;
      border-radius: 6px;
      pointer-events: auto;
    }
    .nav-btn:hover { opacity: 1; background: rgba(0,0,0,0.7); border-color: var(--gold); }
    .nav-btn:disabled { opacity: 0.2; cursor: not-allowed; }
    .nav-center { display: flex; flex-direction: column; align-items: center; gap: 0.2rem; pointer-events: auto; }
    .slide-counter { font-size: 0.7rem; opacity: 0.5; }
    .progress-dots { display: flex; gap: 3px; flex-wrap: wrap; max-width: 220px; }
    .progress-dot {
      width: 44px;
      height: 44px;
      display: flex;
      align-items: center;
      justify-content: center;
      cursor: pointer;
      background: none;
      border: none;
      padding: 0;
    }
    .progress-dot::after {
      content: '';
      width: 12px;
      height: 12px;
      border-radius: 50%;
      background: var(--text-muted, rgba(255,255,255,0.25));
      transition: all 0.2s ease;
    }
    .progress-dot.active::after,
    .progress-dot.completed::after {
      background: var(--gold);
      width: 14px;
      height: 14px;
    }

    /* Course Progress Bar */
    .course-progress {
      padding: 0.75rem 1rem;
      border-bottom: 1px solid rgba(212,175,55,0.2);
      background: rgba(0,0,0,0.2);
    }
    .course-progress-label {
      display: flex;
      justify-content: space-between;
      font-size: 0.7rem;
      color: rgba(255,255,255,0.6);
      margin-bottom: 0.35rem;
    }
    .course-progress-bar {
      height: 6px;
      background: rgba(255,255,255,0.1);
      border-radius: 3px;
      overflow: hidden;
    }
    .course-progress-fill {
      height: 100%;
      background: linear-gradient(90deg, var(--green), #22d3ee);
      border-radius: 3px;
      transition: width 0.5s ease;
    }

    /* Learning Objectives */
    .objectives-box {
      background: linear-gradient(135deg, rgba(59,130,246,0.15), rgba(30,39,97,0.25));
      border: 2px solid #3b82f6;
      border-radius: 12px;
      padding: 1.25rem;
      margin: 0.75rem 0;
      max-width: 700px;
      width: 100%;
    }
    .objectives-header {
      display: flex;
      align-items: center;
      gap: 0.75rem;
      margin-bottom: 0.75rem;
    }
    .objectives-icon {
      width: 36px;
      height: 36px;
      background: #3b82f6;
      border-radius: 50%;
      display: flex;
      align-items: center;
      justify-content: center;
      font-size: 1.1rem;
    }
    .objectives-title {
      font-family: 'Cormorant Garamond', serif;
      font-size: 1.1rem;
      font-weight: 700;
      color: #60a5fa;
    }
    .objectives-list {
      list-style: none;
      padding: 0;
    }
    .objectives-list li {
      display: flex;
      align-items: flex-start;
      gap: 0.5rem;
      padding: 0.4rem 0;
      font-size: 0.9rem;
    }
    .objectives-list li::before {
      content: '‚óã';
      color: #3b82f6;
      font-weight: bold;
    }
    .objectives-list li.completed::before {
      content: '‚óè';
      color: var(--green);
    }

    /* Module Summary */
    .summary-box {
      background: linear-gradient(135deg, rgba(34,197,94,0.15), rgba(30,39,97,0.25));
      border: 2px solid var(--green);
      border-radius: 12px;
      padding: 1.5rem;
      margin: 0.75rem 0;
      max-width: 700px;
      width: 100%;
      text-align: center;
    }
    .summary-icon { font-size: 2.5rem; margin-bottom: 0.5rem; }
    .summary-title {
      font-family: 'Cormorant Garamond', serif;
      font-size: 1.4rem;
      color: var(--green);
      margin-bottom: 0.5rem;
    }
    .summary-stats {
      display: flex;
      justify-content: center;
      gap: 1.5rem;
      margin: 1rem 0;
    }
    .summary-stat {
      text-align: center;
    }
    .summary-stat-value {
      font-size: 1.5rem;
      font-weight: 700;
      color: var(--gold);
    }
    .summary-stat-label {
      font-size: 0.75rem;
      opacity: 0.7;
    }
    .summary-next {
      margin-top: 1rem;
      padding: 0.75rem 1.5rem;
      background: var(--green);
      color: white;
      border: none;
      border-radius: 8px;
      font-weight: 600;
      cursor: pointer;
      transition: all 0.2s;
    }
    .summary-next:hover { transform: scale(1.05); }

    /* Badge Progress Tooltip */
    .badge-progress {
      font-size: 0.55rem;
      color: rgba(255,255,255,0.4);
      position: absolute;
      bottom: -2px;
      right: -2px;
      background: var(--deep-navy);
      padding: 0 3px;
      border-radius: 3px;
    }
    .badge-item { position: relative; }

    /* Glossary Panel */
    .glossary-toggle {
      position: fixed;
      bottom: 1.5rem;
      right: 1.5rem;
      width: 50px;
      height: 50px;
      background: var(--gold);
      color: var(--navy);
      border: none;
      border-radius: 50%;
      font-size: 1.3rem;
      cursor: pointer;
      box-shadow: 0 4px 15px rgba(0,0,0,0.3);
      z-index: 500;
      transition: all 0.2s;
    }
    .glossary-toggle:hover { transform: scale(1.1); }
    .glossary-panel {
      position: fixed;
      bottom: 0;
      right: 0;
      width: 350px;
      max-height: 70vh;
      background: var(--deep-navy);
      border: 1px solid var(--gold);
      border-radius: 12px 0 0 0;
      transform: translateY(100%);
      transition: transform 0.3s ease;
      z-index: 501;
      display: flex;
      flex-direction: column;
    }
    .glossary-panel.open { transform: translateY(0); }
    .glossary-header {
      padding: 1rem;
      border-bottom: 1px solid rgba(212,175,55,0.2);
      display: flex;
      justify-content: space-between;
      align-items: center;
    }
    .glossary-header h3 {
      font-family: 'Cormorant Garamond', serif;
      color: var(--gold);
      margin: 0;
    }
    .glossary-close {
      background: none;
      border: none;
      color: var(--cream);
      font-size: 1.2rem;
      cursor: pointer;
    }
    .glossary-content {
      flex: 1;
      overflow-y: auto;
      padding: 1rem;
    }
    .glossary-item {
      margin-bottom: 1rem;
      padding-bottom: 1rem;
      border-bottom: 1px solid rgba(255,255,255,0.1);
    }
    .glossary-term {
      font-weight: 700;
      color: var(--gold);
      font-size: 0.9rem;
    }
    .glossary-def {
      font-size: 0.8rem;
      color: rgba(255,255,255,0.8);
      margin-top: 0.25rem;
    }

    /* Streak Warning */
    .streak-warning {
      background: rgba(239,68,68,0.2);
      border: 1px solid var(--red);
      color: var(--red);
      animation: pulse-warning 2s infinite;
    }
    @keyframes pulse-warning {
      0%, 100% { opacity: 1; }
      50% { opacity: 0.6; }
    }

    /* Perfect Module Bonus */
    .perfect-bonus {
      background: linear-gradient(135deg, var(--gold), #fbbf24);
      color: var(--navy);
      padding: 0.5rem 1rem;
      border-radius: 20px;
      font-weight: 700;
      display: inline-flex;
      align-items: center;
      gap: 0.5rem;
      margin-top: 0.5rem;
      animation: shine 2s infinite;
    }
    @keyframes shine {
      0%, 100% { box-shadow: 0 0 10px rgba(212,175,55,0.5); }
      50% { box-shadow: 0 0 20px rgba(212,175,55,0.8); }
    }

    /* Focus States for Accessibility */
    .decision-option:focus,
    .quiz-option:focus,
    .predict-btn:focus,
    .btn:focus,
    .nav-btn:focus {
      outline: 2px solid var(--gold);
      outline-offset: 2px;
    }

    /* Print Stylesheet */
    @media print {
      .sidebar, .slide-nav, .stats-panel, .badges-panel, .glossary-toggle, .glossary-panel, .header-actions { display: none !important; }
      .main-content { width: 100%; }
      .slide { position: relative !important; page-break-inside: avoid; padding: 1rem; }
      .slide.active, .slide { opacity: 1 !important; visibility: visible !important; display: block !important; }
      .module-slides { display: block !important; }
    }

    /* Responsive */
    @media (max-width: 900px) {
      .sidebar { width: 70px; }
      .sidebar-header h1, .sidebar-header p, .module-title, .module-subtitle, .module-xp,
      .stats-panel, .badges-panel, .course-progress { display: none; }
      .module-item { padding: 0.6rem; justify-content: center; }
      .glossary-panel { width: 100%; border-radius: 12px 12px 0 0; }
      .progress-dot { width: 44px; height: 44px; }
      .progress-dot::after { width: 8px; height: 8px; }
      .progress-dot.active::after,
      .progress-dot.completed::after { width: 10px; height: 10px; }
    }

    /* Touch feedback */
    @media (hover: none) {
      .decision-option:active { background: rgba(124,58,237,0.3); }
      .quiz-option:active { background: rgba(212,175,55,0.2); }
    }

    /* Reduced motion support */
    @media (prefers-reduced-motion: reduce) {
      *, *::before, *::after {
        animation-duration: 0.01ms !important;
        animation-iteration-count: 1 !important;
        transition-duration: 0.01ms !important;
      }
      .confetti { display: none; }
    }

    /* Skip to content link */
    .skip-link {
      position: absolute;
      top: -40px;
      left: 0;
      background: var(--gold);
      color: var(--navy);
      padding: 0.5rem 1rem;
      z-index: 10000;
      font-weight: 600;
      text-decoration: none;
      border-radius: 0 0 8px 0;
    }
    .skip-link:focus {
      top: 0;
    }

    /* Course completion modal */
    .completion-modal {
      position: fixed;
      top: 0; left: 0; right: 0; bottom: 0;
      background: rgba(0,0,0,0.95);
      display: none;
      justify-content: center;
      align-items: center;
      z-index: 1002;
    }
    .completion-modal.show { display: flex; }
    .completion-content {
      background: linear-gradient(135deg, var(--deep-navy), #0a0f1a);
      border: 3px solid var(--gold);
      border-radius: 20px;
      padding: 2.5rem;
      text-align: center;
      max-width: 450px;
      animation: completion-pop 0.5s ease;
    }
    @keyframes completion-pop {
      0% { transform: scale(0.5); opacity: 0; }
      50% { transform: scale(1.05); }
      100% { transform: scale(1); opacity: 1; }
    }
    .completion-trophy { font-size: 5rem; margin-bottom: 1rem; }
    .completion-title {
      font-family: 'Cormorant Garamond', serif;
      font-size: 2rem;
      color: var(--gold);
      margin-bottom: 0.5rem;
    }
    .completion-subtitle { font-size: 1rem; opacity: 0.8; margin-bottom: 1.5rem; }
    .completion-stats {
      display: flex;
      justify-content: center;
      gap: 1.5rem;
      margin-bottom: 1.5rem;
    }
    .completion-stat { text-align: center; }
    .completion-stat-value {
      font-size: 1.8rem;
      font-weight: 700;
      color: var(--gold);
    }
    .completion-stat-label { font-size: 0.75rem; opacity: 0.7; }
    .completion-close {
      padding: 0.75rem 2rem;
      background: var(--gold);
      color: var(--navy);
      border: none;
      border-radius: 8px;
      font-weight: 700;
      font-size: 1rem;
      cursor: pointer;
    }

    /* Review mistakes button */
    .review-mistakes-btn {
      position: fixed;
      bottom: 1.5rem;
      left: 1.5rem;
      padding: 0.6rem 1rem;
      background: rgba(239,68,68,0.2);
      border: 1px solid var(--red);
      color: var(--red);
      border-radius: 8px;
      font-size: 0.8rem;
      cursor: pointer;
      z-index: 500;
      display: none;
    }
    .review-mistakes-btn.show { display: block; }
    .review-mistakes-btn:hover { background: rgba(239,68,68,0.3); }

    /* Review panel */
    .review-panel {
      position: fixed;
      top: 0; left: 0; right: 0; bottom: 0;
      background: rgba(0,0,0,0.9);
      display: none;
      z-index: 1003;
      overflow-y: auto;
      padding: 2rem;
    }
    .review-panel.show { display: block; }
    .review-header {
      display: flex;
      justify-content: space-between;
      align-items: center;
      margin-bottom: 1.5rem;
      max-width: 700px;
      margin-left: auto;
      margin-right: auto;
    }
    .review-title {
      font-family: 'Cormorant Garamond', serif;
      font-size: 1.5rem;
      color: var(--red);
    }
    .review-close {
      background: none;
      border: 1px solid var(--cream);
      color: var(--cream);
      padding: 0.5rem 1rem;
      border-radius: 6px;
      cursor: pointer;
    }
    .review-item {
      background: rgba(255,255,255,0.05);
      border: 1px solid rgba(239,68,68,0.3);
      border-radius: 12px;
      padding: 1.25rem;
      margin-bottom: 1rem;
      max-width: 700px;
      margin-left: auto;
      margin-right: auto;
    }
    .review-module { font-size: 0.75rem; color: var(--gold); margin-bottom: 0.5rem; }
    .review-question { font-weight: 600; margin-bottom: 0.75rem; }
    .review-your-answer { color: var(--red); font-size: 0.9rem; margin-bottom: 0.5rem; }
    .review-correct-answer { color: var(--green); font-size: 0.9rem; margin-bottom: 0.75rem; }
    .review-explanation { font-size: 0.85rem; opacity: 0.8; padding: 0.75rem; background: rgba(0,0,0,0.2); border-radius: 6px; }
  </style>
</head>
<body>
<a class="skip-link" href="#main-content">Skip to content</a>
<div class="course-container">
<!-- SIDEBAR -->
<nav aria-label="ÏΩîÏä§ ÌÉêÏÉâ" class="sidebar">
<div class="sidebar-header">
<a href="index.html" onmouseout="this.style.color='rgba(212,175,55,0.7)'" onmouseover="this.style.color='#D4AF37'" style="display:block;font-size:0.7rem;color:rgba(212,175,55,0.7);text-decoration:none;margin-bottom:0.5rem;">‚Üê Course Library</a>
<h1>META-SPRINT</h1>
<p>40Ïùº ÎßåÏóê Ïã†Î¢∞Ìï† Ïàò ÏûàÎäî Ï¶ùÍ±∞ ÌôïÎ≥¥</p>
</div>
<!-- Course Progress -->
<div class="course-progress">
<div class="course-progress-label">
<span>Course Progress</span>
<span id="courseProgressPct">0%</span>
</div>
<div class="course-progress-bar">
<div class="course-progress-fill" id="courseProgressFill" style="width: 0%"></div>
</div>
</div>
<!-- Gamification Stats -->
<div class="stats-panel">
<div class="level-display">
<div aria-label="Level icon" class="level-badge" id="levelIcon" role="img">üìä</div>
<div class="level-info">
<div class="level-title" id="levelTitle">Novice Analyst</div>
<div class="level-subtitle">Level <span id="levelNum">1</span></div>
</div>
</div>
<div aria-label="XP progress" class="xp-bar" role="progressbar">
<div class="xp-fill" id="xpFill" style="width: 0%"></div>
</div>
<div class="xp-text"><span id="xpCurrent">0</span> / <span id="xpNeeded">100</span> XP</div>
<div class="quick-stats">
<div class="quick-stat">
<div class="quick-stat-value" id="correctCount">0</div>
<div class="quick-stat-label">Correct</div>
</div>
<div class="quick-stat">
<div class="quick-stat-value" id="decisionCount">0</div>
<div class="quick-stat-label">Decisions</div>
</div>
<div class="quick-stat">
<div class="quick-stat-value" id="predictCount">0</div>
<div class="quick-stat-label">Predictions</div>
</div>
</div>
</div>
<div class="module-list" id="moduleList" role="list"></div>
<!-- Badges -->
<div class="badges-panel">
<div class="badges-title">Achievements</div>
<div class="badges-grid" id="badgesGrid"></div>
</div>
</nav>
<!-- MAIN -->
<div class="main-content">
<div class="content-header">
<div class="breadcrumb">META-SPRINT / <span id="currentModule">Introduction</span></div>
<div class="header-actions">
<div class="streak-display" id="streakDisplay">
<span class="streak-flame">üî•</span>
<span class="streak-count" id="streakCount">0</span>
<span style="font-size:0.7rem;opacity:0.7">streak</span>
</div>
<button class="btn" onclick="resetProgress()">Reset</button>
<button class="btn primary" onclick="nextSlide()">Continue ‚Üí</button>
</div>
</div>
<div class="content-body">
<div class="slides-container" id="main-content"></div>
</div>
</div>
</div>
<!-- XP Popup -->
<div class="xp-popup" id="xpPopup">
<span class="xp-amount" id="xpAmount">+25</span>
    XP
  </div>
<!-- Badge Modal -->
<div aria-labelledby="badgeModalTitle" aria-modal="true" class="badge-modal" id="badgeModal" role="dialog">
<div class="badge-modal-content">
<div class="badge-modal-icon" id="badgeModalIcon">üèÜ</div>
<div class="badge-modal-title" id="badgeModalTitle">Badge Earned!</div>
<div class="badge-modal-desc" id="badgeModalDesc">ÏÉàÎ°úÏö¥ ÏóÖÏ†ÅÏùÑ Îã¨ÏÑ±ÌïòÏÖ®ÏäµÎãàÎã§.</div>
<button class="badge-modal-close" onclick="closeBadgeModal()">Awesome!</button>
</div>
</div>
<!-- Confetti Container -->
<div class="confetti-container" id="confettiContainer"></div>
<!-- Combo Counter -->
<div class="combo-display" id="comboDisplay">üî• <span id="comboCount">0</span>x Combo!</div>
<!-- Mobile Sidebar Toggle -->
<button aria-expanded="false" aria-label="Toggle menu" class="sidebar-toggle" onclick="toggleSidebar()">‚ò∞</button>
<div class="sidebar-overlay" id="sidebarOverlay" onclick="toggleSidebar()"></div>
<!-- Glossary Toggle -->
<button aria-label="Open glossary" class="glossary-toggle" onclick="toggleGlossary()" title="Quick Reference">üìñ</button>
<!-- Glossary Panel -->
<div aria-label="Glossary" class="glossary-panel" id="glossaryPanel" role="dialog">
<div class="glossary-header">
<h3>Quick Reference</h3>
<button aria-label="Close glossary" class="glossary-close" onclick="toggleGlossary()">√ó</button>
</div>
<div class="glossary-content">
<div class="glossary-item">
<div class="glossary-term">DoD (Definition of Done)</div>
<div class="glossary-def">Binary gate checklist. All items must pass before proceeding to next phase.</div>
</div>
<div class="glossary-item">
<div class="glossary-term">PICOS</div>
<div class="glossary-def">Ïù∏Íµ¨, Í∞úÏûÖ, ÎπÑÍµê, Í≤∞Í≥º, Ïó∞Íµ¨ ÏÑ§Í≥Ñ - Ïó∞Íµ¨ ÏßàÎ¨∏ÏùÑ ÏúÑÌïú ÌîÑÎ†àÏûÑÏõåÌÅ¨.</div>
</div>
<div class="glossary-item">
<div class="glossary-term">Provenance</div>
<div class="glossary-def">Ïà´ÏûêÍ∞Ä Ïñ¥ÎîîÏóêÏÑú ÏôîÎäîÏßÄ Ï†ïÌôïÌïòÍ≤å Î≥¥Ïó¨Ï£ºÎäî Í∞êÏÇ¨ Ï∂îÏ†Å(Ïòà: "Ìëú 2, p.1234").</div>
</div>
<div class="glossary-item">
<div class="glossary-term">Red-Team</div>
<div class="glossary-def">Daily adversarial checking by 2 rotating members to catch errors in extraction.</div>
</div>
<div class="glossary-item">
<div class="glossary-term">CondGO</div>
<div class="glossary-def">Emergency protocol: 72 hours to fix a failed DoD gate or terminate with documented reasons.</div>
</div>
<div class="glossary-item">
<div class="glossary-term">Surrogate Outcome</div>
<div class="glossary-def">A measurable marker (e.g., cholesterol) used as proxy for patient-important outcomes (e.g., death).</div>
</div>
<div class="glossary-item">
<div class="glossary-term">FREEZE (Day 34)</div>
<div class="glossary-def">Î≤îÏúÑ Ïû†Í∏à - Ïù¥ ÏãúÏ†ê Ïù¥ÌõÑÏóêÎäî ÏÉàÎ°úÏö¥ Ïó∞Íµ¨Î•º Ï∂îÍ∞ÄÌï† Ïàò ÏóÜÏäµÎãàÎã§.</div>
</div>
<div class="glossary-item">
<div class="glossary-term">I¬≤ (I-squared)</div>
<div class="glossary-def">Heterogeneity statistic. Low &lt;30%, Moderate 30-60%, High &gt;60%.</div>
</div>
<div class="glossary-item">
<div class="glossary-term">Analysis Capsule</div>
<div class="glossary-def">ÏôÑÏ†ÑÌûà Ïû¨ÌòÑ Í∞ÄÎä•Ìïú Ìå®ÌÇ§ÏßÄ: ÏΩîÎìú, Îç∞Ïù¥ÌÑ∞, ÏßÄÏπ®. ÎàÑÍµ¨ÎÇò Ïã§ÌñâÌïòÍ≥† ÎèôÏùºÌïú Í≤∞Í≥ºÎ•º ÏñªÏùÑ Ïàò ÏûàÏäµÎãàÎã§.</div>
</div>
<div class="glossary-item">
<div class="glossary-term">Consult Pack</div>
<div class="glossary-def">ÌåÄ ÏùòÏÇ¨ Í≤∞Ï†ïÏùÑ ÏúÑÌïú ÏòµÏÖò, Ï¶ùÍ±∞ Î∞è Ïû•Îã®Ï†êÏù¥ Ìè¨Ìï®Îêú Íµ¨Ï°∞ÌôîÎêú Î¨∏ÏÑúÏûÖÎãàÎã§.</div>
</div>
<div class="glossary-item">
<div class="glossary-term">PROSPERO</div>
<div class="glossary-def">Ï≤¥Í≥ÑÏ†ÅÏù∏ Í≤ÄÌÜ† ÌîÑÎ°úÌÜ†ÏΩúÏùÑ ÏúÑÌïú Íµ≠Ï†ú Îì±Î°ùÏÜåÏûÖÎãàÎã§. ÎØ∏Î¶¨ ÏßÄÏ†ïÎêú Î∞©Î≤ïÏùò ÌÉÄÏûÑÏä§ÌÉ¨ÌîÑÎ•º Í∏∞Î°ùÌï©ÎãàÎã§.</div>
</div>
<div class="glossary-item">
<div class="glossary-term">PRISMA</div>
<div class="glossary-def">Ï≤¥Í≥ÑÏ†ÅÏù∏ Í≤ÄÌÜ†Î•º ÏúÑÌïú Î≥¥Í≥† ÏßÄÏπ®ÏûÖÎãàÎã§. Ïó∞Íµ¨ ÏÑ†ÌÉùÏùÑ Î≥¥Ïó¨Ï£ºÎäî ÌùêÎ¶ÑÎèÑÍ∞Ä Ìè¨Ìï®ÎêòÏñ¥ ÏûàÏäµÎãàÎã§.</div>
</div>
</div>
</div>
 Í≥ºÏ†ï ÏôÑÎ£å Î™®Îã¨ 
<div aria-label="Í≥ºÏ†ï ÏôÑÎ£å" class="completion-modal" id="completionModal" role="dialog">
<div class="completion-content">
<div class="completion-trophy">üèÜ</div>
<div class="completion-title">Course Complete!</div>
<div class="completion-subtitle">You've mastered the META-SPRINT methodology</div>
<div class="completion-stats">
<div class="completion-stat">
<div class="completion-stat-value" id="finalXP">0</div>
<div class="completion-stat-label">Total XP</div>
</div>
<div class="completion-stat">
<div class="completion-stat-value" id="finalCorrect">0</div>
<div class="completion-stat-label">Correct Answers</div>
</div>
<div class="completion-stat">
<div class="completion-stat-value" id="finalBadges">0</div>
<div class="completion-stat-label">Badges Earned</div>
</div>
</div>
<p style="font-size:0.9rem;opacity:0.7;margin-bottom:1rem">ÏßÑÌñâÌïòÍ≥† Ïã†Î¢∞Ìï† Ïàò ÏûàÎäî Ï¶ùÍ±∞Î•º ÏÉùÏÑ±ÌïòÏÑ∏Ïöî!</p>
<div class="completion-actions" style="display: flex; gap: 0.5rem; justify-content: center; flex-wrap: wrap;">
<button class="btn primary" onclick="downloadCertificate()">Download Certificate</button>
<button class="completion-close" onclick="closeCompletionModal()">Continue</button>
</div>
</div>
</div>
 Ïã§Ïàò Í≤ÄÌÜ† Î≤ÑÌäº 
<button aria-label="Ïò§Îãµ Í≤ÄÌÜ†" class="review-mistakes-btn" id="reviewMistakesBtn" onclick="showReviewPanel()">
    üìù Review Mistakes
  </button>
<!-- Review Panel -->
<div aria-label="Ïò§Îãµ Í≤ÄÌÜ†" class="review-panel" id="reviewPanel" role="dialog">
<div class="review-header">
<div class="review-title">üìù Ïã§Ïàò Í≤ÄÌÜ†</div>
<button class="review-close" onclick="closeReviewPanel()">Close</button>
</div>
<div id="reviewContent"></div>
</div>
<script>
// ===== GAMIFICATION STATE =====
const DEFAULT_STATE = {
  xp: 0,
  level: 1,
  streak: 0,
  lastActive: null,
  correctAnswers: 0,
  decisionsCompleted: 0,
  predictionsCorrect: 0,
  predictionsTotal: 0,
  badges: [],
  completedModules: [],
  perfectModules: [],
  answeredQuestions: {},
  consecutiveCorrect: 0
};

// Safe localStorage with fallback
function safeGetStorage(key, fallback) {
  try {
    const item = localStorage.getItem(key);
    return item ? JSON.parse(item) : fallback;
  } catch (e) {
    console.warn('localStorage unavailable, using session storage');
    return fallback;
  }
}

function safeSetStorage(key, value) {
  try {
    localStorage.setItem(key, JSON.stringify(value));
  } catch (e) {
    console.warn('Could not save to localStorage');
  }
}

// Migration from old storage key to versioned key
(function migrateStorage() {
  try {
    const oldData = localStorage.getItem('metasprintGame');
    if (oldData && !localStorage.getItem('metasprintGame_v1')) {
      localStorage.setItem('metasprintGame_v1', oldData);
      localStorage.removeItem('metasprintGame');
    }
  } catch (e) {}
})();

let gameState = safeGetStorage('metasprintGame_v1', DEFAULT_STATE);

const LEVELS = [
  { level: 1, title: "Novice Analyst", icon: "üìä", xp: 0 },
  { level: 2, title: "Protocol Apprentice", icon: "üìã", xp: 100 },
  { level: 3, title: "Search Specialist", icon: "üîç", xp: 250 },
  { level: 4, title: "Extraction Expert", icon: "üìù", xp: 450 },
  { level: 5, title: "Analysis Adept", icon: "üìà", xp: 700 },
  { level: 6, title: "Quality Guardian", icon: "üõ°Ô∏è", xp: 1000 },
  { level: 7, title: "Evidence Master", icon: "üèÜ", xp: 1400 },
  { level: 8, title: "Meta-Analysis Sage", icon: "üëë", xp: 1900 }
];

const BADGES = [
  { id: "first_blood", icon: "üéØ", name: "First Blood", desc: "Ï≤´ Î≤àÏß∏ ÏßàÎ¨∏Ïóê Ïò¨Î∞îÎ•¥Í≤å ÎãµÌïòÏÑ∏Ïöî" },
  { id: "perfect_5", icon: "‚≠ê", name: "Five Star", desc: "Get 5 correct answers in a row" },
  { id: "decision_maker", icon: "‚öñÔ∏è", name: "Decision Maker", desc: "10Í∞úÏùò ÏùòÏÇ¨Í≤∞Ï†ï Ìä∏Î¶¨ ÏôÑÎ£å" },
  { id: "oracle", icon: "üîÆ", name: "The Oracle", desc: "Predict 5 outcomes correctly" },
  { id: "protocol_pro", icon: "üìã", name: "Protocol Pro", desc: "AÎã®Í≥Ñ Î™®Îìà ÏôÑÎ£å" },
  { id: "search_savant", icon: "üîç", name: "Search Savant", desc: "BÎã®Í≥Ñ Î™®Îìà ÏôÑÎ£å" },
  { id: "data_detective", icon: "üïµÔ∏è", name: "Data Detective", desc: "CÎã®Í≥Ñ Î™®Îìà ÏôÑÎ£å" },
  { id: "stats_wizard", icon: "üßô", name: "Stats Wizard", desc: "DÎã®Í≥Ñ ÏôÑÎ£å Î™®Îìà" },
  { id: "finisher", icon: "üèÅ", name: "Finisher", desc: "Ï†ÑÏ≤¥ Í≥ºÏ†ï ÏôÑÎ£å" },
  { id: "streak_3", icon: "üî•", name: "On Fire", desc: "Maintain a 3-day streak" },
  { id: "streak_7", icon: "üí´", name: "Weekly Warrior", desc: "Maintain a 7-day streak" },
  { id: "colchicine_hero", icon: "üíä", name: "Colchicine Hero", desc: "ÏÇ¨Î°Ä Ïó∞Íµ¨ ÏôÑÎ£å" }
];

// ===== MODULES DATA =====
const MODULES = [
  {
    id: 1, title: "Why META-SPRINT?", subtitle: "ÏûòÎ™ªÎêú Ï¶ùÍ±∞Ïùò ÎπÑÏö©", xp: 150,
    slides: [
      { type: "title", theme: "dark", content: { title: "Why META-SPRINT?", subtitle: "ÏûòÎ™ªÎêú Ï¶ùÍ±∞Ïùò ÎπÑÏö©" }},
      { type: "objectives", theme: "dark", content: {
        objectives: [
          "Understand why bad evidence causes real harm",
          "CAST ÎπÑÍ∑πÍ≥º PoldermansÎ°úÎ∂ÄÌÑ∞ Î∞∞Ïö∞Í∏∞ ÏÇ¨Í∏∞",
          "Recognize surrogate outcome traps",
          "Understand what provenance verification means"
        ],
        tip: "Ïù¥ Î™®ÎìàÏùÄ Ïù¥ÌõÑÏùò Î™®Îì† Í≤ÉÏóê ÎåÄÌïú Î¨¥ÎåÄÎ•º ÏÑ§Ï†ïÌï©ÎãàÎã§."
      }},
      { type: "prediction", theme: "dark", content: {
        icon: "üîÆ", title: "ÏòàÏ∏°",
        subtitle: "1980ÎÖÑÎåÄÏóêÎäî Ïã¨Ïû•ÎßàÎπÑ ÌõÑ Î∂àÍ∑úÏπôÌïú Ïã¨Ïû• Î∞ïÎèô(PVC)ÏùÑ ÏñµÏ†úÌïòÍ∏∞ ÏúÑÌïú ÏïΩÎ¨ºÏù¥ Í∞úÎ∞úÎêòÏóàÏäµÎãàÎã§. ÏïΩÎ¨ºÏùÄ ECG ÌåêÎèÖÍ∞íÏùÑ ÏÑ±Í≥µÏ†ÅÏúºÎ°ú ÏàòÏ†ïÌñàÏäµÎãàÎã§. ÏÇ¨ÎßùÎ•†Ïù¥ Ïñ¥ÎñªÍ≤å ÎêòÏóàÎã§Í≥† ÏÉùÍ∞ÅÌïòÏãúÎÇòÏöî?",
        options: [
          { id: "benefit", label: "üíö Deaths decreased", text: "ÏïΩÎ¨ºÏù¥ ÏÉùÎ™ÖÏùÑ Íµ¨ÌñàÏäµÎãàÎã§" },
          { id: "neutral", label: "‚ö™ No change", text: "ÏÇ¨ÎßùÎ•†ÏùÄ Î≥ÄÌï®Ïù¥ ÏóÜÏäµÎãàÎã§" },
          { id: "harm", label: "‚ù§Ô∏è Deaths increased", text: "ÏïΩÎ¨ºÏù¥ Ìï¥Î•º ÏûÖÌòîÏäµÎãàÎã§" }
        ],
        answer: "harm",
        xp: 30
      }},
      { type: "story", theme: "red-bg", content: {
        label: "CAST ÎπÑÍ∑π", title: "50,000 Deaths",
        text: "The drugs that 'fixed' the ECG <strong>tripled</strong> death rates. 50,000 Americans died from drugs that made their monitors look better.",
        followup: "Suppressing PVCs was a surrogate outcome‚Äîit looked like benefit but masked real harm."
      }},
      { type: "decision", theme: "dark", content: {
        icon: "üìä", title: "ÏãúÎÇòÎ¶¨Ïò§: Ïù∏ÏÉÅÏ†Å Numbers",
        xp: 25,
        scenario: "ÏÉàÎ°úÏö¥ ÎãπÎá®Î≥ë ÏπòÎ£åÏ†úÎäî ÌëúÏ§Ä ÏπòÎ£åÎ≤ïÎ≥¥Îã§ HbA1c(ÌòàÎãπ ÏßÄÌëú)Î•º 40% Îçî Í∞êÏÜåÏãúÌÇ§Îäî Í≤ÉÏúºÎ°ú ÎÇòÌÉÄÎÇ¨ÏäµÎãàÎã§. Ï†úÏ°∞ÏóÖÏ≤¥Îäî Ïù¥ 'Ïù∏ÏÉÅÏ†ÅÏù∏ Ìö®Îä• Îç∞Ïù¥ÌÑ∞'Î•º Í∏∞Î∞òÏúºÎ°ú Îπ†Î•∏ ÏäπÏù∏ÏùÑ ÏõêÌï©ÎãàÎã§.",
        question: "What should regulators demand?",
        options: [
          { letter: "A", text: "Approve it‚Äî40% better HbA1c is significant", correct: false },
          { letter: "B", text: "Require trials showing reduced heart attacks, strokes, or death", correct: true },
          { letter: "C", text: "ÏãúÌåê ÌõÑ Î™®ÎãàÌÑ∞ÎßÅÏùÑ ÌÜµÌï¥ ÏäπÏù∏", correct: false },
          { letter: "D", text: "Request larger HbA1c trials for confirmation", correct: false }
        ],
        feedback: {
          correct: "Correct! HbA1c is a surrogate like PVCs. The CAST tragedy taught us: surrogates can improve while patients die. Demand patient-important outcomes.",
          incorrect: "HbA1c is a surrogate marker. CAST showed us that 'fixing' lab values can mask fatal harm. Always demand patient-important outcomes: death, heart attack, stroke."
        }
      }},
      { type: "stats", theme: "dark", content: {
        title: "Ï¶ùÍ±∞ Ïã§Ìå® Í∑úÎ™®",
        stats: [
          { value: "50,000", label: "CAST drug deaths" },
          { value: "800,000", label: "Poldermans fraud deaths" },
          { value: "70%", label: "Studies unreproducible" }
        ],
        caption: "Ïù¥Îü∞ ÏÉÅÌô©ÏùÄ ÎìúÎ¨∏ Ïû¨ÎÇúÏù¥ ÏïÑÎãôÎãàÎã§. Ïù¥Îäî ÏÜêÏÉÅÎêú ÌîÑÎ°úÏÑ∏Ïä§Ïùò ÏòàÏ∏° Í∞ÄÎä•Ìïú Í≤∞Í≥ºÏûÖÎãàÎã§."
      }},
      { type: "story", theme: "dark", content: {
        label: "Vioxx Í≥ÑÏÇ∞", title: "The Memo They Tried to Hide",
        text: "In 1996, Merck scientists discovered their painkiller Vioxx caused heart attacks. They wrote internal memos. They calculated the excess deaths. They did <strong>nothing</strong>. For eight years, doctors prescribed Vioxx while Merck executives debated how to spin the data.",
        followup: "When the truth emerged in 2004: 88,000 Americans had suffered heart attacks. 38,000 died. One internal email read: 'The cardiovascular events are clearly there.' They knew. They waited. People died."
      }},
      { type: "decision", theme: "dark", content: {
        icon: "üìß", title: "ÏãúÎÇòÎ¶¨Ïò§: ÎÇ¥Î∂Ä Ïã†Ìò∏",
        xp: 25,
        scenario: "ÎãπÏã†ÏùÄ Ï†úÏïΩ ÌöåÏÇ¨Ïùò Ïó∞Íµ¨ÏõêÏûÖÎãàÎã§. Í∑ÄÌïòÏùò Î∂ÑÏÑùÏóê Îî∞Î•¥Î©¥ Î∏îÎ°ùÎ≤ÑÏä§ÌÑ∞ ÏïΩÎ¨ºÏù¥ Ïã¨Ïû• ÏßàÌôòÏùÑ 31% Ï¶ùÍ∞ÄÏãúÌÇ§Îäî Í≤ÉÏúºÎ°ú ÎÇòÌÉÄÎÇ¨ÏäµÎãàÎã§. Í¥ÄÎ¶¨ÏûêÎäî ÏóêÏä§Ïª¨Î†àÏù¥ÏÖòÌïòÍ∏∞ Ï†ÑÏóê 'Ï∂îÍ∞Ä Îç∞Ïù¥ÌÑ∞ ÎåÄÍ∏∞' Î∞è 'ÎåÄÏ≤¥ Ìï¥ÏÑù ÌÉêÏÉâ'ÏùÑ Ï†úÏïàÌï©ÎãàÎã§.",
        question: "Ïñ¥ÎñªÍ≤å Ìï¥Ïïº Ìï©ÎãàÍπå?",
        options: [
          { letter: "A", text: "Ï†úÏïàÎêú ÎåÄÎ°ú Ï∂îÍ∞Ä Îç∞Ïù¥ÌÑ∞Î•º Í∏∞Îã§Î¶ΩÎãàÎã§", correct: false },
          { letter: "B", text: "Í≤∞Í≥ºÎ•º Ï¶âÏãú ÏïàÏ†Ñ ÏúÑÏõêÌöåÏóê Î≥¥Í≥†Ìï©ÎãàÎã§", correct: true },
          { letter: "C", text: "Run alternative analyses to see if the signal disappears", correct: false },
          { letter: "D", text: "Document your concerns in an email but take no action", correct: false }
        ],
        feedback: {
          correct: "Correct! The Vioxx lesson: 'waiting for more data' while people die is a decision that kills. Safety signals require immediate escalation.",
          incorrect: "ÏßÄÏó∞ÎêòÎäî ÎÇ†ÎßàÎã§ ÏÇ¨ÎßùÏûêÍ∞Ä Î∞úÏÉùÌï©ÎãàÎã§. VioxxÏùò ÎÇ¥Î∂Ä Î©îÎ™®Ïóê Îî∞Î•¥Î©¥ Í∑∏Îì§ÏùÄ ÏïåÍ≥† ÏûàÏóàÏßÄÎßå 'Îçî ÎßéÏùÄ Îç∞Ïù¥ÌÑ∞Î•º Í∏∞Îã§Î¶¨Îã§Í∞Ä' 38,000Î™ÖÏù¥ ÏÇ¨ÎßùÌñàÏäµÎãàÎã§. ÏïàÏ†Ñ Ïã†Ìò∏Î•º Ï¶âÏãú Î≥¥Í≥†ÌïòÏÑ∏Ïöî."
        }
      }},
      { type: "story", theme: "red-bg", content: {
        label: "ÌÉÄÎØ∏ÌîåÎ£® ÏÜçÏûÑÏàò", title: "Ïà®Í≤®ÏßÑ Îç∞Ïù¥ÌÑ∞Ïóê ÎåÄÌïú 4Ïñµ 7300Îßå ÌååÏö¥Îìú",
        text: "In 2009, governments stockpiled Tamiflu for pandemic flu. The UK spent ¬£473 million. The evidence? Manufacturer-funded trials showing 'reduced complications.' The catch? Roche refused to release the full trial data for <strong>five years</strong>.",
        followup: "When researchers finally obtained the raw data, they found: No evidence Tamiflu reduced hospitalizations. No evidence it prevented complications. Half a billion pounds spent on a promise that couldn't be verified."
      }},
      { type: "decision", theme: "dark", content: {
        icon: "‚ö†Ô∏è", title: "ÏãúÎÇòÎ¶¨Ïò§: Ìè¥ÎçîÎßåÏä§ Îç∞Ïù¥ÌÑ∞",
        xp: 25,
        scenario: "Î©îÌÉÄ Î∂ÑÏÑùÏùÑ Í≤ÄÌÜ† Ï§ëÏù∏Îç∞ Ìïú Ïó∞Íµ¨ÏõêÏù¥ 15Í∞úÏóê Í∏∞Ïó¨Ìïú Í≤ÉÏùÑ Î∞úÍ≤¨ÌñàÏäµÎãàÎã§. 40Í∞úÏùò Ïó∞Íµ¨Í∞Ä Ìè¨Ìï®ÎêòÏóàÏäµÎãàÎã§. Í∑∏Ïùò Îç∞Ïù¥ÌÑ∞Îäî Îã§Î•∏ Îç∞Ïù¥ÌÑ∞Î≥¥Îã§ Ìõ®Ïî¨ Îçî ÎÇòÏùÄ Í≤∞Í≥ºÎ•º Î≥¥Ïó¨Ï§çÎãàÎã§. ÏõêÏãú Îç∞Ïù¥ÌÑ∞Í∞Ä Ï°¥Ïû¨ÌïòÎäîÏßÄ ÌôïÏù∏Ìïú ÏÇ¨ÎûåÏùÄ ÏïÑÎ¨¥ÎèÑ ÏóÜÏäµÎãàÎã§.",
        question: "Ïñ¥ÎñªÍ≤å Ìï¥Ïïº Ìï©ÎãàÍπå?",
        options: [
          { letter: "A", text: "Î™®Îì† Ïó∞Íµ¨Î•º Ìè¨Ìï®Ìï©ÎãàÎã§. ÎèôÎ£å Í≤ÄÌÜ†Î•º ÌÜµÍ≥ºÌñàÏäµÎãàÎã§.", correct: false },
          { letter: "B", text: "Ïó∞Íµ¨Ïóê ÎåÄÌïú Ï∂úÏ≤ò ÌôïÏù∏ÏùÑ ÏöîÏ≤≠Ìï©ÎãàÎã§.", correct: true },
          { letter: "C", text: "Exclude his studies without explanation", correct: false },
          { letter: "D", text: "ÏòÅÌñ•ÏùÑ Ï§ÑÏù¥Í∏∞ ÏúÑÌï¥ Îã§Î•∏ ÏÇ¨ÎûåÏùò Í≤∞Í≥ºÎ•º ÌèâÍ∑†ÌôîÌï©ÎãàÎã§", correct: false }
        ],
        feedback: {
          correct: "ÎßûÏäµÎãàÎã§! Ï∂úÏ≤ò ÌôïÏù∏ÏóêÏÑúÎäî 'Ïù¥ Î≤àÌò∏Ïùò Ï∂úÏ≤òÎ•º Ï∂îÏ†ÅÌï† Ïàò ÏûàÏäµÎãàÍπå?'ÎùºÍ≥† Î¨ªÏäµÎãàÎã§. ÏïÑÎ¨¥ÎèÑ Ïù¥ ÏßàÎ¨∏ÏùÑ ÌïòÏßÄ ÏïäÏïòÍ∏∞ ÎïåÎ¨∏Ïóê PoldermansÏùò ÏÇ¨Í∏∞Î°ú Ïù∏Ìï¥ 800,000Î™ÖÏù¥ ÏÇ¨ÎßùÌñàÏäµÎãàÎã§.",
          incorrect: "Not quite. Peer review doesn't verify raw data exists. You need provenance‚Äîthe trail from number to source document."
        }
      }},
      { type: "story", theme: "dark", content: {
        label: "ÌÖåÎùºÎÖ∏Ïä§Ïùò ÏÜçÏûÑÏàò", title: "One Drop of Blood, Billions in Lies",
        text: "In 2003, a 19-year-old Stanford dropout named <strong>Elizabeth Holmes</strong> made a promise that captivated the world: revolutionary blood tests from a single drop. No more needles. No more vials. Investors poured in $700 million. Walgreens signed a deal to put Theranos machines in 8,200 stores. Holmes graced magazine covers. Her company was valued at $9 billion.",
        followup: "The technology never worked. Not once. Theranos ran patient samples on competitors' machines, then hid the results. When the lies unraveled in 2015, the damage was done: <strong>thousands of patients received incorrect diagnoses</strong>. Cancer missed. HIV false positives. Treatment decisions based on fabricated data. Holmes is now serving 11 years in federal prison. The lesson: extraordinary claims without verifiable evidence aren't innovation‚Äîthey're fraud."
      }},
      { type: "decision", theme: "dark", content: {
        icon: "ü©∏", title: "ÏãúÎÇòÎ¶¨Ïò§: ÌòÅÎ™ÖÏ†ÅÏù∏ Í∏∞Ïà†",
        xp: 25,
        scenario: "Ìïú Ïä§ÌÉÄÌä∏ÏóÖÏóêÏÑúÎäî ÏûêÏÇ¨Ïùò AIÍ∞Ä Ìïú Î≤àÏùò ÌòàÏï° Ï±ÑÏ∑®Î°ú 99%Ïùò Ï†ïÌôïÎèÑÎ°ú 50Í∞ÄÏßÄ ÏïîÏùÑ ÌÉêÏßÄÌï† Ïàò ÏûàÎã§Í≥† Ï£ºÏû•Ìï©ÎãàÎã§. Í∑∏Îì§ÏùÄ 5Ïñµ Îã¨Îü¨Î•º Î™®Í∏àÌñàÏäµÎãàÎã§. Ïú†Î™ÖÏù∏Ïùò ÏßÄÏßÄÍ∞Ä ÌíçÎ∂ÄÌï©ÎãàÎã§. Í∑∏Îü¨ÎÇò Í∑∏Îì§ÏùÄ 'ÏòÅÏóÖÎπÑÎ∞Ä'ÏùÑ Ïù¥Ïú†Î°ú Í≤ÄÏ¶ù Îç∞Ïù¥ÌÑ∞ Í≥µÍ∞úÎ•º Í±∞Î∂ÄÌñàÏäµÎãàÎã§. Î≥ëÏõê ÏãúÏä§ÌÖúÏóêÏÑúÎäî Ïù¥Î•º Ï¶âÏãú Î∞∞Ìè¨ÌïòÎ†§Í≥† Ìï©ÎãàÎã§.",
        question: "What should the hospital demand before deployment?",
        options: [
          { letter: "A", text: "FDA ÏäπÏù∏ÏùÑ ÎØøÍ≥† Î∞∞Ìè¨ÌïòÏÑ∏Ïöî", correct: false },
          { letter: "B", text: "Require independent validation on their own patient population", correct: true },
          { letter: "C", text: "ÌöåÏÇ¨ Îç∞Ïù¥ÌÑ∞Î•º Í∏∞Î∞òÏúºÎ°ú ÏÜåÍ∑úÎ™® ÌååÏùºÎüøÏúºÎ°ú ÏãúÏûëÌïòÏÑ∏Ïöî", correct: false },
          { letter: "D", text: "ÎèôÎ£å Í≤ÄÌÜ† Ï∂úÌåêÎ¨ºÏùÑ Í∏∞Îã§Î¶¨ÏÑ∏Ïöî", correct: false }
        ],
        feedback: {
          correct: "ÎßûÏäµÎãàÎã§! TheranosÎäî Ìïú Í∞ÄÏßÄ ÌÖåÏä§Ìä∏Ïóê ÎåÄÌï¥ FDA ÏäπÏù∏ÏùÑ Î∞õÏïòÏßÄÎßå Îã§Î•∏ ÌÖåÏä§Ìä∏Ïóê ÎåÄÌï¥ÏÑúÎäî Í±∞ÏßìÎßêÏùÑ ÌñàÏäµÎãàÎã§. Í∑ÄÌïòÏùò ÌôòÏûêÏóê ÎåÄÌïú ÎèÖÎ¶ΩÏ†ÅÏù∏ Í≤ÄÏ¶ùÏùÄ ÌòëÏÉÅÌï† Ïàò ÏóÜÏäµÎãàÎã§. Í≤ÄÏ¶ù Îç∞Ïù¥ÌÑ∞Î•º Ïà®Í∏∞Îäî ÏòÅÏóÖ ÎπÑÎ∞ÄÏùÄ ÏúÑÌóò Ïã†Ìò∏ÏûÖÎãàÎã§.",
          incorrect: "Theranos fooled Walgreens, investors, and patients. The lesson: no independent validation, no deployment. 'Trust us' is not evidence."
        }
      }},
      { type: "story", theme: "red-bg", content: {
        label: "OxyContin Ïû¨Ïïô", title: "Ï†ÑÏóºÎ≥ëÏùÑ ÏùºÏúºÌÇ® ÏïΩ",
        text: "In 1996, Purdue Pharma launched OxyContin with a bold claim: their new opioid was <strong>'less than 1% addictive.'</strong> They cited a brief letter to the editor in a 1980 New England Journal of Medicine‚Äîfive sentences about hospital patients, not outpatient prescriptions. Sales reps repeated the claim 500,000 times to doctors. Purdue spent $200 million marketing it as safe.",
        followup: "The Sackler family knew. Internal documents showed they tracked addiction reports. They knew their 12-hour pill was wearing off early, driving patients to take more. They did the math: more pills, more profit. By 2021: <strong>500,000 Americans dead from opioid overdoses</strong>. Purdue pleaded guilty to federal charges‚Äîtwice. The Sacklers paid $6 billion but admitted no personal wrongdoing. One misrepresented paragraph. Half a million graves."
      }},
      { type: "decision", theme: "dark", content: {
        icon: "üíä", title: "ÏãúÎÇòÎ¶¨Ïò§: Ïù∏Ïö© Ï∂îÏ†Å",
        xp: 25,
        scenario: "ÏïΩÍµ≠ Îã¥ÎãπÏûêÎäî ÏûêÏÇ¨Ïùò ÏÉàÎ°úÏö¥ ÏßÑÌÜµÏ†úÍ∞Ä 'ÏµúÏÜå' ÏàòÏ§ÄÏù¥ÎùºÍ≥† Ï£ºÏû•Ìï©ÎãàÎã§. Ï§ëÎèÖ ÏúÑÌóòÏù¥ Î¨∏ÌóåÏóêÏÑú ÏûÖÏ¶ùÎêòÏóàÏäµÎãàÎã§.' Í∑∏Îì§ÏùÄ ÎãπÏã†ÏóêÍ≤å Ï∞∏Í≥†ÏûêÎ£åÎ•º Í±¥ÎÑ§Ï§çÎãàÎã§. Ïù¥Îäî Í∑ÄÌïòÍ∞Ä ÏπòÎ£åÌïòÎäî Ïô∏Îûò ÌôòÏûê ÏßëÎã®Ïù¥ ÏïÑÎãàÎùº ÏûÖÏõê ÌôòÏûêÎ•º Ïó∞Íµ¨ÌïòÎ©¥ÏÑú 1980ÎÖÑÏóê Ìé∏ÏßëÏûêÏóêÍ≤å Î≥¥ÎÇ∏ 5Î¨∏Ïû• Ìé∏ÏßÄÏûÖÎãàÎã§.",
        question: "Ïñ¥ÎñªÍ≤å Ìï¥Ïïº Ìï©ÎãàÍπå?",
        options: [
          { letter: "A", text: "It's in NEJM, so it's credible enough", correct: false },
          { letter: "B", text: "Demand RCTs with addiction as a pre-specified outcome in relevant populations", correct: true },
          { letter: "C", text: "Prescribe cautiously and monitor patients yourself", correct: false },
          { letter: "D", text: "Wait for colleagues to report problems first", correct: false }
        ],
        feedback: {
          correct: "ÎßûÏäµÎãàÎã§! Ïò•ÏãúÏΩòÌã¥Ïùò ÎπÑÍ∑πÏùÄ Ï¶ùÍ±∞Î°ú ÏûòÎ™ª ÌëúÍ∏∞Îêú 5Î¨∏Ïû•ÏßúÎ¶¨ Ìé∏ÏßÄÏóêÏÑú ÏãúÏûëÎêêÎã§. Ìé∏ÏßÄÎäî Ï¶ùÍ±∞Í∞Ä ÎêòÏßÄ ÏïäÏäµÎãàÎã§. Í¥ÄÎ†® Ïù∏Íµ¨Î•º ÎåÄÏÉÅÏúºÎ°ú Í¥ÄÎ†® Í≤∞Í≥ºÍ∞Ä Ìè¨Ìï®Îêú Ïã§Ï†ú ÏãúÌóòÏùÑ ÏöîÍµ¨Ìï©ÎãàÎã§.",
          incorrect: "ÌçºÎìÄÎäî 5Î¨∏Ïû•ÏúºÎ°ú Ï†úÍµ≠ÏùÑ Í±¥ÏÑ§ÌñàÏäµÎãàÎã§. 'Í≥µÍ∞úÎêêÎã§'Îäî Í≤ÉÏù¥ 'Ï¶ùÍ±∞'ÎùºÎäî ÎúªÏùÄ ÏïÑÎãàÎã§. Î™®ÏßëÎã®, ÎîîÏûêÏù∏ Î∞è Í≤∞Í≥ºÎäî ÏûÑÏÉÅ ÏßàÎ¨∏Í≥º ÏùºÏπòÌï¥Ïïº Ìï©ÎãàÎã§."
        }
      }},
      { type: "story", theme: "dark", content: {
        label: "ÏÑúÏßÄÏä§ÌîºÏñ¥ Ïä§Ï∫îÎì§", title: "Ï°¥Ïû¨ÌïòÏßÄ ÏïäÎäî Îç∞Ïù¥ÌÑ∞Î≤†Ïù¥Ïä§",
        text: "In May 2020, the world was desperate for COVID-19 answers. Then <strong>The Lancet</strong> published a bombshell: hydroxychloroquine increased deaths in COVID patients. The study claimed data from 96,000 patients across 671 hospitals on six continents. The WHO halted trials. Countries banned the drug. The paper had one problem: <strong>the data was fabricated</strong>.",
        followup: "Surgisphere, a tiny company with 11 employees, claimed to have a global hospital database larger than any healthcare system on Earth. One employee was a science fiction author. Another was an adult content model. When journalists asked for verification, the company couldn't produce a single hospital contract. Both The Lancet and NEJM retracted their Surgisphere papers within weeks. During a pandemic, fabricated data hijacked global health policy. The peer reviewers never asked: 'Can we see proof this database exists?'"
      }},
      { type: "decision", theme: "dark", content: {
        icon: "üè•", title: "Scenario: The Impossibly Large Dataset",
        xp: 25,
        scenario: "Ìïú Î≤àÎèÑ Îì§Ïñ¥Î≥∏ Ï†Å ÏóÜÎäî ÌöåÏÇ¨ÏóêÏÑú ÏàòÏßëÌïú 47Í∞úÍµ≠ 1,500Í∞ú Î≥ëÏõêÏùò 200,000Î™ÖÏùò ÌôòÏûêÎ•º Î∂ÑÏÑùÌïúÎã§Í≥† Ï£ºÏû•ÌïòÎäî ÎÖºÎ¨∏Ïù¥ 6Í∞ú ÏûàÏäµÎãàÎã§. ÏßÅÏõê. Í≤∞Í≥ºÎäî ÏπòÎ£å ÏßÄÏπ®ÏùÑ Î≥ÄÍ≤ΩÌï©ÎãàÎã§. ÎèôÎ£å Í≤ÄÌÜ†ÏûêÎì§Ïù¥ ÏäπÏù∏ÌñàÏäµÎãàÎã§.",
        question: "Ï≤¥Í≥ÑÏ†Å Í≤ÄÌÜ†ÏóêÏÑú Ïù¥Î•º Ïù∏Ïö©ÌïòÍ∏∞ Ï†ÑÏóê Î¨¥ÏóáÏùÑ ÌôïÏù∏Ìï¥Ïïº Ìï©ÎãàÍπå?",
        options: [
          { letter: "A", text: "ÏµúÍ≥† Ï†ÄÎÑêÏóê Í≤åÏû¨Îêú Í≤ΩÏö∞ ÎèôÎ£å Í≤ÄÌÜ†Î°ú Ï∂©Î∂ÑÌñàÏäµÎãàÎã§.", correct: false },
          { letter: "B", text: "Îç∞Ïù¥ÌÑ∞ ÌöåÏÇ¨Ïóê Ïó∞ÎùΩÌïòÏó¨ Î≥ëÏõê ÌååÌä∏ÎÑàÏã≠ Î¨∏ÏÑúÎ•º ÏöîÏ≤≠ÌïòÏÑ∏Ïöî", correct: true },
          { letter: "C", text: "Check if other researchers have cited it positively", correct: false },
          { letter: "D", text: "ÌÜµÍ≥ÑÎ•º Ï∞æÏïÑÎ≥¥ÏÑ∏Ïöî Í≤åÏãúÎêú ÌÖåÏù¥Î∏îÏóê Ïù¥ÏÉÅÏù¥ ÏûàÏäµÎãàÎã§", correct: false }
        ],
        feedback: {
          correct: "ÎßûÏäµÎãàÎã§! SurgisphereÎäî Ï†ÑÏóºÎ≥ë ÎèôÏïà The LancetÍ≥º NEJMÏùÑ ÏÜçÏòÄÏäµÎãàÎã§. Ï∂úÏ≤ò ÌôïÏù∏('Ïù¥ Îç∞Ïù¥ÌÑ∞Í∞Ä Ï°¥Ïû¨ÌïòÎäîÏßÄ Ï¶ùÎ™Ö')ÏùÑ ÌÜµÌï¥ Ìè¨Ï∞©ÌñàÏùÑ Í≤ÉÏûÖÎãàÎã§. Î™ÖÎßù ÏûàÎäî Ï†ÄÎÑêÏùÄ Ï∂úÏ≤òÍ∞Ä ÏïÑÎãôÎãàÎã§.",
          incorrect: "LancetÍ≥º NEJMÏùÄ ÏÜçÏïòÏäµÎãàÎã§. ÎèôÎ£å Í≤ÄÌÜ†ÏóêÏÑúÎäî Îç∞Ïù¥ÌÑ∞Î≤†Ïù¥Ïä§Í∞Ä Ï°¥Ïû¨ÌïòÎäîÏßÄ ÌôïÏù∏ÌïòÏßÄ ÏïäÏäµÎãàÎã§. ÌäπÎ≥ÑÌïú Îç∞Ïù¥ÌÑ∞Î•º Ïã†Î¢∞ÌïòÍ∏∞ Ï†ÑÏóê ÏÜåÏä§Í∞Ä Í∑∏Í≤ÉÏù¥ ÏßÑÏßúÎùºÎäî Í≤ÉÏùÑ Ï¶ùÎ™ÖÌï† Ïàò ÏûàÎäîÏßÄ ÌôïÏù∏ÌïòÏã≠ÏãúÏò§."
        }
      }},
      { type: "story", theme: "red-bg", content: {
        label: "ÌéúÌéú Ïû¨Ïïô", title: "Ïã¨Ïû•ÏùÑ ÌååÍ¥¥ÌïòÎäî Îã§Ïù¥Ïñ¥Ìä∏ ÏïΩ",
        text: "In 1992, a researcher combined two FDA-approved drugs‚Äîfenfluramine and phentermine‚Äîfor weight loss. The combination was never tested together. The results seemed miraculous: patients lost weight effortlessly. Doctors prescribed it to <strong>6 million Americans</strong>. Weight loss clinics sprouted everywhere. Women's magazines celebrated the breakthrough.",
        followup: "Then the Mayo Clinic noticed something terrifying. Young, healthy women were developing a rare heart valve disease. One cardiologist saw 24 cases in a single year‚Äîhe'd seen only a handful in his entire career. The FDA investigated: <strong>30% of fen-phen users had abnormal heart valves</strong>. The combination was destroying hearts. By the time it was pulled in 1997, the damage was catastrophic. American Home Products paid $13 billion in settlements. The lesson: combining 'safe' drugs without testing the combination is not science‚Äîit's an uncontrolled experiment on patients."
      }},
      { type: "decision", theme: "dark", content: {
        icon: "üíî", title: "ÏãúÎÇòÎ¶¨Ïò§: ÎùºÎ≤® Ïô∏ Ï°∞Ìï©",
        xp: 25,
        scenario: "ÎèôÎ£åÍ∞Ä Î≥¥Ïó¨Ï§çÎãàÎã§. Ïù∏ÏÉÅÏ†ÅÏù∏ Ï≤¥Ï§ë Í∞êÎüâÏùÄ ÏäπÏù∏Îêú Îëê Í∞ÄÏßÄ ÏïΩÎ¨ºÏùÑ ÏûÑÏÉÅÏãúÌóòÏóêÏÑú Ìïú Î≤àÎèÑ ÌÖåÏä§Ìä∏Ìïú Ï†ÅÏù¥ ÏóÜÎäî Î∞©ÏãùÏúºÎ°ú Í≤∞Ìï©Ìïú Í≤∞Í≥ºÏûÖÎãàÎã§. 'Îëò Îã§ FDA ÏäπÏù∏ÏùÑ Î∞õÏïòÍ∏∞ ÎïåÎ¨∏Ïóê Ï°∞Ìï©ÏùÄ ÏïàÏ†ÑÌï¥Ïïº Ìï©ÎãàÎã§.' Í∑∏Îì§ÏùÄ ÏÇ¨Î°Ä ÏãúÎ¶¨Ï¶àÎ•º Í≤åÏãúÌïòÍ≥† ÌîÑÎ°úÌÜ†ÏΩúÏùÑ Ï∂îÏ≤úÌïòÎ†§Í≥† Ìï©ÎãàÎã§.",
        question: "Ïù¥ Ï∂îÎ°†Ïùò ÏπòÎ™ÖÏ†ÅÏù∏ Í≤∞Ìï®ÏùÄ Î¨¥ÏóáÏûÖÎãàÍπå?",
        options: [
          { letter: "A", text: "ÏÇ¨Î°Ä ÏãúÎ¶¨Ï¶àÍ∞Ä ÎÑàÎ¨¥ ÏûëÏïÑÏÑú Í≤åÏãúÌï† Ïàò ÏóÜÏäµÎãàÎã§", correct: false },
          { letter: "B", text: "Drug interactions can create harms not present in either drug alone", correct: true },
          { letter: "C", text: "Off-label use requires special FDA permission", correct: false },
          { letter: "D", text: "Weight loss drugs are too controversial", correct: false }
        ],
        feedback: {
          correct: "ÎßûÏäµÎãàÎã§! ÌéúÌéúÏùÄ Îëê Í∞ÄÏßÄ 'ÏïàÏ†ÑÌïú' ÏïΩÎ¨ºÏùÑ Í≤∞Ìï©ÌïòÏó¨ Ïã¨Ïû•ÏùÑ ÌååÍ¥¥ÌïòÎäî Ï°∞Ìï©ÏúºÎ°ú ÎßåÎì§ÏóàÏäµÎãàÎã§. ÏïΩÎ¨º ÏÉÅÌò∏ ÏûëÏö©ÏùÄ Í∞úÎ≥Ñ ÌîÑÎ°úÌïÑÏóêÏÑú ÏòàÏ∏°Ìï† Ïàò ÏóÜÏäµÎãàÎã§. ÌÖåÏä§Ìä∏ÎêòÏßÄ ÏïäÏùÄ Ï°∞Ìï©ÏùÄ ÏûêÏ≤¥ Ïã§ÌóòÏù¥ ÌïÑÏöîÌï©ÎãàÎã§.",
          incorrect: "ÌéúÌîåÎ£®ÎùºÎØºÏùÄ 'ÏïàÏ†Ñ'ÌñàÏäµÎãàÎã§. ÌéúÌÑ∞ÎØºÏùÄ 'ÏïàÏ†Ñ'ÌñàÏäµÎãàÎã§. Í∑∏Îì§ÏùÄ Ìï®Íªò ÏÇ¨Ïö©ÏûêÏùò 30%ÏóêÏÑú Ïã¨Ïû• ÌåêÎßâÏùÑ ÌååÍ¥¥ÌñàÏäµÎãàÎã§. Ï°∞Ìï©ÏóêÎäî Í∑∏ ÏûêÏ≤¥Ïùò Ï¶ùÍ±∞Í∞Ä ÌïÑÏöîÌï©ÎãàÎã§. Í∞ÄÏ†ïÏùÄ Ï£ΩÏù¥Îäî Í≤ÉÏûÖÎãàÎã§."
        }
      }},
      { type: "story", theme: "dark", content: {
        label: "DES ÎπÑÍ∑π", title: "3ÏÑ∏ÎåÄÎ•º Í¥¥Î°≠Ìûå ÏïΩÎ¨º",
        text: "In 1938, scientists synthesized DES‚Äîa synthetic estrogen. By 1941, doctors were prescribing it to pregnant women to prevent miscarriages. It seemed logical: estrogen supports pregnancy. <strong>5 million American women</strong> took it between 1940 and 1971. Nobody ran a controlled trial. Nobody tracked the babies.",
        followup: "In 1971, a physician noticed something impossible: <strong>young women in their teens and twenties were developing a rare vaginal cancer</strong> that typically struck women over 50. He traced it back: their mothers had all taken DES during pregnancy. The drug hadn't caused immediate harm‚Äîit had planted a time bomb in the womb. DES daughters had higher rates of infertility, miscarriage, and cancer. DES granddaughters‚Äîthe third generation‚Äîshowed elevated cancer risks too. One untested assumption. Three generations of harm. The first controlled trial of DES, run in 1953, showed it <strong>didn't even prevent miscarriages</strong>‚Äîthe original indication was worthless."
      }},
      { type: "decision", theme: "dark", content: {
        icon: "ü§∞", title: "ÏãúÎÇòÎ¶¨Ïò§: ÎÖºÎ¶¨Ï†Å ÏπòÎ£å",
        xp: 25,
        scenario: "ÏûÑÏã† Ìï©Î≥ëÏ¶ùÏóê ÎåÄÌï¥ ÏÉùÎ¨ºÌïôÏ†ÅÏúºÎ°ú Í∑∏Îü¥ÎìØÌïú ÏπòÎ£åÎ≤ïÏù¥ 15ÎÖÑ ÎèôÏïà ÏÇ¨Ïö©ÎêòÏñ¥ ÏôîÏßÄÎßå Ï¶âÍ∞ÅÏ†ÅÏù∏ Ìï¥ÏïÖÏùÄ ÏóÜÏóàÏäµÎãàÎã§. ÌÜµÏ†úÎêú ÏãúÌóòÏùÄ Ï°¥Ïû¨ÌïòÏßÄ ÏïäÏäµÎãàÎã§. Ìïú ÎèôÎ£åÎäî 'Ïö∞Î¶¨Îäî ÏàòÏ≤ú Î™ÖÏùò ÌôòÏûêÏóêÍ≤å Ïù¥ Ï†úÌíàÏùÑ ÏÇ¨Ïö©ÌñàÏäµÎãàÎã§. Î¨∏Ï†úÍ∞Ä Î∞úÏÉùÌñàÎã§Î©¥ ÏßÄÍ∏àÏØ§ Ïïå Ïàò ÏûàÏùÑ Í≤ÉÏûÖÎãàÎã§.'",
        question: "What critical assumption does this reasoning miss?",
        options: [
          { letter: "A", text: "15 years isn't long enough to judge safety", correct: false },
          { letter: "B", text: "Pregnancy exposures can cause harms that only appear decades later in offspring", correct: true },
          { letter: "C", text: "Observational experience is never valid", correct: false },
          { letter: "D", text: "Colleagues might be hiding adverse events", correct: false }
        ],
        feedback: {
          correct: "Correct! DES taught us the cruelest lesson: pregnancy exposures can cause cancers that appear 20-30 years later in children and grandchildren. 'No immediate harm' is not 'no harm.'",
          incorrect: "DESÎäî Í∑∏Îì§Ïùò Îî∏Ïù¥ 10ÎåÄÏóê ÏïîÏóê Í±∏Î¶¨Í∏∞ Ï†ÑÍπåÏßÄ 30ÎÖÑ ÎèôÏïàÏùÄ ÏïàÏ†ÑÌï¥ Î≥¥ÏòÄÏäµÎãàÎã§. Ïñ¥Îñ§ ÌîºÌï¥Îäî ÎÇòÌÉÄÎÇòÍ∏∞ÍπåÏßÄ ÏàòÏã≠ ÎÖÑÏù¥ Í±∏Î¶ΩÎãàÎã§. ÏûÑÏã† ÎÖ∏Ï∂úÏóê ÎåÄÌï¥ÏÑúÎäî ÏûêÏÜêÏóê ÎåÄÌïú Ïû•Í∏∞Ï†ÅÏù∏ Ï∂îÏ†Å Ï°∞ÏÇ¨Í∞Ä ÌïÑÏàòÏ†ÅÏûÖÎãàÎã§."
        }
      }},
      { type: "refrain", theme: "black", content: { text: "ÎÇòÏÅú Ï¶ùÍ±∞Í∞Ä ÏûàÏúºÎ©¥ ÏÇ¨ÎßùÌï©ÎãàÎã§. META-SPRINTÎäî Ïã†Î¢∞Ìï† Ïàò ÏûàÎäî Ï¶ùÍ±∞Î•º ÏÉùÏÑ±ÌïòÍ∏∞ ÏúÑÌï¥ Ï°¥Ïû¨Ìï©ÎãàÎã§." }},
      { type: "quiz", theme: "dark", content: {
        question: "Why did the CAST drugs increase deaths despite 'working' on ECGs?",
        options: [
          { text: "ECG ÌåêÎèÖÍ∞íÏù¥ ÏûòÎ™ª Ï∏°Ï†ïÎêòÏóàÏäµÎãàÎã§.", correct: false },
          { text: "PVC ÏñµÏ†úÎäî Ïã§Ï†ú Í≤∞Í≥ºÍ∞Ä ÏïÑÎãå ÎåÄÏö©Î¨ºÏù¥ÏóàÏäµÎãàÎã§.", correct: true },
          { text: "ÌëúÎ≥∏ ÌÅ¨Í∏∞Í∞Ä ÎÑàÎ¨¥ ÏûëÏïòÏäµÎãàÎã§.", correct: false },
          { text: "ÏïΩÏù¥ Ïò§ÏóºÎêêÏñ¥Ïöî", correct: false }
        ],
        xp: 20,
        feedback: {
          correct: "Exactly. PVC suppression was a surrogate outcome‚Äîit looked like benefit but masked real harm.",
          incorrect: "ÏïΩÎ¨ºÏùÄ ECGÏóêÏÑú ÏùòÎèÑÌïú ÎåÄÎ°ú Ï†ïÌôïÌïòÍ≤å ÏûëÎèôÌñàÏäµÎãàÎã§. Î¨∏Ï†úÎäî 'Í≥†Ï†ï'Îêú ECGÍ∞Ä ÏÉùÎ™ÖÏùÑ Íµ¨ÌñàÎã§Îäî ÏùòÎØ∏Í∞Ä ÏïÑÎãàÎùºÎäî Í≤ÉÏûÖÎãàÎã§."
        }
      }}
    ]
  },
  {
    id: 2, title: "40Ïùº ÌîÑÎ†àÏûÑÏõåÌÅ¨", subtitle: "Five phases, five gates", xp: 120,
    slides: [
      { type: "title", theme: "dark", content: { title: "40 Days, 5 Gates", subtitle: "Ïã†Î¢∞Ìï† Ïàò ÏûàÎäî Ï¶ùÍ±∞Î•º Ï∞æÍ∏∞ ÏúÑÌïú Íµ¨Ï°∞ÌôîÎêú Ïä§ÌîÑÎ¶∞Ìä∏" }},
      { type: "objectives", theme: "dark", content: {
        objectives: [
          "Learn the five phases of META-SPRINT",
          "Understand Definition of Done (DoD) gates",
          "ÌåÄ Íµ¨Ï°∞ÏôÄ ÏùºÏùº ÏãúÍ∞Ñ ÏïΩÏÜçÏùÑ ÌååÏïÖÌïòÏÑ∏Ïöî."
        ],
        tip: "The framework overview - you'll learn each phase in detail later."
      }},
      { type: "timeline", theme: "dark", content: {
        title: "5Îã®Í≥Ñ",
        items: [
          { days: "Days 1-3", title: "Phase A: Protocol", desc: "ÏßàÎ¨∏Í≥º Î∞©Î≤ïÏùÑ Ïû†Í∑∏ÏÑ∏Ïöî", phase: "a" },
          { days: "Days 4-10", title: "Phase B: Search", desc: "Î¨∏Ìóå Ï∞æÍ∏∞ Î∞è ÌïÑÌÑ∞ÎßÅ", phase: "b" },
          { days: "Days 11-28", title: "Phase C: Extraction", desc: "Í≤ÄÏ¶ùÏùÑ ÌÜµÌï¥ Îç∞Ïù¥ÌÑ∞ Í∞ÄÏ†∏Ïò§Í∏∞", phase: "c" },
          { days: "Days 29-33", title: "Phase D: Analysis", desc: "Î∂ÑÏÑù Ïã§Ìñâ Î∞è ÌôïÏù∏", phase: "d" },
          { days: "Days 34-40", title: "Phase E: Submit", desc: "Write, audit, submit", phase: "e" }
        ]
      }},
      { type: "decision", theme: "dark", content: {
        icon: "üö™", title: "Scenario: The 'Almost Done' Gate",
        xp: 25,
        scenario: "3ÏùºÏ∞®ÏûÖÎãàÎã§. Í∑ÄÌïòÏùò ÌåÄÏùÄ DoD-A Ï≤¥ÌÅ¨Î¶¨Ïä§Ìä∏ Ìï≠Î™© 8Í∞ú Ï§ë 7Í∞úÎ•º ÏôÑÎ£åÌñàÏäµÎãàÎã§. ÎàÑÎùΩÎêú Ìï≠Î™©: PROSPEROÏùò ÌîÑÎ°úÌÜ†ÏΩú Îì±Î°ùÏù¥ 'Í≤ÄÌÜ† ÎåÄÍ∏∞ Ï§ë'ÏûÖÎãàÎã§(Î≥¥ÌÜµ 24~48ÏãúÍ∞Ñ ÏÜåÏöî).",
        question: "DoD-AÎ•º ÌÜµÍ≥ºÌï¥Ïïº Ìï©ÎãàÍπå?",
        options: [
          { letter: "A", text: "Yes‚Äî7/8 is close enough, proceed to search", correct: false },
          { letter: "B", text: "No‚Äîwait for registration before passing gate", correct: true },
          { letter: "C", text: "Ïòà - ÎÇòÏ§ëÏóê Îì±Î°ùÌïòÍ≥† ÌîÑÎ°úÌÜ†ÏΩúÏùÑ ÏÜåÍ∏â Ï†ÅÏö©ÌïòÏÑ∏Ïöî", correct: false },
          { letter: "D", text: "Skip registration‚Äîit's just bureaucracy", correct: false }
        ],
        feedback: {
          correct: "Correct! Gates are binary: pass or fail. 'Almost done' with protocol isn't done. Incomplete PICOS led to 50,000 CAST deaths.",
          incorrect: "Í≤åÏù¥Ìä∏Îäî Î∞îÏù¥ÎÑàÎ¶¨ÏûÖÎãàÎã§. Î∂ÄÎ∂ÑÌïôÏ†êÏù¥ ÏóÜÏäµÎãàÎã§. Îì±Î°ù ÌÉÄÏûÑÏä§ÌÉ¨ÌîÑÎäî ÏïΩÏÜçÏùÑ Í∏∞Î°ùÌï©ÎãàÎã§. Ïù¥Í≤ÉÏù¥ ÏóÜÏúºÎ©¥ Îç∞Ïù¥ÌÑ∞Î•º Î≥∏ ÌõÑ Í≤∞Í≥ºÍ∞Ä Î≥ÄÍ≤ΩÎêòÏßÄ ÏïäÏïòÎã§Îäî Í≤ÉÏùÑ Ï¶ùÎ™ÖÌï† Ïàò ÏóÜÏäµÎãàÎã§."
        }
      }},
      { type: "concept", theme: "dark", content: {
        title: "Definition of Done (DoD)",
        subtitle: "Binary gates: Pass or Fail",
        text: "Í∞Å Îã®Í≥ÑÎäî 100% ÏôÑÎ£åÎêòÏñ¥Ïïº ÌïòÎäî Ï≤¥ÌÅ¨Î¶¨Ïä§Ìä∏Ïù∏ DoD Í≤åÏù¥Ìä∏Î°ú ÎÅùÎÇ©ÎãàÎã§. Î∂ÄÎ∂ÑÌïôÏ†êÏù¥ ÏóÜÏäµÎãàÎã§. ÏïÑÎãàÏöî 'Í±∞Ïùò ÏôÑÎ£åÎêòÏóàÏäµÎãàÎã§.'",
        highlight: "The CAST lesson: 'Almost done' with protocol isn't done."
      }},
      { type: "story", theme: "red-bg", content: {
        label: "Ï£ΩÏùåÏùÑ Í∞ÄÏ†∏Ïò® ÏßÄÏπ®", title: "ÏÇ¨Í∏∞Íæº Ìïú Î™ÖÏúºÎ°ú Ïù∏Ìï¥ 80Îßå Î™ÖÏù¥ ÏÇ¨ÎßùÌï®",
        text: "ÏàòÎÖÑ ÎèôÏïà ÏûÑÏÉÅ ÏßÄÏπ®ÏóêÏÑúÎäî Ïã¨Ïû• ÎßàÎπÑÎ•º ÏòàÎ∞©ÌïòÍ∏∞ ÏúÑÌï¥ ÏàòÏà† Ï†ÑÏóê Î≤†ÌÉÄ Ï∞®Îã®Ï†úÎ•º Í∂åÏû•ÌñàÏäµÎãàÎã§. Ï¶ùÍ±∞? Ï£ºÎ°ú Î©îÌÉÄ Î∂ÑÏÑùÏóê ÎåÄÌïú 15Í∞ú Ïó∞Íµ¨Ïóê Í∏∞Ïó¨Ìïú Ïó∞Íµ¨ÏõêÏù∏ Don PoldermansÏùò Í∏ÄÏûÖÎãàÎã§. Í∑∏Ïùò Îç∞Ïù¥ÌÑ∞Îäî Í∑πÏ†ÅÏù∏ Ïù¥Ï†êÏùÑ Î≥¥Ïó¨Ï£ºÏóàÏäµÎãàÎã§. Í∑∏Ïùò Îç∞Ïù¥ÌÑ∞Îäî Ï°∞ÏûëÎêòÏóàÏäµÎãàÎã§.",
        followup: "When the fraud was discovered and his studies removed, the math changed. Beta-blockers didn't prevent heart attacks during surgery‚Äîthey caused them. Researchers calculated: following guidelines based on Poldermans' fraud may have killed <strong>800,000 patients</strong> over a decade. One man's lies. Global guidelines. Mass harm."
      }},
      { type: "decision", theme: "dark", content: {
        icon: "üìã", title: "ÏãúÎÇòÎ¶¨Ïò§: Ï£ºÏöî Í∏∞Ïó¨Ïûê",
        xp: 25,
        scenario: "ÏûÑÏÉÅ ÏßÄÏπ®ÏùÑ ÏóÖÎç∞Ïù¥Ìä∏ÌïòÍ≥† ÏûàÏäµÎãàÎã§. Í∑ÄÌïòÏùò Ï≤¥Í≥ÑÏ†Å Í≤ÄÌÜ†ÏóêÎäî 40Í∞úÏùò Ïó∞Íµ¨Í∞Ä Ìè¨Ìï®Îê©ÎãàÎã§. Ìïú Ïó∞Íµ¨ÏõêÏù¥ Í∑∏ Ï§ë 15Í∞úÏóê Í∏∞Ïó¨ÌñàÏúºÎ©∞ Í∑∏Ïùò Ïó∞Íµ¨Îäî Îã§Î•∏ Î™®Îì† Ïó∞Íµ¨Î≥¥Îã§ Ìõ®Ïî¨ Îçî ÌÅ∞ Ìö®Í≥ºÎ•º Î≥¥Ïó¨Ï§çÎãàÎã§. Í∑∏Ïùò ÏûëÌíàÏùÄ ÎèÖÎ¶ΩÏ†ÅÏúºÎ°ú Î≥µÏ†úÎêú Ï†ÅÏù¥ ÏóÜÏäµÎãàÎã§.",
        question: "What should the guideline committee do?",
        options: [
          { letter: "A", text: "Î™®Îì† Ïó∞Íµ¨Î•º Ìè¨Ìï®Ìï©ÎãàÎã§. ÎèôÎ£å Í≤ÄÌÜ†Î•º ÌÜµÌï¥ ÌíàÏßàÏù¥ Î≥¥Ïû•Îê©ÎãàÎã§.", correct: false },
          { letter: "B", text: "Ïó∞Íµ¨ Ïú†Î¨¥Ïóê Í¥ÄÍ≥ÑÏóÜÏù¥ ÎØºÍ∞êÎèÑ Î∂ÑÏÑù Ïã§Ìñâ", correct: true },
          { letter: "C", text: "Exclude his studies as obvious outliers", correct: false },
          { letter: "D", text: "Weight his studies lower due to 'heterogeneity'", correct: false }
        ],
        feedback: {
          correct: "Correct! Sensitivity analysis would have shown Poldermans' outsized influence. When one researcher dominates a field, verify their work independently before basing guidelines on it.",
          incorrect: "The Poldermans lesson: one dominant contributor can corrupt an entire field. Sensitivity analysis (with/without their studies) reveals dangerous dependencies."
        }
      }},
      { type: "stats", theme: "light", content: {
        title: "META-SPRINT Î≤àÌò∏",
        stats: [
          { value: "40", label: "Days total" },
          { value: "5", label: "Quality gates" },
          { value: "12", label: "Team members" },
          { value: "2h", label: "Max daily work" }
        ]
      }},
      { type: "quiz", theme: "dark", content: {
        question: "What happens if a DoD gate fails?",
        options: [
          { text: "Í≤ΩÍ≥†Í∞Ä ÌëúÏãúÎêòÎ©¥ Í≥ÑÏÜç ÏßÑÌñâÌï† Ïàò ÏûàÏäµÎãàÎã§.", correct: false },
          { text: "You must fix all items before proceeding", correct: true },
          { text: "You skip to the next phase and return later", correct: false },
          { text: "ÌîÑÎ°úÏ†ùÌä∏Í∞Ä ÏûêÎèôÏúºÎ°ú Ï∑®ÏÜåÎê©ÎãàÎã§", correct: false }
        ],
        xp: 15,
        feedback: {
          correct: "Right! Gates are non-negotiable. All items must pass before moving forward.",
          incorrect: "Í≤åÏù¥Ìä∏Îäî Î∞îÏù¥ÎÑàÎ¶¨Ïù¥ÎØÄÎ°ú Î™®Îì† Ìï≠Î™©Ïù¥ ÏôÑÎ£åÎê† ÎïåÍπåÏßÄ ÏßÑÌñâÌï† Ïàò ÏóÜÏäµÎãàÎã§. Ïù¥Î†áÍ≤å ÌïòÎ©¥ Ïò§Î•òÍ∞Ä Î≥µÌï©Ï†ÅÏúºÎ°ú Î∞úÏÉùÌïòÎäî Í≤ÉÏùÑ Î∞©ÏßÄÌï† Ïàò ÏûàÏäµÎãàÎã§."
        }
      }}
    ]
  },
  {
    id: 3, title: "Phase A: Protocol", subtitle: "1~3Ïùº: ÏïΩÏÜçÏùÑ ÏßÄÌÇ§ÏÑ∏Ïöî", xp: 180,
    slides: [
      { type: "title", theme: "purple-bg", content: { title: "Phase A: Protocol", subtitle: "1~3Ïùº: Îç∞Ïù¥ÌÑ∞Î•º Î≥¥Í∏∞ Ï†ÑÏóê ÏïΩÏÜçÏùÑ Ïû†Í∑∏ÏÑ∏Ïöî" }},
      { type: "objectives", theme: "dark", content: {
        objectives: [
          "Understand why protocol registration prevents outcome switching",
          "Learn to write unambiguous PICOS criteria",
          "Master the DoD-A checklist requirements",
          "Recognize the danger of surrogate outcomes"
        ],
        tip: "Î™®Îì† Í≤∞Ï†ï ÏãúÎÇòÎ¶¨Ïò§Î•º ÏôÑÎ£åÌïòÏó¨ Protocol Pro Î∞∞ÏßÄÎ•º ÌöçÎìùÌïòÏÑ∏Ïöî!"
      }},
      { type: "story", theme: "dark", content: {
        label: "Í≤∞Í≥º Ï†ÑÌôò Ï†ÑÏóºÎ≥ë", title: "31% of Trials Cheat",
        text: "PLOS Ïó∞Íµ¨Ïóê Îî∞Î•¥Î©¥ ÏûÑÏÉÅÏãúÌóòÏùò 31%Í∞Ä Îì±Î°ùÍ≥º Ï∂úÌåê ÏÇ¨Ïù¥Ïùò Í∏∞Î≥∏ Í≤∞Í≥ºÎ•º Ìï≠ÏÉÅ Í≤∞Í≥ºÍ∞Ä Îçî Ï¢ãÍ≤å Î≥¥Ïù¥Îäî Î∞©Ìñ•ÏúºÎ°ú Î≥ÄÍ≤ΩÌïú Í≤ÉÏúºÎ°ú ÎÇòÌÉÄÎÇ¨ÏäµÎãàÎã§."
      }},
      { type: "decision", theme: "dark", content: {
        icon: "üîÑ", title: "ÏãúÎÇòÎ¶¨Ïò§: Ïú†ÌòπÏ†ÅÏù∏ Ïä§ÏúÑÏπò",
        xp: 25,
        scenario: "Í∑ÄÌïòÏùò Î©îÌÉÄ Î∂ÑÏÑù ÌîÑÎ°úÌÜ†ÏΩúÏóêÏÑúÎäî 'Î™®Îì† ÏõêÏù∏ÏúºÎ°ú Ïù∏Ìïú ÏÇ¨ÎßùÎ•†'ÏùÑ Ï£ºÏöî Í≤∞Í≥ºÎ°ú ÏßÄÏ†ïÌñàÏäµÎãàÎã§. Ï∂îÏ∂ú ÌõÑ ÏÇ¨ÎßùÎ•†ÏùÑ Î≥¥Í≥†Ìïú Ïó∞Íµ¨Îäî 4Í∞úÎøêÏù¥ÏóàÍ≥†, 'Ïã¨Ïû•ÌòàÍ¥Ä ÏÇ¨Í±¥'ÏùÑ Î≥¥Í≥†Ìïú Ïó∞Íµ¨Îäî 12Í∞úÏòÄÏäµÎãàÎã§. Í∑ÄÌïòÏùò Ï°∞Ïñ∏ÏûêÎäî 'Îç∞Ïù¥ÌÑ∞Í∞Ä Îçî Ïûò Îí∑Î∞õÏπ®ÎêòÎØÄÎ°ú' Í∏∞Î≥∏ Í≤∞Í≥ºÎ•º Ï†ÑÌôòÌï† Í≤ÉÏùÑ Ï†úÏïàÌï©ÎãàÎã§.",
        question: "Ïñ¥ÎñªÍ≤å Ìï¥Ïïº Ìï©ÎãàÍπå?",
        options: [
          { letter: "A", text: "Switch to cardiovascular events‚Äîmore data is better", correct: false },
          { letter: "B", text: "Keep mortality as primary, add CV events as secondary", correct: true },
          { letter: "C", text: "Report both as co-primary outcomes", correct: false },
          { letter: "D", text: "ÌîÑÎ°úÌÜ†ÏΩúÏùÑ ÏàòÏ†ïÌïòÍ≥† Ïû¨Îì±Î°ùÌïú ÌõÑ ÏßÑÌñâÌïòÏÑ∏Ïöî.", correct: false }
        ],
        feedback: {
          correct: "Ïò≥ÏùÄ! ÌîÑÎ°úÌÜ†ÏΩúÏùÄ ÎãπÏã†ÏùÑ ÎãπÏã† ÏûêÏã†ÏúºÎ°úÎ∂ÄÌÑ∞ Î≥¥Ìò∏Ìï©ÎãàÎã§. Ïã§ÌóòÏùò 31%Í∞Ä Í≤∞Í≥ºÎ•º Î∞îÍøâÎãàÎã§. Ïù¥Í≤ÉÏù¥ Î∂ÄÏ†ïÏ†ÅÏù∏ Ïã§ÌóòÏù¥ 'Í∏çÏ†ïÏ†Å'Ïù¥ ÎêòÎäî Î∞©ÏãùÏûÖÎãàÎã§. ÏõêÎûòÏùò Í∏∞Î≥∏ÏùÑ Ïú†ÏßÄÌïòÏÑ∏Ïöî.",
          incorrect: "Îç∞Ïù¥ÌÑ∞Î•º Î≥∏ ÌõÑ Í≤∞Í≥ºÎ•º Î∞îÍæ∏Îäî Í≤ÉÏùÄ Ï†ïÌôïÌûà 31%Ïùò ÏãúÌóòÏù¥ Î∂ÄÏ†ï ÌñâÏúÑÎ•º ÌïòÎäî Î∞©ÏãùÏûÖÎãàÎã§. Í∑ÄÌïòÏùò ÌîÑÎ°úÌÜ†ÏΩúÏùÄ Í∑ÄÌïòÏùò ÏïΩÏÜçÏûÖÎãàÎã§. CV Ïù¥Î≤§Ìä∏Îäî 2Ï∞® Î∂ÑÏÑùÏù¥ Îê† Ïàò ÏûàÏäµÎãàÎã§."
        }
      }},
      { type: "story", theme: "red-bg", content: {
        label: "HRT Ïó≠Ï†Ñ", title: "Two Million Women",
        text: "40ÎÖÑ ÎèôÏïà ÏùòÏÇ¨Îì§ÏùÄ ÌèêÍ≤ΩÍ∏∞ Ïó¨ÏÑ±Ïùò Ïã¨Ïû•Î≥ëÏùÑ ÏòàÎ∞©ÌïòÍ∏∞ ÏúÑÌï¥ Ìò∏Î•¥Î™¨ ÎåÄÏ≤¥ ÏöîÎ≤ïÏùÑ Ï≤òÎ∞©ÌñàÏäµÎãàÎã§. Í¥ÄÏ∞∞ Ïó∞Íµ¨Ïóê Îî∞Î•¥Î©¥ Ïã¨Ïû• ÎßàÎπÑÍ∞Ä 50% Í∞êÏÜåÌïú Í≤ÉÏúºÎ°ú ÎÇòÌÉÄÎÇ¨ÏäµÎãàÎã§. Î∂ÑÎ™ÖÌï¥ Î≥¥ÏòÄÏäµÎãàÎã§. Í∑∏Í≤ÉÏùÄ ÌãÄÎ†∏Îã§.",
        followup: "In 2002, the Women's Health Initiative RCT was stopped early. HRT <strong>increased</strong> heart attacks by 29%. Increased strokes by 41%. Increased breast cancer by 26%. Two million women had been taking a drug that harmed them, prescribed based on evidence that looked good but wasn't."
      }},
      { type: "decision", theme: "dark", content: {
        icon: "üî¨", title: "ÏãúÎÇòÎ¶¨Ïò§: Í¥ÄÏ∞∞Ïùò Ïú†Ìòπ",
        xp: 25,
        scenario: "ÎãπÏã†ÏùÄ ÏÉàÎ°úÏö¥ Í∞úÏûÖÏóê ÎåÄÌïú Ï≤¥Í≥ÑÏ†ÅÏù∏ Í≤ÄÌÜ†Î•º ÏúÑÌïú ÌîÑÎ°úÌÜ†ÏΩúÏùÑ ÏûëÏÑ±ÌïòÍ≥† ÏûàÏäµÎãàÎã§. 50Í∞úÏùò Í¥ÄÏ∞∞ Ïó∞Íµ¨Îäî Í∑πÏ†ÅÏù∏ Ïù¥Ï†êÏùÑ Î≥¥Ïó¨Ï§çÎãàÎã§. Í≤∞Í≥ºÍ∞Ä ÌòºÌï©Îêú ÏÜåÍ∑úÎ™® RCTÎäî 3Í∞úÎøêÏûÖÎãàÎã§. Í∑ÄÌïòÏùò ÌåÄÏóêÏÑúÎäî 'Îç∞Ïù¥ÌÑ∞Í∞Ä Îçî Í∞ïÎ†•Ìïú' Í¥ÄÏ∞∞ Ïó∞Íµ¨ÏóêÎßå ÏßëÏ§ëÌï† Í≤ÉÏùÑ Ï†úÏïàÌï©ÎãàÎã§.",
        question: "ÌîÑÎ°úÌÜ†ÏΩúÏùÑ Ïñ¥ÎñªÍ≤å Íµ¨ÏÑ±Ìï¥Ïïº Ìï©ÎãàÍπå?",
        options: [
          { letter: "A", text: "Include only observational studies‚Äîlarger sample sizes", correct: false },
          { letter: "B", text: "Analyze RCTs and observational separately, RCTs primary", correct: true },
          { letter: "C", text: "ÌíÄ RCTÏôÄ Í¥ÄÏ∞∞ Ïó∞Íµ¨Î•º Ìï®Íªò", correct: false },
          { letter: "D", text: "Í¥ÄÏ∞∞ Ïó∞Íµ¨Î•º ÏôÑÏ†ÑÌûà Ï†úÏô∏", correct: false }
        ],
        feedback: {
          correct: "Correct! HRT observational studies showed 50% benefit; the RCT showed 29% harm. Confounding bias in observational studies can create illusions. RCTs must be primary.",
          incorrect: "The HRT reversal: observational studies said 'benefit,' the RCT said 'harm.' Healthy women chose HRT‚Äîconfounding created an illusion. RCTs break confounding."
        }
      }},
      { type: "story", theme: "dark", content: {
        label: "Ïó∞Íµ¨ Ïù¥ÏïºÍ∏∞ 329", title: "Ghostwritten Lies",
        text: "In 2001, SmithKline Beecham published Study 329: paroxetine was 'safe and effective' for adolescent depression. Doctors prescribed it to millions of teenagers. But the published paper was ghostwritten. The actual data showed something else entirely.",
        followup: "The raw data: paroxetine was <strong>no better than placebo</strong> for depression. Worse: it increased suicidal thinking in adolescents by 200%. The ghostwriters had cherry-picked outcomes, hidden adverse events, and turned failure into success. It took 14 years to get the truth published."
      }},
      { type: "decision", theme: "dark", content: {
        icon: "üìã", title: "ÏãúÎÇòÎ¶¨Ïò§: ÏãúÏ†ê ÎîúÎ†àÎßà",
        xp: 30,
        scenario: "You're writing the protocol for a colchicine meta-analysis. Trials report MACE at 30 days, 90 days, 1 year, and 3 years. Two team members disagree: one wants 'longest follow-up,' another wants 'fixed 1-year for all.'",
        question: "Í∞ÄÏû• Ï¢ãÏùÄ Ï†ëÍ∑º Î∞©ÏãùÏùÄ Î¨¥ÏóáÏûÖÎãàÍπå?",
        options: [
          { letter: "A", text: "Use longest follow-up per trial (maximizes data)", correct: false },
          { letter: "B", text: "Use fixed 1-year for all (cleaner comparison)", correct: false },
          { letter: "C", text: "Write a specific rule: 'Longest ‚â•1 year, else longest available'", correct: true },
          { letter: "D", text: "ÎÇòÏ§ëÏóê Ïñ¥Îñ§ Îç∞Ïù¥ÌÑ∞Í∞Ä Ï°¥Ïû¨ÌïòÎäîÏßÄ ÌôïÏù∏Ìïú ÌõÑ Í≤∞Ï†ïÌïòÏÑ∏Ïöî", correct: false }
        ],
        feedback: {
          correct: "ÌõåÎ•≠Ìï¥Ïöî! Íµ¨Ï≤¥Ï†ÅÏù¥Í≥† ÎØ∏Î¶¨ ÏßÄÏ†ïÎêú Í∑úÏπôÏùÄ Î™®Ìò∏ÏÑ±ÏùÑ Î∞©ÏßÄÌï©ÎãàÎã§. ÏòµÏÖò CÎäî Îç∞Ïù¥ÌÑ∞ ÏµúÎåÄÌôîÏôÄ Ìï¥ÏÑù Í∞ÄÎä•ÏÑ±Ïùò Í∑†ÌòïÏùÑ ÎßûÏ∂•ÎãàÎã§.",
          incorrect: "Both A and B have merit, but they're still ambiguous. A specific rule like 'longest ‚â•1 year where available, else longest available' prevents disagreement during extraction."
        }
      }},
      { type: "checklist", theme: "dark", content: {
        title: "DoD-A Checklist",
        items: [
          "PICOS + inclusion/exclusion defined",
          "Primary outcome specified",
          "Timepoint rule documented",
          "Model choice (fixed/random)",
          "Sensitivity set defined",
          "Secondary outcomes labelled exploratory",
          "Protocol registered (PROSPERO/protocols.io)",
          "Signed by Integrator + non-integrator"
        ]
      }},
      { type: "decision", theme: "dark", content: {
        icon: "üî¨", title: "ÏãúÎÇòÎ¶¨Ïò§: ÎåÄÎ¶¨ Ìï®Ï†ï",
        xp: 25,
        scenario: "ÏûÑÏÉÅ Í≥†Î¨∏ÏùÄ 'ÏΩúÎ†àÏä§ÌÖåÎ°§ Í∞êÏÜå'Î•º 1Ï∞® Í≤∞Í≥ºÎ°ú ÏÇ¨Ïö©ÌïòÎèÑÎ°ù Ï†úÏïàÌï©ÎãàÎã§. Îçî ÎßéÏùÄ ÏûÑÏÉÅÏãúÌóòÏóêÏÑú Î≥¥Í≥†ÎêòÍ∏∞ ÎïåÎ¨∏ÏûÖÎãàÎã§. ÌïòÏßÄÎßå Í∑ÄÌïòÏùò ÏõêÎûò ÏßàÎ¨∏ÏùÄ 'Ïã¨Ïû•ÌòàÍ¥Ä ÏÇ¨Îßù'Ïóê Í¥ÄÌïú Í≤ÉÏù¥ÏóàÏäµÎãàÎã§.",
        question: "Ïñ¥ÎñªÍ≤å Ìï¥Ïïº Ìï©ÎãàÍπå?",
        options: [
          { letter: "A", text: "Switch to cholesterol‚Äîmore data is better", correct: false },
          { letter: "B", text: "Keep cardiovascular death as primary", correct: true },
          { letter: "C", text: "Use both as co-primary outcomes", correct: false },
          { letter: "D", text: "Add cholesterol as exploratory sensitivity", correct: false }
        ],
        feedback: {
          correct: "Correct! The CAST tragedy taught us: surrogate outcomes (like cholesterol) can mask real harm. Keep patient-important outcomes primary.",
          incorrect: "Cholesterol is a surrogate‚Äîit can improve while patients die (as in CAST). The Vioxx lesson: stick to patient-important outcomes."
        }
      }},
      { type: "story", theme: "red-bg", content: {
        label: "ÎßàÌÇ§ÏïÑÎ¶¨Îãà Ïä§Ï∫îÎì§", title: "The Surgeon Who Implanted Death",
        text: "Paolo Macchiarini was called a miracle worker. The Italian surgeon claimed he could grow synthetic tracheas and implant them in dying patients. <strong>The Lancet</strong> published his 'breakthroughs.' The Karolinska Institute‚Äîhome of the Nobel Prize‚Äîhired him. Patients flew from around the world seeking his revolutionary procedure.",
        followup: "One by one, his patients died. Of the eight who received his synthetic tracheas, <strong>seven died</strong>‚Äîmost within two years, suffocating as the plastic scaffolds disintegrated inside their throats. Karolinska's own doctors raised alarms. They were ignored. When a documentary exposed the truth, investigators found: falsified ethics approvals, fabricated patient outcomes, and co-authors who had never seen the data. The prestigious institute that awards the Nobel Prize had harbored a fraud who killed patients for fame. The Lancet retracted multiple papers. Macchiarini was convicted of assault. The lesson: prestige protects nothing. Only verification protects patients."
      }},
      { type: "decision", theme: "dark", content: {
        icon: "üèõÔ∏è", title: "ÏãúÎÇòÎ¶¨Ïò§: Î™ÖÎßù ÎÜíÏùÄ ÌòÅÏã†Í∞Ä",
        xp: 25,
        scenario: "ÏÑ∏Í≥ÑÏ†ÅÏúºÎ°ú Ïú†Î™ÖÌïú Í∏∞Í¥ÄÏùò Ï†ÄÎ™ÖÌïú Ïô∏Í≥ºÏùòÏÇ¨Í∞Ä ÏµúÍ≥†Ïùò Ï†ÄÎÑêÏóê ÌòÅÏã†Ï†ÅÏù∏ Í≤∞Í≥ºÎ•º Î∞úÌëúÌñàÏäµÎãàÎã§. Í∑∏Ïùò Í∏∞Ïà†ÏùÄ ÏàòÏ≤ú Î™ÖÏùÑ Íµ¨Ìï† Ïàò ÏûàÏóàÏäµÎãàÎã§. ÌõÑÎ∞∞ ÎèôÎ£åÎì§ÏùÄ ÌôòÏûêÏùò Í≤∞Í≥ºÏóê ÎåÄÌï¥ Ïö∞Î†§Î•º ÌëúÎ™ÖÌïòÏßÄÎßå Í≥†ÏúÑ Í≤ΩÏòÅÏßÑÏùÄ Ïù¥Î•º ÏßàÌà¨Î°ú ÏùºÏ∂ïÌï©ÎãàÎã§. Îã§ÌÅêÎ©òÌÑ∞Î¶¨ Ï†úÏûëÏßÑÏù¥ Ïù∏ÌÑ∞Î∑∞Î•º ÏöîÏ≤≠Ìï©ÎãàÎã§.",
        question: "Í∏∞Í¥ÄÏóêÏÑúÎäî Ïñ¥ÎñªÍ≤å Ìï¥Ïïº Ìï†ÍπåÏöî?",
        options: [
          { letter: "A", text: "Protect the surgeon's reputation‚Äîbad press harms everyone", correct: false },
          { letter: "B", text: "Immediately audit all patient outcomes with independent reviewers", correct: true },
          { letter: "C", text: "Wait for peer-reviewed rebuttals before acting", correct: false },
          { letter: "D", text: "Let the surgeon respond to critics in his own publications", correct: false }
        ],
        feedback: {
          correct: "ÎßûÏäµÎãàÎã§! KarolinskaÏùò Í∞ÄÏû• ÌÅ∞ Ïã§Ìå®Îäî Î™ÖÏÑ±ÏùÑ Î≥¥Ìò∏ÌïòÍ∏∞ ÏúÑÌï¥ ÎÇ¥Î∂Ä Í≤ΩÍ≥†Î•º Î¨¥ÏãúÌïú Í≤ÉÏûÖÎãàÎã§. ÌèâÌåê Í¥ÄÎ¶¨Í∞Ä ÏïÑÎãå ÎèÖÎ¶ΩÏ†ÅÏù∏ Í≤∞Í≥º Í∞êÏÇ¨Î•º ÌÜµÌï¥ ÌôòÏûêÎ•º Î≥¥Ìò∏Ìï©ÎãàÎã§. ÌõÑÎ∞∞ ÎèôÎ£åÎì§ÏùÄ Î¶¨ÎçîÎì§Ïù¥ Î≥¥ÏßÄ Î™ªÌïòÎäî Í≤ÉÏùÑ Î≥¥Îäî Í≤ΩÏö∞Í∞Ä ÎßéÏäµÎãàÎã§.",
          incorrect: "Karolinska InstituteÎäî ÌôòÏûêÎ≥¥Îã§ ÌèâÌåêÏùÑ ÏÑ†ÌÉùÌñàÏäµÎãàÎã§. 7Î™ÖÏù¥ ÏÇ¨ÎßùÌñàÏäµÎãàÎã§. ÎÇ¥Î∂ÄÏûêÍ∞Ä Ïö∞Î†§ÏÇ¨Ìï≠ÏùÑ Ï†úÍ∏∞ÌïòÎ©¥ Ï¶âÏãú Í∞êÏÇ¨ÌïòÏã≠ÏãúÏò§. Î™ÖÏÑ±ÏùÄ ÏïàÏ†ÑÏùò Ï¶ùÍ±∞Í∞Ä ÏïÑÎãôÎãàÎã§."
        }
      }},
      { type: "story", theme: "dark", content: {
        label: "Ìô©Ïö∞ÏÑù ‚Äã‚ÄãÏÇ¨Í∏∞", title: "The Pride of a Nation, Built on Lies",
        text: "In 2004, South Korean scientist <strong>Hwang Woo-suk</strong> announced he had cloned human embryos and created patient-specific stem cells‚Äîa breakthrough that could cure Parkinson's, diabetes, and paralysis. He was a national hero. The government issued postage stamps in his honor. Schools taught his achievements. His papers in <strong>Science</strong> were celebrated as Nobel-worthy.",
        followup: "A junior researcher noticed the photos looked wrong. The same cells appeared in multiple images, supposedly from different experiments. When Science investigated, the fa√ßade crumbled: the breakthrough data was fabricated. Hwang had pressured junior researchers‚Äîmostly women‚Äîto donate eggs under ethically questionable conditions. He had fabricated results to meet impossible expectations. The 'cloned' stem cells never existed. South Korea's national pride evaporated overnight. Hwang was convicted of embezzlement and bioethics violations. He had spent $40 million in government funds on research that produced nothing but lies."
      }},
      { type: "decision", theme: "dark", content: {
        icon: "üî¨", title: "ÏãúÎÇòÎ¶¨Ïò§: Íµ≠Í∞Ä Ïö∞ÏÑ†ÏàúÏúÑ",
        xp: 25,
        scenario: "ÎãπÏã† ÎÇòÎùºÏùò ÏµúÍ≥† Í≥ºÌïôÏûêÍ∞Ä ÌòÅÎ™ÖÏ†ÅÏù∏ ÎèåÌååÍµ¨Î•º Ï£ºÏû•Ìï©ÎãàÎã§. Ï†ïÎ∂ÄÎäî ÎåÄÍ∑úÎ™® ÌôïÏû•Ïóê ÏûêÍ∏àÏùÑ ÏßÄÏõêÌïòÍ≥† ÏûàÏäµÎãàÎã§. Íµ≠Ï†úÏ†ÅÏù∏ Í≤ΩÏüÅÏûêÎì§Ïù¥ Î≥µÏ†úÎ•º ÏúÑÌï¥ Í≤ΩÏüÅÌïòÍ≥† ÏûàÏäµÎãàÎã§. ÌõÑÎ∞∞ Ïó∞Íµ¨Ïã§ Íµ¨ÏÑ±ÏõêÏù¥ Ïù¥ÎØ∏ÏßÄ Îç∞Ïù¥ÌÑ∞Í∞Ä Ï°∞ÏûëÎêú Í≤É Í∞ôÎã§Í≥† Ï°∞Ïö©Ìûà ÎßêÌïòÏßÄÎßå Î∞úÏñ∏Ïóê ÎåÄÌïú Î≥¥Î≥µÏùÑ ÎëêÎ†§ÏõåÌï©ÎãàÎã§.",
        question: "What is the correct first step?",
        options: [
          { letter: "A", text: "ÎèÖÎ¶ΩÏ†ÅÏù∏ Ïù¥ÎØ∏ÏßÄ Î∂ÑÏÑùÏùÑ ÏöîÏ≤≠ÌïòÎ©¥ÏÑú ÎÇ¥Î∂ÄÍ≥†Î∞úÏûêÏùò Ïã†ÏõêÏùÑ Î≥¥Ìò∏ÌïòÏÑ∏Ïöî", correct: true },
          { letter: "B", text: "Ïö∞Î†§ÏÇ¨Ìï≠ÏùÑ ÏÑ†ÏûÑ Í≥ºÌïôÏûêÏóêÍ≤å ÏßÅÏ†ë ÎåÄÎ©¥ÌïòÏÑ∏Ïöî", correct: false },
          { letter: "C", text: "Wait for international labs to attempt replication", correct: false },
          { letter: "D", text: "Report to government funders immediately", correct: false }
        ],
        feedback: {
          correct: "ÎßûÏäµÎãàÎã§! ÎÇ¥Î∂Ä Í≥†Î∞úÏûêÎ•º ÎÖ∏Ï∂úÏãúÌÇ§ÏßÄ ÏïäÍ≥† ÎèÖÎ¶ΩÏ†ÅÏù∏ Î∂ÑÏÑùÍ∞ÄÍ∞Ä ÏàòÌñâÌïòÎäî Ïù¥ÎØ∏ÏßÄ Ìè¨Î†åÏãùÏùÄ ÏïàÏ†ÑÌïú Î∞©Î≤ïÏûÖÎãàÎã§. Ìô©Ïî®Ïùò ÏÇ¨Í∏∞ ÌñâÏúÑÎäî Ïù¥ÎØ∏ÏßÄ Î∂ÑÏÑùÏúºÎ°ú Ï†ÅÎ∞úÎêêÎã§. Î∞úÏñ∏ÌïòÎäî ÌïòÍ∏â Ïó∞Íµ¨ÏõêÏùÄ Î≥¥Ìò∏Í∞Ä ÌïÑÏöîÌï©ÎãàÎã§.",
          incorrect: "ÏßÅÏ†ë ÎåÄÍ≤∞ÌïòÎ©¥ ÎÇ¥Î∂Ä Í≥†Î∞úÏûêÍ∞Ä ÏúÑÌóòÌï¥ÏßÄÍ≥† Ï¶ùÍ±∞Í∞Ä ÌååÍ¥¥Îê† Ïàò ÏûàÏäµÎãàÎã§. Ï§ëÎ≥µÎêú ÏÑ∏Ìè¨Î•º Î≥¥Ïó¨Ï£ºÎäî Ïù¥ÎØ∏ÏßÄ Î∂ÑÏÑùÏúºÎ°ú Ìô©Ïî®Ïùò ÏÇ¨Í∏∞ ÌñâÏúÑÍ∞Ä Ï†ÅÎ∞úÎêêÎã§. ÎèÖÎ¶ΩÏ†ÅÏù∏ Ìè¨Î†åÏãù ÌõÑ ÏóêÏä§Ïª¨Î†àÏù¥ÏÖò"
        }
      }},
      { type: "concept", theme: "light", content: {
        title: "Îëê Í∞úÏùò ÏÑúÎ™Ö Í∑úÏπô",
        subtitle: "Why two people must sign",
        text: "The Poldermans fraud succeeded because one researcher controlled everything. Single points of authority enable fraud.",
        highlight: "Two signatures means two people verified."
      }},
      { type: "quiz", theme: "dark", content: {
        question: "Why must the protocol be registered BEFORE DoD-A passes?",
        options: [
          { text: "It's a journal requirement only", correct: false },
          { text: "Îç∞Ïù¥ÌÑ∞Î•º Î≥¥Í∏∞ Ï†ÑÏóê ÏïΩÏÜçÏùò ÌÉÄÏûÑÏä§ÌÉ¨ÌîÑÎ•º Ï∞çÏäµÎãàÎã§.", correct: true },
          { text: "Í≤ÄÌÜ†Í∞Ä ÎçîÏö± Ï†ÑÎ¨∏Ï†ÅÏúºÎ°ú Î≥¥ÏûÖÎãàÎã§", correct: false },
          { text: "It's optional for non-Cochrane reviews", correct: false }
        ],
        xp: 20,
        feedback: {
          correct: "Ï†ïÌôïÌï©ÎãàÎã§! Îì±Î°ùÌïòÎ©¥ ÌÉÄÏûÑÏä§ÌÉ¨ÌîÑÍ∞Ä ÏÉùÏÑ±Îê©ÎãàÎã§. Ïù¥Í≤ÉÏù¥ ÏóÜÏúºÎ©¥ Ìö®Í≥ºÍ∞Ä ÏûàÏóàÎçò Í≤ÉÏùÑ ÌôïÏù∏Ìïú ÌõÑ Í≤∞Í≥ºÎ•º Î≥ÄÍ≤ΩÌïòÏßÄ ÏïäÏïòÎã§Îäî Í≤ÉÏùÑ Ï¶ùÎ™ÖÌï† Ïàò ÏóÜÏäµÎãàÎã§.",
          incorrect: "Îì±Î°ù ÌÉÄÏûÑÏä§ÌÉ¨ÌîÑÏóêÎäî ÎØ∏Î¶¨ ÏßÄÏ†ïÎêú Î∞©Î≤ïÏù¥ ÌëúÏãúÎê©ÎãàÎã§. ÏãúÌóò Ï§ë 31%Í∞Ä Í≤∞Í≥ºÎ•º Î≥ÄÍ≤ΩÌï©ÎãàÎã§. Îì±Î°ùÏùÑ ÌïòÎ©¥ Î≥ÄÍ≤ΩÎêòÏßÄ ÏïäÏïòÏùåÏùÑ Ï¶ùÎ™ÖÌï† Ïàò ÏûàÏäµÎãàÎã§."
        }
      }}
    ]
  },
  {
    id: 4, title: "Phase B: Search", subtitle: "Days 4-10: Document everything", xp: 150,
    slides: [
      { type: "title", theme: "dark", content: { title: "Phase B: Search & Screen", subtitle: "Days 4-10: Systematic, documented, reproducible" }},
      { type: "objectives", theme: "dark", content: {
        objectives: [
          "Understand why search strings must be saved verbatim",
          "Learn calibration requirements for dual screening",
          "Master PRISMA reporting requirements",
          "Know when exclusion reasons are required"
        ],
        tip: "Ïù¥ Î™®ÎìàÏùÑ ÏôÑÎ£åÌïòÏó¨ Search Savant Î∞∞ÏßÄÎ•º ÌöçÎìùÌïòÏÑ∏Ïöî!"
      }},
      { type: "story", theme: "dark", content: {
        label: "Cochrane Ï≤†Ìöå", title: "Every Character Matters",
        text: "Í∞êÏÇ¨ÏûêÍ∞Ä Í≤ÄÏÉâÏùÑ Ïû¨ÌòÑÌï† Ïàò ÏóÜÏùÑ Îïå Cochrane Í≤ÄÌÜ†Í∞Ä Ï≤†ÌöåÎêòÏóàÏäµÎãàÎã§. 'Ïö∞Î¶¨Îäî PubMedÎ•º ÏÇ¨Ïö©ÌñàÏäµÎãàÎã§'Îäî Î∞©Î≤ïÏù¥ ÏïÑÎãôÎãàÎã§."
      }},
      { type: "decision", theme: "dark", content: {
        icon: "üíæ", title: "ÏãúÎÇòÎ¶¨Ïò§: Ïû¨Íµ¨ÏÑ±Îêú Í≤ÄÏÉâ",
        xp: 25,
        scenario: "You're at Day 8. A team member admits they didn't save the exact search string from last week‚Äîbut they 'remember most of it' and have reconstructed it. The search yielded 2,400 results then; the reconstructed search yields 2,380.",
        question: "Ïñ¥ÎñªÍ≤å Ìï¥Ïïº Ìï©ÎãàÍπå?",
        options: [
          { letter: "A", text: "Accept it‚Äî20 missing records won't matter", correct: false },
          { letter: "B", text: "ÏÉà Í≤ÄÏÉâÏùÑ Îã§Ïãú Ïã§ÌñâÌïòÍ≥† Í≥µÏãù Í≤ÄÏÉâÏúºÎ°ú Î¨∏ÏÑúÌôîÌï©ÎãàÎã§.", correct: true },
          { letter: "C", text: "Ïû¨Íµ¨ÏÑ±Îêú Í≤ÄÏÉâÏùÑ ÏÇ¨Ïö©ÌïòÍ≥† Ï†úÌïú ÏÇ¨Ìï≠Ïóê Ïú†ÏùòÌïòÏÑ∏Ïöî", correct: false },
          { letter: "D", text: "Contact the database to get search history", correct: false }
        ],
        feedback: {
          correct: "ÎßûÏäµÎãàÎã§! Ïû¨ÌòÑÌï† Ïàò ÏóÜÎäî ÏàòÏÉâÏùÄ Ï¶ùÍ±∞Í∞Ä ÏïÑÎãôÎãàÎã§. ÏÉàÎ°úÏö¥ Í≤ÄÏÉâÏùÑ Í≥µÏãùÏ†ÅÏù∏ Í≤ÉÏúºÎ°ú Í∏∞Î°ùÌïòÍ≥†, Ìé∏Ï∞®Î•º Í∏∞Î°ùÌïòÍ≥†, Ìà¨Î™ÖÌïú Î∞©Î≤ïÏúºÎ°ú ÏßÑÌñâÌïòÏã≠ÏãúÏò§.",
          incorrect: "The Cochrane retraction: 'We used PubMed' isn't a method. You need the exact string, exact date, exact filters. Start fresh with documented methods."
        }
      }},
      { type: "story", theme: "red-bg", content: {
        label: "Îß§Ïû•Îêú Ïû¨Ìåê", title: "74Í∞ú Ïó∞Íµ¨Îäî Ïñ¥ÎîîÎ°ú Í∞îÏäµÎãàÍπå?",
        text: "2008ÎÖÑÏóê Ïó∞Íµ¨ÏûêÎì§ÏùÄ Îì±Î°ùÎêú Î™®Îì† Ìï≠Ïö∞Ïö∏Ï†ú ÏûÑÏÉÅÏãúÌóòÏùÑ Í≤ÄÏÉâÌñàÏäµÎãàÎã§. Í∑∏Îì§ÏùÄ 74Í∞úÏùò Ïã§ÌóòÏùÑ Ï∞æÏïòÏäµÎãàÎã§. Í∑∏Îü∞ Îã§Ïùå Í∑∏Îì§ÏùÄ Ï∂úÌåêÎ¨ºÏùÑ Í≤ÄÏÉâÌñàÏäµÎãàÎã§. 38Í∞úÎßå Ï∂úÌåêÎêòÏóàÏäµÎãàÎã§. ÎÇòÎ®∏ÏßÄ 36Í∞úÎäîÏöî? Î¨ªÌòÄÏûàÎã§. Ïà®Í≤®ÏßÑ. ÏÇ¨ÎùºÏ°åÏäµÎãàÎã§.",
        followup: "Every single buried trial showed negative results. Every published trial showed positive results. The published literature told doctors: 'Antidepressants work 94% of the time.' The truth: they worked 51% of the time. Half the evidence had simply vanished."
      }},
      { type: "decision", theme: "dark", content: {
        icon: "üîé", title: "ÏãúÎÇòÎ¶¨Ïò§: Îì±Î°ù ÎàÑÎùΩ",
        xp: 25,
        scenario: "Ï∂úÌåê Î¨∏ÌóåÏùÑ Í≤ÄÏÉâÌï¥ Î≥¥Î©¥ Ïã†ÏïΩÏóê ÎåÄÌïú 12Í±¥Ïùò ÏûÑÏÉÅÏãúÌóòÏù¥ Î∞úÍ≤¨ÎêòÏóàÏúºÎ©∞ Î™®Îëê Í∏çÏ†ïÏ†ÅÏù¥ÏóàÏäµÎãàÎã§. ÏãúÌóò Îì±Î°ùÏùÑ ÌôïÏù∏ÌïòÍ≥† Í≤åÏãúÎêòÏßÄ ÏïäÏùÄ Ï∂îÍ∞Ä Îì±Î°ù ÏãúÌóò 8Í∞úÎ•º Ï∞æÏäµÎãàÎã§. ÌöåÏÇ¨Îäî ÎØ∏Î∞úÌëú ÏãúÌóòÏóê 'Îç∞Ïù¥ÌÑ∞ ÌíàÏßà Î¨∏Ï†ú'Í∞Ä ÏûàÎã§Í≥† ÎßêÌï©ÎãàÎã§.",
        question: "Ïñ¥ÎñªÍ≤å Ìï¥Ïïº Ìï©ÎãàÍπå?",
        options: [
          { letter: "A", text: "Î∞úÌëúÎêú 12Í∞úÏùò ÏãúÌóòÎßå Ìè¨Ìï®Ìï©ÎãàÎã§. ÏÇ¨Ïö© Í∞ÄÎä•Ìïú Îç∞Ïù¥ÌÑ∞Í∞Ä ÏûàÏäµÎãàÎã§.", correct: false },
          { letter: "B", text: "Îì±Î°ù Í∏∞Í¥Ä Ïó∞ÎùΩÏ≤ò Î∞è FDAÏóê ÎØ∏Î∞úÌëú Îç∞Ïù¥ÌÑ∞Î•º ÏöîÏ≤≠", correct: true },
          { letter: "C", text: "Note the 8 missing trials as a limitation", correct: false },
          { letter: "D", text: "Ìé∏Ìñ•ÏúºÎ°ú Ïù∏Ìï¥ Í≤ÄÌÜ†ÏóêÏÑú Ìï¥Îãπ ÏïΩÎ¨ºÏùÑ Ï†úÏô∏Ìï©ÎãàÎã§. Ïö∞Î†§ ÏÇ¨Ìï≠", correct: false }
        ],
        feedback: {
          correct: "Correct! The buried trials lesson: 48% of antidepressant data was hidden. Request unpublished data from registries, FDA, authors. Half the truth is a lie.",
          incorrect: "36 of 74 antidepressant trials were buried‚Äîall negative. Published-only evidence showed 94% efficacy; true efficacy was 51%. Always hunt for unpublished data."
        }
      }},
      { type: "story", theme: "dark", content: {
        label: "Î†àÎ≥µÏÑ∏Ìã¥ Ïä§Ï∫îÎì§", title: "Ìö®Í≥ºÍ∞Ä ÏóÜÎäî ÏïΩÎ¨º",
        text: "Reboxetine was approved in Europe for depression. Published trials showed it worked. Doctors prescribed it. Then researchers obtained the unpublished data. <strong>74% of the patient data had never been published.</strong>",
        followup: "Ïà®Í≤®ÏßÑ Îç∞Ïù¥ÌÑ∞Ïóê Îî∞Î•¥Î©¥ Î†àÎ≥µÏÑ∏Ìã¥ÏùÄ ÏúÑÏïΩÎ≥¥Îã§ ÎÇòÏùÑ Í≤ÉÏù¥ ÏóÜÏóàÏäµÎãàÎã§. Îã§Î•∏ Ìï≠Ïö∞Ïö∏Ï†úÎ≥¥Îã§ Îçî ÎÇòÎπ¥ÏäµÎãàÎã§. Î∂ÄÏûëÏö©Ïù¥ Îçî ÎßéÏïòÏäµÎãàÎã§. ÏÑ†Î≥ÑÎêú Ï¶ùÍ±∞Î•º Î∞îÌÉïÏúºÎ°ú Í∑úÏ†ú ÎãπÍµ≠Ïù¥ ÏäπÏù∏Ìïú ÏïΩÎ¨ºÎ°ú Ïù∏Ìï¥ ÌôòÏûêÎì§ÏùÄ ÏàòÎÖÑ ÎèôÏïà Í≥†ÌÜµÏùÑ Í≤™ÏóàÏäµÎãàÎã§."
      }},
      { type: "decision", theme: "dark", content: {
        icon: "üîç", title: "ÏãúÎÇòÎ¶¨Ïò§: Ïã¨ÏÇ¨ Î∂àÏùºÏπò",
        xp: 25,
        scenario: "Îëê Ïã¨ÏÇ¨ÏõêÏù¥ Î≥¥Ï†ïÏùÑ ÏúÑÌï¥ 50Í∞úÏùò Ï†úÎ™©/Ï¥àÎ°ùÏùÑ ÎèÖÎ¶ΩÏ†ÅÏúºÎ°ú Í≤ÄÌÜ†ÌñàÏäµÎãàÎã§. Í∑∏Îì§ÏùÄ Îã®ÏßÄ 28Í∞úÏóêÎßå ÎèôÏùòÌñàÏäµÎãàÎã§(56% ÎèôÏùò). Î™©ÌëúÎäî ‚â•80%ÏûÖÎãàÎã§.",
        question: "What should happen next?",
        options: [
          { letter: "A", text: "Proceed anyway‚Äî56% is acceptable for complex topics", correct: false },
          { letter: "B", text: "Discuss disagreements, revise criteria, re-calibrate on new 25", correct: true },
          { letter: "C", text: "Have a third person break all ties", correct: false },
          { letter: "D", text: "Switch to single-screener with random verification", correct: false }
        ],
        feedback: {
          correct: "ÎßûÏäµÎãàÎã§! ÎèôÏùòÍ∞Ä ÎÇÆÎã§Îäî Í≤ÉÏùÄ Í∏∞Ï§ÄÏù¥ Î™®Ìò∏ÌïòÎã§Îäî Í≤ÉÏùÑ ÏùòÎØ∏Ìï©ÎãàÎã§. ‚â•80%Ïóê ÎèÑÎã¨Ìï† ÎïåÍπåÏßÄ ÌÜ†Î°†ÌïòÍ≥† ÏàòÏ†ïÌïòÍ≥† Î∞òÎ≥µÌïòÏã≠ÏãúÏò§.",
          incorrect: "56% ÎèôÏùòÎäî Í∏∞Ï§ÄÏù¥ Î™®Ìò∏ÌïòÎã§Îäî Í≤ÉÏùÑ ÏùòÎØ∏Ìï©ÎãàÎã§. Î≥∏ÏßàÏ†ÅÏúºÎ°ú Î¨¥ÏûëÏúÑÎ°ú ÏÑ†Î≥ÑÌïòÍ≥† ÏûàÏäµÎãàÎã§. ÌÜ†Î°†ÌïòÍ≥† ÏàòÏ†ïÌïòÍ≥† Ïû¨Î≥¥Ï†ïÌïòÏÑ∏Ïöî."
        }
      }},
      { type: "checklist", theme: "dark", content: {
        title: "DoD-B Checklist",
        items: [
          "Search strings saved verbatim",
          "Search dates + limits recorded",
          "Í∏∞Î°ùÎêú Ï§ëÎ≥µ Ï†úÍ±∞ Î∞©Î≤ï",
          "Screening calibration (‚â•80%)",
          "PRISMA counts live",
          "Screening log exportable"
        ]
      }},
      { type: "decision", theme: "dark", content: {
        icon: "üìä", title: "ÏãúÎÇòÎ¶¨Ïò§: PRISMA ÌçºÏ¶ê",
        xp: 25,
        scenario: "Your PRISMA shows: Identified: 2,400 | After dedup: 1,800 | Screened: 1,800 | Full-text: 150 | Included: 45. A peer reviewer asks: 'What happened to the 1,650 excluded at screening?'",
        question: "Ï†ïÎãµÏùÄ Î¨¥ÏóáÏûÖÎãàÍπå?",
        options: [
          { letter: "A", text: "'They didn't meet criteria'‚Äîno need for details", correct: false },
          { letter: "B", text: "Provide counts by exclusion reason", correct: false },
          { letter: "C", text: "Explain that screening exclusions don't need reasons", correct: true },
          { letter: "D", text: "Go back and document each exclusion reason", correct: false }
        ],
        feedback: {
          correct: "Correct! Title/abstract screening exclusions don't require individual reasons (too many). Full-text exclusions DO need documented reasons.",
          incorrect: "Screening exclusions (title/abstract) don't require individual reasons‚Äîthere are too many. But FULL-TEXT exclusions must have documented reasons."
        }
      }},
      { type: "stats", theme: "dark", content: {
        title: "PRISMA Requirements",
        stats: [
          { value: "100%", label: "Numbers add up" },
          { value: "Every", label: "Full-text exclusion documented" },
          { value: "Zero", label: "Black boxes" }
        ]
      }},
      { type: "story", theme: "dark", content: {
        label: "The Missing Ï†àÎ∞ò", title: "NeurontinÏùò ÎπÑÎ∞Ä Ïó∞Íµ¨",
        text: "PfizerÎäî NeurontinÏùÑ ÏñëÍ∑πÏÑ± Ïû•Ïï†, Ìé∏ÎëêÌÜµ Î∞è ÌÜµÏ¶ùÏóê ÎåÄÌï¥ ÌôçÎ≥¥ÌñàÏßÄÎßå FDAÏóêÏÑúÎäî ÏäπÏù∏ÌïòÏßÄ ÏïäÏïòÏäµÎãàÎã§. ÎÇ¥Î∂Ä Î¨∏ÏÑúÏóê Îî∞Î•¥Î©¥ Ïó∞Íµ¨Î•º ÏùòÎ¢∞Ìïú Í≤ÉÏúºÎ°ú ÎÇòÌÉÄÎÇ¨ÏäµÎãàÎã§. Í≤∞Í≥ºÍ∞Ä Î∂ÄÏ†ïÏ†ÅÏù¥ÏóàÏùÑ Îïå, Ïó∞Íµ¨Îäî Îã®ÏàúÌûà... ÏÇ¨ÎùºÏ°åÏäµÎãàÎã§.",
        followup: "Ï∂úÌåêÎêú Î¨∏ÌóåÏóê Îî∞Î•¥Î©¥ NeurontinÏùÄ ÎùºÎ≤® Ïô∏ Ïö©ÎèÑÎ°ú ÏÇ¨Ïö©ÎêòÏóàÏäµÎãàÎã§. Ï∂úÌåêÎêòÏßÄ ÏïäÏùÄ Î¨∏ÌóåÏóêÏÑúÎäî Í∑∏Î†áÏßÄ ÏïäÏùÄ Í≤ÉÏúºÎ°ú ÎÇòÌÉÄÎÇ¨ÏäµÎãàÎã§. ÏùòÏÇ¨Îì§ÏùÄ Ï¶ùÍ±∞Ïùò Ï†àÎ∞òÎßå Î≥¥Í≥† Î™ÖÎ∞±ÌïòÍ≥† ÏûòÎ™ªÎêú Í≤∞Î°†ÏùÑ ÎÇ¥Î†∏ÏäµÎãàÎã§. ÌôîÏù¥ÏûêÎäî Î≤åÍ∏àÏúºÎ°ú 4Ïñµ3Ï≤úÎßå Îã¨Îü¨Î•º ÏßÄÎ∂àÌñàÎã§. Í∑∏Îü∞Îç∞ Ìö®Í≥ºÍ∞Ä ÏóÜÎäî ÏπòÎ£åÎ•º Î∞õÏùÄ ÌôòÏûêÎì§ÏùÄ? Í∑∏Îì§ÏùÄ Îçî ÎßéÏùÄ ÎπÑÏö©ÏùÑ ÏßÄÎ∂àÌñàÏäµÎãàÎã§."
      }},
      { type: "decision", theme: "dark", content: {
        icon: "üìÅ", title: "ÏãúÎÇòÎ¶¨Ïò§: ÌöåÏÇ¨ Ï†úÏïà",
        xp: 25,
        scenario: "Ìïú Ï†úÏïΩ ÌöåÏÇ¨Í∞Ä Í∑ÄÌïòÏùò Ï≤¥Í≥ÑÏ†ÅÏù∏ Í≤ÄÌÜ†Î•º ÏúÑÌï¥ 'ÏôÑÏ†ÑÌïú ÎÇ¥Î∂Ä Îç∞Ïù¥ÌÑ∞Î≤†Ïù¥Ïä§'Î•º Í≥µÏú†ÌïòÍ≤†Îã§Í≥† Ï†úÏïàÌñàÏäµÎãàÎã§. Í∑∏Îì§ÏùÄ Î™®Îì† ÏãúÌóò Îç∞Ïù¥ÌÑ∞Î•º ÏïΩÏÜçÌï©ÎãàÎã§. Îã®, Í∑ÄÌïòÍ∞Ä ÏäπÏù∏ ÏóÜÏù¥ Í∞úÎ≥Ñ ÏãúÌóò Í≤∞Í≥ºÎ•º Í≤åÏãúÌïòÏßÄ Î™ªÌïòÎèÑÎ°ù ÌïòÎäî Í∏∞Î∞Ä Ïú†ÏßÄ Í≥ÑÏïΩÏóê ÏÑúÎ™ÖÌïú Í≤ΩÏö∞ÏóêÎßå Ìï¥ÎãπÎê©ÎãàÎã§.",
        question: "Ïñ¥ÎñªÍ≤å Ìï¥Ïïº Ìï©ÎãàÍπå?",
        options: [
          { letter: "A", text: "ÏàòÎùΩ - Îç∞Ïù¥ÌÑ∞Î•º ÏñªÎäî Í≤ÉÏù¥ Ï§ëÏöîÌï©ÎãàÎã§", correct: false },
          { letter: "B", text: "ÏàòÎùΩÌïòÎêò Î∞©Î≤ï Ï†úÌïúÏóê Ïú†ÏùòÌïòÏÑ∏Ïöî", correct: false },
          { letter: "C", text: "Í≥µÏãù Ï±ÑÎÑêÏùÑ ÌÜµÌï¥ Îç∞Ïù¥ÌÑ∞Î•º Í±∞Î∂ÄÌïòÍ≥† ÏöîÏ≤≠ÌïòÏÑ∏Ïöî ÎåÄÏã†", correct: true },
          { letter: "D", text: "Ïù¥ Î¶¨Î∑∞Î•º ÏàòÎùΩÌïòÍ≥† ÎÇòÏ§ëÏóê Ìà¨Î™ÖÏÑ±ÏùÑ ÏúÑÌï¥ Ïã∏Ïö∞Ïã≠ÏãúÏò§.", correct: false }
        ],
        feedback: {
          correct: "Correct! Neurontin's lesson: companies hide what they don't want seen. Confidentiality agreements can be weaponized. Request data through FDA, EMA, or AllTrials instead.",
          incorrect: "Îâ¥Î°†Ìã¥ Ïä§Ï∫îÎì§: Í∏∞ÏóÖÎì§ÏùÄ Î∂ÄÏ†ïÏ†ÅÏù∏ Ïã§ÌóòÏùÑ ÏñµÏ†úÌñàÏäµÎãàÎã§. Í∏∞Î∞Ä Ïú†ÏßÄ Í≥ÑÏïΩÏùÄ Í∑ÄÌïòÍ∞Ä Î≥¥Í≥†ÌïòÎäî ÎÇ¥Ïö©Ïóê ÎåÄÌï¥ Í±∞Î∂ÄÍ∂åÏùÑ Î∂ÄÏó¨Ìï©ÎãàÎã§. ÎèÖÎ¶ΩÏÑ±ÏùÑ Ïú†ÏßÄÌïòÏÑ∏Ïöî."
        }
      }},
      { type: "quiz", theme: "dark", content: {
        question: "Why must search dates be recorded?",
        options: [
          { text: "Ï†ÄÎÑê Í∏∞Î°ùÏùò Í≤ΩÏö∞", correct: false },
          { text: "Îç∞Ïù¥ÌÑ∞Î≤†Ïù¥Ïä§Îäî Îß§Ïùº ÏóÖÎç∞Ïù¥Ìä∏Îê©ÎãàÎã§. ÎÇ†ÏßúÎäî ÌÉÄÏûÑÏä§ÌÉ¨ÌîÑÏûÖÎãàÎã§", correct: true },
          { text: "To calculate how long the search took", correct: false },
          { text: "It's optional metadata", correct: false }
        ],
        xp: 15,
        feedback: {
          correct: "Ï†ïÌôïÌï©ÎãàÎã§! ÏõîÏöîÏùºÏóê Í≤ÄÏÉâÌïòÎ©¥ ÌôîÏöîÏùºÍ≥º Îã§Î•∏ Ïó∞Íµ¨ Í≤∞Í≥ºÍ∞Ä ÎÇòÏòµÎãàÎã§. ÎÇ†ÏßúÎäî Í≤ÄÏÉâÌïú Ïú†ÎãàÎ≤ÑÏä§Î•º Ï†ïÏùòÌï©ÎãàÎã§.",
          incorrect: "Îç∞Ïù¥ÌÑ∞Î≤†Ïù¥Ïä§Îäî ÏßÄÏÜçÏ†ÅÏúºÎ°ú ÏóÖÎç∞Ïù¥Ìä∏Îê©ÎãàÎã§. Í∑ÄÌïòÏùò Í≤ÄÏÉâ ÎÇ†ÏßúÎäî Í∑ÄÌïòÍ∞Ä Í≤ÄÏÉâÌïú Î¨∏Ìóå ÏÑ∏Í≥ÑÏùò ÌÉÄÏûÑÏä§ÌÉ¨ÌîÑÏûÖÎãàÎã§."
        }
      }}
    ]
  },
  {
    id: 5, title: "Phase C: Extraction", subtitle: "Days 11-28: Provenance for every number", xp: 200,
    slides: [
      { type: "title", theme: "dark", content: { title: "Phase C: Extraction", subtitle: "Days 11-28: Every number needs a source" }},
      { type: "objectives", theme: "dark", content: {
        objectives: [
          "Understand what provenance means and why it matters",
          "Learn the Red-Team daily checking system",
          "Handle conflicting numbers with pre-specified rules",
          "Recognize the COLCOT near-disaster pattern"
        ],
        tip: "COLCOT ÏÇ¨Î°Ä Ïó∞Íµ¨Îäî ÌåîÏùÑ Î∞îÍæº Ìïú Ï™ΩÏù¥ Ïñ¥ÎñªÍ≤å Í≤∞Î°†ÏùÑ Í±∞Ïùò Îí§ÏßëÏóàÎäîÏßÄ Î≥¥Ïó¨Ï§çÎãàÎã§."
      }},
      { type: "prediction", theme: "dark", content: {
        icon: "üîÆ", title: "COLCOT Ïû¨Ìåê",
        subtitle: "The largest trial (n=4,745) in a colchicine meta-analysis. The extractor pulls data from Figure 3 showing colchicine vs placebo events. Quick forest plot shows colchicine INCREASES events, while all other trials show benefit. What happened?",
        options: [
          { id: "benefit", label: "üìä Statistical fluke", text: "Random variation‚Äîinclude as-is" },
          { id: "neutral", label: "‚ùì Îç∞Ïù¥ÌÑ∞ ÏûÖÎ†• Ïò§Î•ò", text: "Wrong numbers typed" },
          { id: "harm", label: "üîÑ Arms swapped", text: "Intervention/control mixed up" }
        ],
        answer: "harm",
        xp: 30
      }},
      { type: "story", theme: "red-bg", content: {
        label: "COLCOT Ïû¨ÎÇú ÏßÅÏ†Ñ", title: "One Swapped Arm",
        text: "The extractor assumed left bar = intervention. It was right = intervention. One error in one critical field would have reversed the entire conclusion.",
        followup: "Î†àÎìúÌåÄ ÏùºÏùº Ï†êÍ≤ÄÏóêÏÑú Ïù¥Î•º Ìè¨Ï∞©ÌñàÏäµÎãàÎã§. Í∑∏Î†áÍ∏∞ ÎïåÎ¨∏Ïóê ÏòÅÌñ•Î†• ÏûàÎäî Ïó∞Íµ¨Í∞Ä Í≤ÄÏ¶ùÎêòÎäî Í≤ÉÏûÖÎãàÎã§."
      }},
      { type: "decision", theme: "dark", content: {
        icon: "üî¥", title: "Scenario: Red-Team Finds an Error",
        xp: 30,
        scenario: "Î†àÎìúÌåÄ Í≤ÄÏÇ¨Ïõê ÌååÌã∞Îßà(Fatima)Îäî COLCOT ÌåîÏù¥ ÍµêÏ≤¥Îêú Í≤ÉÏùÑ Î∞úÍ≤¨Ìï©ÎãàÎã§. Ïù¥Îäî Í∞ÄÏû• ÌÅ∞ ÏãúÌóòÏûÖÎãàÎã§(Ï†ÑÏ≤¥ Ï§ëÎüâÏùò 40%). Ï∂îÏ∂úÍ∏∞Îäî 'Í∑∏Î¶ºÏù¥ Î™®Ìò∏ÌñàÏäµÎãàÎã§.'",
        question: "What should happen?",
        options: [
          { letter: "A", text: "Ìëú 2Ïùò Ï∂úÏ≤òÎ°ú ÏàòÏ†ï, Î°úÍ∑∏ ÏàòÏ†ï", correct: true },
          { letter: "B", text: "Exclude COLCOT‚Äîtoo risky to include", correct: false },
          { letter: "C", text: "Expand audit to ALL studies immediately", correct: false },
          { letter: "D", text: "Ask the original authors to clarify", correct: false }
        ],
        feedback: {
          correct: "ÎßûÏäµÎãàÎã§! Ï∂úÏ≤òÎ•º ÏàòÏ†ïÌïòÍ≥†(Ìëú 2ÏóêÏÑú Ìï†Îãπ ÌôïÏù∏) ÏàòÏ†ï ÎÇ¥Ïö©ÏùÑ Í∏∞Î°ùÌï©ÎãàÎã§. Îã®Ïùº Î™ÖÌôïÌïú ÏõêÏù∏ Ïò§Î•òÏóêÎäî ÌôïÏû• Í∞êÏÇ¨Í∞Ä ÌïÑÏöîÌïòÏßÄ ÏïäÏäµÎãàÎã§.",
          incorrect: "Îã®Ïùº Î™ÖÌôïÌïú ÏõêÏù∏ Ïò§Î•òÏóê ÎåÄÌï¥ ÏñëÌò∏Ìïú Îç∞Ïù¥ÌÑ∞Î•º Ï†úÏô∏ÌïòÍ±∞ÎÇò Í∞êÏÇ¨Î•º Í≥ºÎèÑÌïòÍ≤å ÌôïÏû•ÌïòÏßÄ ÎßàÏã≠ÏãúÏò§. Ï∂úÏ≤òÎ•º ÏàòÏ†ïÌïòÍ≥† Í∏∞Î°ùÌïòÍ≥† Ï∂îÏ∂úÍ∏∞Ïóê Î∏åÎ¶¨ÌïëÌï©ÎãàÎã§."
        }
      }},
      { type: "concept", theme: "dark", content: {
        title: "Î†àÎìúÌåÄ ÏãúÏä§ÌÖú",
        subtitle: "Daily adversarial checking",
        text: "Îß§Ïùº 11ÏùºÏ∞®Î∂ÄÌÑ∞ 2Î™ÖÏùò ÏàúÌôò ÌåÄÏõêÏù¥ ÏûêÎèô ÏÑ†ÌÉùÎêú Ïó∞Íµ¨Î•º ÌôïÏù∏ÌïòÎäî Îç∞ 12~15Î∂ÑÏùÑ ÏÜåÎπÑÌï©ÎãàÎã§.",
        highlight: "Boldt ÌÉêÏßÄ: Í∑∏Ïùò ÏÇ¨Í∏∞(90Í∞ú Ïù¥ÏÉÅÏùò Ïó∞Íµ¨)Í∞Ä Î†àÎìúÌåÄÏóêÏÑú Ï†ÅÎ∞úÎêòÏóàÏäµÎãàÎã§. Î∂àÍ∞ÄÎä•Ìïú Ï±ÑÏö© ÎπÑÏú®ÏùÑ Î∞úÍ≤¨ÌñàÏäµÎãàÎã§."
      }},
      { type: "story", theme: "red-bg", content: {
        label: "Î≥ºÎìú Ïû¨Ìï¥", title: "Í±∞ÏßìÎßêÏóê ÎåÄÌïú 90Í∞ÄÏßÄ Ïó∞Íµ¨",
        text: "ÏöîÏïÑÌÇ¥ Î≥ºÌä∏Îäî ÎßàÏ∑® Î∂ÑÏïºÏóêÏÑú Í∞ÄÏû• ÎßéÏùÄ Ïó∞Íµ¨Î•º Ìïú Ïó∞Íµ¨ÏûêÏòÄÏäµÎãàÎã§. Í∑∏Îäî ÏΩúÎ°úÏù¥Îìú Ïú†Ï≤¥Ïóê Í¥ÄÌïú 90Í∞ú Ïù¥ÏÉÅÏùò Ïó∞Íµ¨Î•º Î∞úÌëúÌñàÏäµÎãàÎã§. Í∑∏Ïùò ÏûëÏóÖÏùÄ Ï†Ñ ÏÑ∏Í≥ÑÏ†ÅÏúºÎ°ú ÏûÑÏÉÅ ÏßÄÏπ®ÏùÑ ÌòïÏÑ±ÌñàÏäµÎãàÎã§. Í∑∏Îü¨Îçò Ï§ë ÎàÑÍµ∞Í∞ÄÍ∞Ä ÏïåÏïÑÏ∞®Î†∏ÏäµÎãàÎã§. Ìïú Î≥ëÏõêÏóêÏÑúÎäî Ïó∞Í∞Ñ 200Î™ÖÏùò ÌôòÏûêÏóêÍ≤åÎßå ÏòÅÌñ•ÏùÑ ÎØ∏ÏπòÎäî Ï°∞Í±¥ÏóêÏÑú 800Î™ÖÏùò ÌôòÏûêÎ•º Î™®ÏßëÌïúÎã§Í≥† Ï£ºÏû•ÌñàÏäµÎãàÎã§.",
        followup: "Investigation revealed: No ethics approval existed. Patient records couldn't be found. Co-authors had never seen the data. <strong>Ninety studies</strong> were retracted‚Äîthe largest fraud in medical history. Clinical guidelines had to be rewritten. The question that would have stopped him? 'Can you show me the source documents?'"
      }},
      { type: "decision", theme: "dark", content: {
        icon: "üî¢", title: "ÏãúÎÇòÎ¶¨Ïò§: Î∂àÍ∞ÄÎä•Ìïú Ïà´Ïûê",
        xp: 25,
        scenario: "Ï∂îÏ∂ú Í≥ºÏ†ïÏóêÏÑú 18Í∞úÏõî ÎèôÏïà Îã®Ïùº Î≥ëÏõêÏóêÏÑú Ìù¨Í∑Ä ÏßàÌôòÏùÑ ÏïìÍ≥† ÏûàÎäî 450Î™ÖÏùò ÌôòÏûêÎ•º Î™®ÏßëÌïú Ïó∞Íµ¨Î•º Î∞úÍ≤¨ÌñàÏäµÎãàÎã§. Ï∂úÌåêÎêú Ï†ÑÏóºÎ≥ëÌïôÏóê Îî∞Î•¥Î©¥ Î≥ëÏõêÏóêÏÑúÎäî Ïó∞Í∞Ñ ÏïΩ 50Î™ÖÏùò ÌôòÏûêÎ•º ÏßÑÎ£åÌïòÎäî Í≤ÉÏúºÎ°ú ÎÇòÌÉÄÎÇ¨ÏäµÎãàÎã§.",
        question: "Ïñ¥ÎñªÍ≤å Ìï¥Ïïº Ìï©ÎãàÍπå?",
        options: [
          { letter: "A", text: "Ïó∞Íµ¨ Ìè¨Ìï® - Î™®Ïßë ÏÑ±Í≥µ Ïó¨Î∂ÄÎäî Îã§ÏñëÌï®", correct: false },
          { letter: "B", text: "Í≤ÄÏ¶ùÏùÑ ÏúÑÌïú ÌîåÎûòÍ∑∏: Ïú§Î¶¨ ÏäπÏù∏ Î∞è ÌôòÏûê Í∏∞Î°ù ÌôïÏù∏", correct: true },
          { letter: "C", text: "Exclude as a statistical outlier", correct: false },
          { letter: "D", text: "Ï†ÄÏûêÎì§ÏóêÍ≤å Ïù¥Î©îÏùºÏùÑ Î≥¥ÎÇ¥ Ï±ÑÏö©ÏùÑ Î™ÖÌôïÌûà ÌïòÏÑ∏Ïöî. Î∞©Î≤ï", correct: false }
        ],
        feedback: {
          correct: "ÎßûÏäµÎãàÎã§! Î≥ºÌä∏Îäî Ï±ÑÏö©Î•†Ïù¥ Î∂àÍ∞ÄÎä•Ìï¥ÏÑú Î∂ôÏû°ÌòîÎã§. Ïà´ÏûêÍ∞Ä ÏùòÎØ∏Í∞Ä ÏóÜÎäî Í≤ΩÏö∞ Ïó∞Íµ¨Î•º Ìè¨Ìï®ÌïòÍ∏∞ Ï†ÑÏóê ÏõêÎ≥∏ Î¨∏ÏÑúÍ∞Ä Ï°¥Ïû¨ÌïòÎäîÏßÄ ÌôïÏù∏ÌïòÏã≠ÏãúÏò§.",
          incorrect: "BoldtÍ∞Ä Ïû°Ìûå Î∞©Î≤ïÏùÄ Îã§ÏùåÍ≥º Í∞ôÏäµÎãàÎã§. Ïó∞Í∞Ñ 200Î™ÖÏóê ÏòÅÌñ•ÏùÑ ÎØ∏ÏπòÎäî ÏßàÌôòÏóêÏÑú 800Î™ÖÏùò ÌôòÏûê. Î∂àÍ∞ÄÎä•Ìïú Ïà´ÏûêÎäî Ïû†Ïû¨Ï†ÅÏù∏ ÏÇ¨Í∏∞Î•º ÎÇòÌÉÄÎÉÖÎãàÎã§. Ïú§Î¶¨ ÏäπÏù∏ Î∞è ÏõêÏãú Îç∞Ïù¥ÌÑ∞Í∞Ä Ï°¥Ïû¨ÌïòÎäîÏßÄ ÌôïÏù∏ÌïòÏã≠ÏãúÏò§."
        }
      }},
      { type: "story", theme: "dark", content: {
        label: "Wakefield ÏÇ¨Í∏∞", title: "12 Children, 12 Million Harmed",
        text: "1998ÎÖÑ Andrew WakefieldÎäî MMR Î∞±Ïã†Í≥º ÏûêÌèêÏ¶ùÏùÑ Ïó∞Í≤∞ÌïòÎäî 12Î™ÖÏùò Ïñ¥Î¶∞Ïù¥Ïóê ÎåÄÌïú Ïó∞Íµ¨Î•º Î∞úÌëúÌñàÏäµÎãàÎã§. ÏòàÎ∞©Ï†ëÏ¢ÖÎ•†Ïù¥ Í∏âÎùΩÌñàÏäµÎãàÎã§. ÌôçÏó≠ Î∞úÎ≥ëÏù¥ Îã§Ïãú Î∞úÏÉùÌñàÏäµÎãàÎã§. ÏïÑÏù¥Îì§ÏùÄ ÏòàÎ∞© Í∞ÄÎä•Ìïú ÏßàÎ≥ëÏúºÎ°ú ÏÇ¨ÎßùÌñàÏäµÎãàÎã§.",
        followup: "It took 12 years to prove the fraud. Wakefield had been paid ¬£435,643 by lawyers to produce evidence for lawsuits. He had manipulated data. He had undisclosed conflicts. But for a decade, his 12-patient study outweighed millions of patients in honest research. One fraudulent paper. Thousands of preventable infections."
      }},
      { type: "decision", theme: "dark", content: {
        icon: "üìù", title: "ÏãúÎÇòÎ¶¨Ïò§: Ï∂úÏ≤ò ÎàÑÎùΩ",
        xp: 25,
        scenario: "An extractor recorded 'events: 45/230' for a study but didn't note the source (table/figure/page). When you check the PDF, you find events reported in Table 2 (45/230), Figure 1 (42/228), and text (43/225).",
        question: "Ïò¨Î∞îÎ•∏ Ï°∞ÏπòÎäî Î¨¥ÏóáÏûÖÎãàÍπå?",
        options: [
          { letter: "A", text: "Use any number‚Äîthey're close enough", correct: false },
          { letter: "B", text: "Use the most conservative estimate (42/228)", correct: false },
          { letter: "C", text: "ÏûëÏÑ±ÏûêÏóêÍ≤å Î¨∏ÏùòÌïòÏó¨ ÌôïÏù∏ÌïòÏÑ∏Ïöî", correct: false },
          { letter: "D", text: "Apply pre-specified hierarchy (e.g., Table > Figure > Text)", correct: true }
        ],
        feedback: {
          correct: "ÎßûÏäµÎãàÎã§! ÌîÑÎ°úÌÜ†ÏΩúÏùÄ Ï∂©ÎèåÌïòÎäî Ïà´ÏûêÏóê ÎåÄÌïú Í≥ÑÏ∏µ Íµ¨Ï°∞Î•º ÏßÄÏ†ïÌï¥Ïïº Ìï©ÎãàÎã§. ÏùºÍ¥ÄÎêòÍ≤å Ï†ÅÏö©ÌïòÍ≥† ÏÜåÏä§Î•º Î¨∏ÏÑúÌôîÌïòÏÑ∏Ïöî.",
          incorrect: "Ïù¥ ÏÉÅÌô©Ïóê ÎåÄÌï¥ÏÑúÎäî ÎØ∏Î¶¨ ÏßÄÏ†ïÎêú Í∑úÏπôÏù¥ ÌïÑÏöîÌï©ÎãàÎã§. 'Í∞ÄÏû• Î≥¥ÏàòÏ†Å'Ïù¥ Í∑úÏπôÏù¥ÏßÄÎßå Ïù¥Îäî ÌîÑÎ°úÌÜ†ÏΩúÏóê Ìè¨Ìï®ÎêòÏñ¥Ïïº Ìï©ÎãàÎã§. Ï∂úÏ≤òÍ∞Ä ÏóÜÏúºÎ©¥ ÏïÑÎ¨¥ Í≤ÉÎèÑ ÌôïÏù∏Ìï† Ïàò ÏóÜÏäµÎãàÎã§."
        }
      }},
      { type: "checklist", theme: "dark", content: {
        title: "DoD-C Checklist",
        items: [
          "Extraction template frozen",
          "RoB tool + decision rules written",
          "Critical fields verified by second person",
          "Overlap rules applied",
          "Arbitration process operating"
        ]
      }},
      { type: "story", theme: "red-bg", content: {
        label: "Î£®Î≤§ ÎßàÏ∑® ÏÇ¨Í∏∞", title: "The Most Prolific Faker in Medicine",
        text: "Scott Reuben was anesthesiology's rising star. Between 1996 and 2008, he published prolifically on postoperative pain management. His studies shaped how surgeons treated patients after operations. Drug companies funded his research. <strong>Pfizer paid him consulting fees</strong> while he published studies showing their drugs worked brilliantly.",
        followup: "In 2009, an anonymous tip led to investigation. Reuben hadn't just manipulated data‚Äî<strong>he had never enrolled a single patient</strong>. Studies claiming to follow hundreds of patients were pure invention. He fabricated everything: consent forms, patient records, outcomes. Twenty-one papers were retracted. Clinical guidelines based on his 'research' had to be rewritten. The patients who received treatment recommendations based on his fabrications? They were experiments in a trial that never happened, with no informed consent, following protocols invented by a liar."
      }},
      { type: "decision", theme: "dark", content: {
        icon: "üë§", title: "ÏãúÎÇòÎ¶¨Ïò§: Îã§Ïûë Ïó∞Íµ¨Ïõê",
        xp: 25,
        scenario: "Ìïú Ïó∞Íµ¨ÏõêÏù¥ 3ÎÖÑ ÎèôÏïà Í∑ÄÌïòÏùò Î∂ÑÏïºÏóêÏÑú 15Í±¥Ïùò ÏûÑÏÉÅÏãúÌóòÏùÑ Î∞úÌëúÌñàÎã§Îäî ÏÇ¨Ïã§ÏùÑ ÏïåÍ≤å ÎêòÏóàÏäµÎãàÎã§. Ïù¥Îäî Ïñ¥Îñ§ Î∂ÄÏÑúÏóêÏÑúÎèÑ ÌòÑÏã§Ï†ÅÏúºÎ°ú ÏàòÌñâÌï† Ïàò ÏûàÎäî Í≤ÉÎ≥¥Îã§ Îçî ÎßéÏùÄ ÏàòÏπòÏûÖÎãàÎã§. Î™®Îëê Í∑∏Ïùò ÏûêÍ∏à Ï†úÍ≥µÏûêÍ∞Ä ÎßåÎì† ÏïΩÎ¨ºÏóê ÎåÄÌï¥ Í∏çÏ†ïÏ†ÅÏù∏ Í≤∞Í≥ºÎ•º Î≥¥Ïó¨Ï§çÎãàÎã§. Í∑∏Ïùò Ïó∞Íµ¨ Í≤∞Í≥ºÎ•º Î≥µÏ†úÌïú Îã§Î•∏ ‚Äã‚ÄãÏÑºÌÑ∞Îäî ÏóÜÏäµÎãàÎã§. Í∑∏Ïùò Í∏∞Í¥ÄÏùÄ Í∑∏Ïùò Îç∞Ïù¥ÌÑ∞Î•º Í∞êÏÇ¨Ìïú Ï†ÅÏù¥ ÏóÜÏäµÎãàÎã§.",
        question: "Í∑∏Ïùò Ïó∞Íµ¨Î•º Í≤ÄÌÜ†Ïóê Ìè¨Ìï®ÌïòÍ∏∞ Ï†ÑÏóê Î¨¥ÏóáÏùÑ Ìï¥Ïïº Ìï©ÎãàÍπå?",
        options: [
          { letter: "A", text: "Include them‚Äîthey're peer-reviewed and published", correct: false },
          { letter: "B", text: "Request verification of ethics approval and patient enrollment records", correct: true },
          { letter: "C", text: "Ïó∞Íµ¨ Ïú†Î¨¥Ïóê Í¥ÄÍ≥ÑÏóÜÏù¥ ÎØºÍ∞êÎèÑ Î∂ÑÏÑù Ïã§Ìñâ", correct: false },
          { letter: "D", text: "Weight his studies lower due to potential bias", correct: false }
        ],
        feedback: {
          correct: "ÎßûÏäµÎãàÎã§! ReubenÏùÄ 12ÎÖÑÏóê Í±∏Ï≥ê 21Í∞úÏùò Ï°∞ÏûëÎêú ÏûÑÏÉÅÏãúÌóòÏùÑ Î∞úÌëúÌñàÏäµÎãàÎã§. ÌôòÏûêÍ∞Ä ÏûàÎäîÏßÄ ÏïÑÎ¨¥ÎèÑ ÌôïÏù∏ÌïòÏßÄ ÏïäÏïòÏäµÎãàÎã§. Ïú§Î¶¨ ÏúÑÏõêÌöå Î¨∏ÏÑú Î∞è Îì±Î°ù ÌôïÏù∏ÏùÑ ÏöîÏ≤≠ÌïòÏã≠ÏãúÏò§. Ï†úÏûëÏûêÎäî Ïù¥Î•º ÏÉùÏÑ±Ìï† Ïàò ÏóÜÏäµÎãàÎã§.",
          incorrect: "Scott ReubenÏùÄ Í∞ÄÏÉÅÏùò ÌôòÏûêÎ•º ÎåÄÏÉÅÏúºÎ°ú 21Í∞úÏùò Ïó∞Íµ¨Î•º Í≥†ÏïàÌñàÏäµÎãàÎã§. ÎèôÎ£å Í≤ÄÌÜ†ÏóêÏÑúÎäî Ïù¥Î•º Ìè¨Ï∞©ÌïòÏßÄ Î™ªÌñàÏäµÎãàÎã§. ÎØºÍ∞êÎèÑ Î∂ÑÏÑùÏóêÏÑúÎäî Ï°∞ÏûëÏùÑ Í∞êÏßÄÌïòÏßÄ Î™ªÌï©ÎãàÎã§. ÌôòÏûêÍ∞Ä Ï°¥Ïû¨ÌïòÎäîÏßÄ ÌôïÏù∏Ìï©ÎãàÎã§."
        }
      }},
      { type: "story", theme: "dark", content: {
        label: "VIGOR ÏÜçÏûÑÏàò", title: "The Three Heart Attacks They Hid",
        text: "Merck knew Vioxx caused heart attacks. Their own trial‚ÄîVIGOR‚Äîshowed it clearly. But the published paper in the <strong>New England Journal of Medicine</strong> had a secret: Merck scientists had chosen a data cutoff date that excluded <strong>three additional heart attacks</strong> that occurred in the Vioxx group.",
        followup: "Those three heart attacks mattered. Including them would have changed the safety signal from 'possibly concerning' to 'clearly dangerous.' Instead, the published paper suggested the increased heart attacks might be because the comparison drug (naproxen) was protective‚Äînot because Vioxx was deadly. The NEJM editors only learned of the missing data years later. They published an 'expression of concern,' calling it 'inaccurate and incomplete.' By then, tens of thousands had suffered heart attacks. The data cutoff wasn't a scientific decision. It was a marketing decision disguised as methodology."
      }},
      { type: "decision", theme: "dark", content: {
        icon: "üìÖ", title: "ÏãúÎÇòÎ¶¨Ïò§: Ï†ÑÎûµÏ†Å Ï§ëÎã®",
        xp: 25,
        scenario: "Îç∞Ïù¥ÌÑ∞Î•º Ï∂îÏ∂úÌïòÎäî Ï§ëÏóê ÏûÑÏÉÅÏãúÌóòÏùò Îç∞Ïù¥ÌÑ∞ ÎßàÍ∞êÏùºÏù¥ Î™ÖÏãúÎêú Ïó∞Íµ¨ Ï¢ÖÎ£åÏùºÎ≥¥Îã§ 2Ï£º Ï†ÑÏù∏ Í≤ÉÏùÑ ÌôïÏù∏ÌñàÏäµÎãàÎã§. Î∞©Î≤ïÏùÄ Ïù¥Ïú†Î•º ÏÑ§Î™ÖÌïòÏßÄ ÏïäÏäµÎãàÎã§. Ïª∑Ïò§ÌîÑ Ïù¥ÌõÑÏóê Î∞úÏÉùÌïòÎäî Ïù¥Î≤§Ìä∏Îäî Î≥¥Í≥†ÎêòÏßÄ ÏïäÏäµÎãàÎã§. ÌÉÄÏù¥Î∞çÏùÄ ÏïàÏ†Ñ Ïã†Ìò∏Í∞Ä ÌÜµÍ≥ÑÏ†ÅÏúºÎ°ú Ïú†ÏùòÎØ∏Ìï¥Ï°åÏùÑ ÎïåÏôÄ Ìé∏Î¶¨ÌïòÍ≤å ÏùºÏπòÌï©ÎãàÎã§.",
        question: "Î¨¥ÏóáÏùÑ Î¨∏ÏÑúÌôîÌïòÍ≥† ÏöîÏ≤≠Ìï¥Ïïº Ìï©ÎãàÍπå?",
        options: [
          { letter: "A", text: "Í≥µÍ∞úÎêú Îç∞Ïù¥ÌÑ∞Î•º ÏÇ¨Ïö©ÌïòÏã≠ÏãúÏò§. Ï†ÄÏûêÎäî Ïª∑Ïò§ÌîÑÎ•º ÏÑ†ÌÉùÌñàÏäµÎãàÎã§.", correct: false },
          { letter: "B", text: "Note unexplained cutoff in Risk of Bias; request complete data from authors/FDA", correct: true },
          { letter: "C", text: "Î∂àÏôÑÏ†ÑÌïú Î≥¥Í≥†Î•º ÏúÑÌï¥ Ïó∞Íµ¨Î•º Ï†úÏô∏", correct: false },
          { letter: "D", text: "Impute likely events based on trends before cutoff", correct: false }
        ],
        feedback: {
          correct: "ÎßûÏäµÎãàÎã§! VIGOR Ïª∑Ïò§ÌîÑÎäî Î™®Îì† Í≤ÉÏùÑ Î≥ÄÌôîÏãúÌÇ® ÏÑ∏ Í∞ÄÏßÄ Ïã¨Ïû• ÎßàÎπÑÎ•º Ïà®Í≤ºÏäµÎãàÎã§. ÏÑ§Î™ÖÎêòÏßÄ ÏïäÎäî Í∏∞Ï§ÄÏ†êÏùÄ Ìé∏Ìñ• ÏúÑÌóòÏù¥ ÎÜíÎã§Îäî ÏÇ¨Ïã§ÏùÑ Î¨∏ÏÑúÌôîÌïòÍ≥† Îì±Î°ù Í∏∞Í¥ÄÏù¥ÎÇò FDAÎ°úÎ∂ÄÌÑ∞ Ï†ÅÍ∑πÏ†ÅÏúºÎ°ú ÏôÑÏ†ÑÌïú Îç∞Ïù¥ÌÑ∞Î•º Íµ¨Ìï©ÎãàÎã§.",
          incorrect: "MerckÏùò VIGOR Í∏∞Ï§ÄÏ†êÏùÄ Î∞©Î≤ïÎ°†Ïù¥ ÏïÑÎãàÎùº ÏùÄÌèêÏòÄÏäµÎãàÎã§. ÏÑ§Î™ÖÌï† Ïàò ÏóÜÎäî Ïª∑Ïò§ÌîÑÎäî ÏúÑÌóò Ïã†Ìò∏ÏûÖÎãàÎã§. Í≥µÏãù Ï±ÑÎÑêÏùÑ ÌÜµÌï¥ ÏúÑÌóòÏùÑ Î¨∏ÏÑúÌôîÌïòÍ≥† ÏôÑÏ†ÑÌïú Îç∞Ïù¥ÌÑ∞Î•º Ï∂îÍµ¨Ìï©ÎãàÎã§."
        }
      }},
      { type: "quiz", theme: "dark", content: {
        question: "What is 'provenance' in META-SPRINT?",
        options: [
          { text: "Ïó∞Íµ¨Í∞Ä ÏàòÌñâÎêú Íµ≠Í∞Ä", correct: false },
          { text: "A citation showing where a number came from", correct: true },
          { text: "ÏãúÌóò ÏûêÍ∏à Ï∂úÏ≤ò", correct: false },
          { text: "Ïó∞Íµ¨ Î∞úÌëú ÎÇ†Ïßú", correct: false }
        ],
        xp: 20,
        feedback: {
          correct: "Right! Provenance like 'Table 2, p.1234' creates an audit trail. No provenance = no trust.",
          incorrect: "Provenance means the exact source: 'Table 2, p.1234.' It's your evidence trail for every extracted number."
        }
      }},
      { type: "summary", theme: "green-bg", content: {
        summary: "You've mastered extraction fundamentals: provenance, Red-Team checking, and handling conflicting data. Next: making your analysis reproducible."
      }}
    ]
  },
  {
    id: 6, title: "Phase D: Analysis", subtitle: "29~33Ïùº: Ïû¨ÌòÑ Í∞ÄÎä• Í≤∞Í≥º", xp: 180,
    slides: [
      { type: "title", theme: "green-bg", content: { title: "Phase D: Analysis", subtitle: "Days 29-33: If you can't reproduce it, neither can anyone else" }},
      { type: "objectives", theme: "dark", content: {
        objectives: [
          "Understand rerun equivalence tolerances",
          "Î∂ÑÏÑù Î∂àÏùºÏπò Ï≤òÎ¶¨ Î∞©Î≤ï ÏïåÏïÑÎ≥¥Í∏∞",
          "Know how to document influential studies",
          "Î∂ÑÏÑù Ï∫°Ïäê Í∞úÎÖê ÏùµÌûàÍ∏∞"
        ],
        tip: "Ïû¨ÌòÑÏÑ±ÏùÄ ÌÉÄÌòëÌï† Ïàò ÏóÜÏäµÎãàÎã§. Ïù¥Í≤ÉÏùÑ ÏôÑÎ£åÌïòÎ©¥ ÌÜµÍ≥Ñ ÎßàÎ≤ïÏÇ¨ Î∞∞ÏßÄÎ•º Î∞õÏùÑ Ïàò ÏûàÏäµÎãàÎã§!"
      }},
      { type: "stats", theme: "dark", content: {
        title: "Ïû¨ÌòÑÏÑ± ÏúÑÍ∏∞",
        stats: [
          { value: "70%", label: "Failed to reproduce others" },
          { value: "50%", label: "Failed to reproduce self" }
        ],
        caption: "Nature (2016): Most researchers can't reproduce published findings."
      }},
      { type: "story", theme: "red-bg", content: {
        label: "Amgen ÌòÑÏã§ Ï†êÍ≤Ä", title: "47 of 53 Failed",
        text: "2012ÎÖÑÏóê Amgen Í≥ºÌïôÏûêÎì§ÏùÄ Ïïî Ïó∞Íµ¨Î•º ÌòïÏÑ±ÌïòÍ≥† ÏûÑÏÉÅ Ïã§ÌóòÏùÑ ÏãúÏûëÌñàÏúºÎ©∞ ÏàòÏã≠Ïñµ Îã¨Îü¨Ïùò ÏûêÍ∏àÏùÑ ÏÜåÎπÑÌïú ÎÖºÎ¨∏Ïù∏ 53Í∞úÏùò 'ÎûúÎìúÎßàÌÅ¨' Ïïî Ïó∞Íµ¨Î•º Ïû¨ÌòÑÌïòÎ†§Í≥† ÌñàÏäµÎãàÎã§. Í∑∏Îì§ÏùÄ ÏõêÏûëÏûêÏôÄ ÏßÅÏ†ë ÏûëÏóÖÌñàÏäµÎãàÎã§. Í∑∏Îì§ÏùÄ ÎèôÏùºÌïú Î∞©Î≤ïÏùÑ ÏÇ¨Ïö©ÌñàÏäµÎãàÎã§.",
        followup: "Result: <strong>47 of 53 studies could not be reproduced.</strong> 89% failure rate. Years of research built on foundations that didn't exist. Clinical trials started based on findings that weren't real. The cancer research community had been chasing phantoms."
      }},
      { type: "decision", theme: "dark", content: {
        icon: "üî¨", title: "ÏãúÎÇòÎ¶¨Ïò§: ÎûúÎìúÎßàÌÅ¨ ÎÖºÎ¨∏",
        xp: 25,
        scenario: "ÏùºÎ•ò Ï†ÄÎÑêÏùò 'ÌöçÍ∏∞Ï†Å' Ï†ÑÏûÑÏÉÅ Ïó∞Íµ¨Îäî ÏÉàÎ°úÏö¥ ÏπòÎ£åÎ≤ïÏùò Í∏∞Ï¥àÎ•º ÌòïÏÑ±Ìï©ÎãàÎã§. ÎèÖÎ¶Ω Ïó∞Íµ¨ÏÜåÏùò ÏÑ∏ Î≤àÏùò Î≥µÏ†ú ÏãúÎèÑÍ∞Ä Ïã§Ìå®ÌñàÏäµÎãàÎã§. ÏõêÏ†ÄÏûêÎì§ÏùÄ Î≥µÏ†úÍ∏∞Í∞Ä 'Í∏∞Ïà†Ï†Å Ï†ÑÎ¨∏ÏÑ±Ïù¥ Î∂ÄÏ°±ÌñàÎã§'Í≥† ÎßêÌï©ÎãàÎã§. ÏõêÎ≥∏ ÏõêÏãú Îç∞Ïù¥ÌÑ∞Î•º Î≥∏ ÏÇ¨ÎûåÏùÄ ÏïÑÎ¨¥ÎèÑ ÏóÜÏäµÎãàÎã§.",
        question: "ÏßÄÏπ®ÏóêÏÑúÎäî Ïù¥ Ï¶ùÍ±∞Î•º Ïñ¥ÎñªÍ≤å Ï≤òÎ¶¨Ìï¥Ïïº Ìï©ÎãàÍπå?",
        options: [
          { letter: "A", text: "Trust the original‚Äîit's in a top journal", correct: false },
          { letter: "B", text: "Downgrade certainty until reproducibility is demonstrated", correct: true },
          { letter: "C", text: "Weight original and replications equally", correct: false },
          { letter: "D", text: "Wait for a fourth replication attempt", correct: false }
        ],
        feedback: {
          correct: "Correct! The Amgen lesson: 89% of landmark cancer studies couldn't be reproduced. If it can't be replicated, it's not evidence‚Äîit's a hypothesis.",
          incorrect: "53Í∞ú ÎûúÎìúÎßàÌÅ¨ Ïó∞Íµ¨ Ï§ë 47Í∞úÎäî Ïû¨ÌòÑÏóê Ïã§Ìå®ÌñàÏäµÎãàÎã§. Ï†ÄÎÑêÏùò Î™ÖÏÑ±ÏùÄ ÏßÑÏã§Í≥º Í∞ôÏßÄ ÏïäÏäµÎãàÎã§. Ïû¨ÌòÑ Î∂àÍ∞ÄÎä•Ìïú Í≤∞Í≥ºÍ∞Ä ÏπòÎ£å ÏßÄÏπ®Ïùò Í∏∞Ï¥àÍ∞Ä ÎêòÏñ¥ÏÑúÎäî Ïïà Îê©ÎãàÎã§."
        }
      }},
      { type: "story", theme: "dark", content: {
        label: "ÎìÄÌÅ¨ Ïä§Ï∫îÎì§", title: "Ï†àÎåÄ Ï≤úÏû¨",
        text: "ÎìÄÌÅ¨ ÎåÄÌïôÏùò ÏïÑÎãê Ìè¨Ìã∞(Anil Potti)Îäî Ïïî ÏπòÎ£åÎ•º Í∞úÏù∏ÌôîÌïòÍ∏∞ ÏúÑÌïú Í≤åÎÜà ÌÖåÏä§Ìä∏Î•º Í∞úÎ∞úÌñàÏäµÎãàÎã§. Í∑∏Ïùò ÎÖºÎ¨∏ÏùÄ ÏµúÍ≥†Ïùò Ï†ÄÎÑêÏóê Í≤åÏû¨ÎêòÏóàÏäµÎãàÎã§. ÏûÑÏÉÅ ÏãúÌóòÏóêÎäî ÌôòÏûêÍ∞Ä Îì±Î°ùÎêòÏóàÏäµÎãàÎã§. Í∑∏Îäî ÏÑ†Íµ¨ÏûêÎ°ú Ï∂îÏïôÎ∞õÏïòÏäµÎãàÎã§.",
        followup: "Then two statisticians noticed: the data was impossible. Gene signatures were backwards. Spreadsheets had been manipulated. Potti had invented his credentials. Over 100 cancer patients had been enrolled in trials based on fraudulent science. Some received treatments that harmed them based on data that never existed."
      }},
      { type: "decision", theme: "dark", content: {
        icon: "üîÑ", title: "ÏãúÎÇòÎ¶¨Ïò§: Ïû¨Ïã§Ìñâ Î∂àÏùºÏπò",
        xp: 30,
        scenario: "Audit 2: Two analysts independently rerun the analysis. Analyst A: I¬≤=34.2%. Analyst B: I¬≤=31.8%. The tolerance is 1%. Difference: 2.4%.",
        question: "What should happen?",
        options: [
          { letter: "A", text: "Í≤∞Í≥ºÎ•º ÌèâÍ∑†ÌôîÌïòÏÑ∏Ïöî. Îëò Îã§ Ìï©Î¶¨Ï†ÅÏûÖÎãàÎã§.", correct: false },
          { letter: "B", text: "Use the more conservative estimate", correct: false },
          { letter: "C", text: "Line-by-line comparison to find the discrepancy", correct: true },
          { letter: "D", text: "Trigger CondGO (emergency mode)", correct: false }
        ],
        feedback: {
          correct: "Correct! Line-by-line comparison found one SE rounded to 2 decimals instead of 4. Fix the source, rerun, verify match.",
          incorrect: "ÌèâÍ∑†ÏùÑ ÎÇ¥Í±∞ÎÇò Î∂àÏùºÏπòÎ•º Ïö©ÎÇ©ÌïòÏßÄ ÎßàÏÑ∏Ïöî. Î∂àÏùºÏπòÏùò ÏõêÏù∏ÏùÑ Ï∞æÏúºÏã≠ÏãúÏò§. Ïù¥ Í≤ΩÏö∞: ÌïòÎÇòÏùò SEÍ∞Ä ÏûòÎ™ª Î∞òÏò¨Î¶ºÎêòÏóàÏäµÎãàÎã§."
        }
      }},
      { type: "concept", theme: "dark", content: {
        title: "Rerun Equivalence Tolerances",
        subtitle: "Two runs must match exactly",
        checkpoints: [
          { day: "Study count", event: "Exactly identical" },
          { day: "Effect sizes", event: "‚â§0.001 (log scale)" },
          { day: "Pooled effect", event: "‚â§0.001" },
          { day: "I¬≤ heterogeneity", event: "Within 1%" }
        ]
      }},
      { type: "decision", theme: "dark", content: {
        icon: "üìà", title: "ÏãúÎÇòÎ¶¨Ïò§: ÏòÅÌñ•Î†• ÏûàÎäî Ïó∞Íµ¨",
        xp: 25,
        scenario: "ÏùºÌöåÏÑ± Î∂ÑÏÑùÏùÑ ÌÜµÌï¥ COLCOT ÏãúÌóòÏùÑ Ï†úÍ±∞ÌïòÎ©¥ ÌíÄÎßÅÎêú RRÏù¥ 0.65(Ïú†ÏùòÏÑ±)ÏóêÏÑú 0.78(Ïó¨Ï†ÑÌûà Ïú†ÏùòÏÑ±)Î°ú Î≥ÄÍ≤ΩÎêòÎäî Í≤ÉÏúºÎ°ú ÎÇòÌÉÄÎÇ¨ÏäµÎãàÎã§. COLCOTÏùÄ Í∞ÄÏ§ëÏπòÏùò 40%Î•º Ï∞®ÏßÄÌï©ÎãàÎã§.",
        question: "Î¨¥ÏóáÏùÑ Î¨∏ÏÑúÌôîÌï¥Ïïº Ìï©ÎãàÍπå?",
        options: [
          { letter: "A", text: "Nothing‚Äîresult is still significant", correct: false },
          { letter: "B", text: "Document that COLCOT is influential but robust", correct: true },
          { letter: "C", text: "Exclude COLCOT as an outlier", correct: false },
          { letter: "D", text: "Downgrade certainty to VERY LOW", correct: false }
        ],
        feedback: {
          correct: "ÎßûÏäµÎãàÎã§! ÏòÅÌñ•Î†• ÏûàÎäî Ïó∞Íµ¨Î•º Î¨∏ÏÑúÌôîÌïòÍ≥† Í≤∞Î°†Ïù¥ ÌôïÏã§ÌïòÎã§Îäî Ï†êÏùÑ Í∏∞Î°ùÌï©ÎãàÎã§. ÏòÅÌñ•Î†•Ïù¥ ÏûàÎã§Îäî Ïù¥Ïú†ÎßåÏúºÎ°ú Ï¢ãÏùÄ Îç∞Ïù¥ÌÑ∞Î•º Ï†úÏô∏ÌïòÏßÄ ÎßàÏã≠ÏãúÏò§.",
          incorrect: "ÏòÅÌñ•Î†• ÏûàÎäî Ïó∞Íµ¨Î•º Î¨∏ÏÑúÌôîÌï¥Ïïº Ìï©ÎãàÎã§. Ïó¨Í∏∞ÏÑú COLCOTÏùÑ Ï†úÍ±∞ÌïòÎ©¥ ÌÅ¨Í∏∞Îäî Î≥ÄÍ≤ΩÎêòÏßÄÎßå Î∞©Ìñ•ÏùÄ Î≥ÄÍ≤ΩÎêòÏßÄ ÏïäÏäµÎãàÎã§. Ïù¥Îäî Í∞ïÎ†•Ìïú Î∞úÍ≤¨ÏûÖÎãàÎã§. Ï¢ãÏùÄ Îç∞Ïù¥ÌÑ∞Î•º Î∞∞Ï†úÌïòÏßÄ ÎßàÏã≠ÏãúÏò§."
        }
      }},
      { type: "checklist", theme: "dark", content: {
        title: "DoD-D Checklist",
        items: [
          "Capsule runs end-to-end",
          "Forest + heterogeneity outputs",
          "Sensitivity set executed",
          "Î¨∏ÏÑúÌôîÎêú ÏòÅÌñ•Î†• ÏûàÎäî Ïó∞Íµ¨",
          "Audit 2 completed",
          "Rerun equivalence satisfied"
        ]
      }},
      { type: "story", theme: "red-bg", content: {
        label: "BMP-2 ÏùÄÌèê", title: "Paid Authors, Hidden Harms",
        text: "Î©îÎìúÌä∏Î°úÎãâÏùÄ Îºà ÏÑ±Ïû• Ï†úÌíàÏù∏ BMP-2Ïóê ÎåÄÌïú ÎÖºÎ¨∏ÏùÑ Ïì¥ Ïô∏Í≥ºÏùòÏÇ¨ÏóêÍ≤å 2Ïñµ 1Ï≤úÎßå Îã¨Îü¨Î•º ÏßÄÎ∂àÌñàÏäµÎãàÎã§. Ï∂úÌåêÎêú Î™®Îì† ÎÖºÎ¨∏ÏùÄ Í∑∏Í≤ÉÏù¥ ÏïàÏ†ÑÌïòÍ≥† Ìö®Í≥ºÏ†ÅÏù¥ÎùºÍ≥† ÎßêÌñàÏäµÎãàÎã§. Î™®Îì† ÎÖºÎ¨∏ÏùÄ Ïû¨Ï†ïÏ†Å Í¥ÄÍ≥ÑÍ∞Ä Í≥µÍ∞úÎêòÏßÄ ÏïäÏùÄ Ï†ÄÏûêÍ∞Ä ÏûëÏÑ±ÌñàÏäµÎãàÎã§. Î©îÎìúÌä∏Î°úÎãâÏù¥ ÏïåÍ≥† ÏûàÎçò Ïù¥ÏÉÅ ÏÇ¨Î°ÄÎäî Î≥¥Í≥†ÎêòÏßÄ ÏïäÏïòÏäµÎãàÎã§.",
        followup: "When independent researchers obtained FDA adverse event reports, they found: <strong>10-50x higher complication rates</strong> than published papers claimed. Cancers. Sterility. Chronic pain. The published literature was a marketing document. The real evidence was in FDA files no one had read."
      }},
      { type: "decision", theme: "dark", content: {
        icon: "üí∞", title: "ÏãúÎÇòÎ¶¨Ïò§: Ïª®ÏÑ§ÌåÖ ÎπÑÏö©",
        xp: 25,
        scenario: "You're extracting data from 15 studies on a medical device. You notice all 15 lead authors have received consulting fees from the manufacturer. The amounts range from $50,000 to $500,000 per author. All 15 studies show benefit; no harms are reported.",
        question: "Í≤ÄÌÜ† Ïãú Î¨¥ÏóáÏùÑ Í∏∞Î°ùÌï¥Ïïº Ìï©ÎãàÍπå?",
        options: [
          { letter: "A", text: "Nothing‚Äîdisclosed conflicts aren't bias", correct: false },
          { letter: "B", text: "Document conflicts and check FDA adverse event database", correct: true },
          { letter: "C", text: "Exclude all studies due to conflict of interest", correct: false },
          { letter: "D", text: "Run sensitivity analysis by funding source", correct: false }
        ],
        feedback: {
          correct: "Correct! BMP-2 lesson: all published papers hid harms that FDA reports revealed. Always cross-check industry-funded device/drug studies against regulatory databases.",
          incorrect: "The BMP-2 cover-up: $210M paid to authors who reported no harms; FDA data showed 10-50x higher complication rates. Industry conflicts require regulatory cross-checking."
        }
      }},
      { type: "story", theme: "red-bg", content: {
        label: "Í∏àÏÜçÍ≥º Í∏àÏÜç Í∞ÑÏùò Í≥†Í¥ÄÏ†à Ïû¨Ìï¥", title: "ÌôòÏûêÎ•º Ï§ëÎèÖÏãúÌÇ§Îäî Í¥ÄÏ†à",
        text: "In the 2000s, device manufacturers promised a revolution: metal-on-metal hip implants that would last forever. DePuy's ASR hip was the flagship. <strong>93,000 patients</strong> worldwide received them. The company cited laboratory testing showing excellent wear characteristics. Surgeons believed the marketing.",
        followup: "Inside patients' bodies, reality was different. The metal surfaces ground against each other, releasing cobalt and chromium ions into tissues. Patients developed <strong>metallosis</strong>‚Äîmetal poisoning causing tissue death, bone destruction, and chronic pain. Some developed neurological symptoms as cobalt reached their brains. The failure rate reached <strong>40% at 5 years</strong>‚Äîcatastrophic for a device meant to last decades. DePuy had internal data showing problems but kept selling. When the hip was finally recalled in 2010, Johnson & Johnson paid $2.5 billion in settlements. The laboratory tests that 'proved' safety had never predicted what happens inside a living, moving human body."
      }},
      { type: "decision", theme: "dark", content: {
        icon: "ü¶¥", title: "ÏãúÎÇòÎ¶¨Ïò§: Ïã§ÌóòÏã§ Ï¶ùÍ±∞",
        xp: 25,
        scenario: "ÏÉàÎ°úÏö¥ ÏàòÏà†Ïö© ÏûÑÌîåÎûÄÌä∏Îäî Ïã§ÌóòÏã§ ÎßàÎ™® ÌÖåÏä§Ìä∏ Î∞è ÎèôÎ¨º Ïó∞Íµ¨ÏóêÏÑú ÌÉÅÏõîÌïú Í≤∞Í≥ºÎ•º Î≥¥Ïó¨Ï§çÎãàÎã§. Ï†úÏ°∞ÏóÖÏ≤¥Îäî ÎåÄÍ∑úÎ™® Ïù∏Ï≤¥ Ïã§ÌóòÏùÑ Í±¥ÎÑàÎõ∞Í≥† ÏãúÌåê ÌõÑ Í∞êÏãúÎ•º ÌÜµÌï¥ ÏßÅÏ†ë ÏãúÏû•Ïóê Ï∂úÏãúÌïòÍ∏∞Î•º ÏõêÌï©ÎãàÎã§. 'Î≤§Ïπò ÌÖåÏä§Ìä∏Îäî Ìö®Í≥ºÍ∞Ä ÏûàÏùåÏùÑ ÏûÖÏ¶ùÌï©ÎãàÎã§'ÎùºÍ≥† Í∑∏Îì§ÏùÄ Ï£ºÏû•Ìï©ÎãàÎã§.",
        question: "Ïù¥ Ï∂îÎ°†Ïùò ÏπòÎ™ÖÏ†ÅÏù∏ Í≤∞Ìï®ÏùÄ Î¨¥ÏóáÏûÖÎãàÍπå?",
        options: [
          { letter: "A", text: "Animal studies should be longer before human use", correct: false },
          { letter: "B", text: "Laboratory conditions cannot replicate the biological environment inside patients", correct: true },
          { letter: "C", text: "Post-marketing surveillance is sufficient for rare harms", correct: false },
          { letter: "D", text: "Î≤§Ïπò ÌÖåÏä§Ìä∏Îäî ÏïΩÎ¨ºÏóêÎßå Ïú†Ìö®ÌïòÎ©∞ Í∏∞Í∏∞ÏóêÎäî Ïú†Ìö®ÌïòÏßÄ ÏïäÏäµÎãàÎã§", correct: false }
        ],
        feedback: {
          correct: "ÎßûÏäµÎãàÎã§! Í∏àÏÜç-Í∏àÏÜç Í≥†Í¥ÄÏ†àÏùÄ Î™®Îì† Ïã§ÌóòÏã§ ÌÖåÏä§Ìä∏Î•º ÌÜµÍ≥ºÌñàÏúºÎ©∞, ÏãúÎÆ¨Î†àÏù¥ÌÑ∞ÏóêÏÑúÎäî ÏòàÏ∏°Ìï† Ïàò ÏóÜÎäî Í∏àÏÜç Ïù¥Ïò®ÏúºÎ°ú ÌôòÏûêÎ•º Ï§ëÎèÖÏãúÏº∞ÏäµÎãàÎã§. Î™∏ÏùÄ Ïã§ÌóòÏã§Ïù¥ ÏïÑÎãàÎã§. Ïã§Ï†ú ÏÉÅÌô©ÏóêÏÑú Ïù∏Í∞ÑÏù¥ Í≤™ÏùÄ ÏãúÌóòÏùÄ Î¨¥ÏóáÍ≥ºÎèÑ Î∞îÍøÄ Ïàò ÏóÜÏäµÎãàÎã§.",
          incorrect: "DePuyÏùò Ïã§ÌóòÏã§ ÌÖåÏä§Ìä∏ÏóêÏÑúÎäî Í≥†Í¥ÄÏ†àÏù¥ ÏòÅÏõêÌûà ÏßÄÏÜçÎêúÎã§Îäî ÏÇ¨Ïã§Ïù¥ ÏûÖÏ¶ùÎêòÏóàÏäµÎãàÎã§. ÌôòÏûê ÎÇ¥Î∂ÄÏùò Ï°∞ÏßÅÏùÑ ÌååÍ¥¥ÌïòÍ≥† Í∏àÏÜç Ïù¥Ïò®ÏùÑ Î∞©Ï∂úÌñàÏäµÎãàÎã§. Ïã§ÌóòÏã§ Ï°∞Í±¥ ‚â† ÏÉùÎ¨ºÌïôÏ†Å ÌòÑÏã§. Ïû•Í∏∞Í∞ÑÏùò Ï∂îÏ†Å Í¥ÄÏ∞∞Ïù¥ Ìè¨Ìï®Îêú ÎåÄÍ∑úÎ™® Ïù∏Ï≤¥ Ïã§ÌóòÏù¥ ÌïÑÏàòÏ†ÅÏûÖÎãàÎã§."
        }
      }},
      { type: "story", theme: "dark", content: {
        label: "Essure Ïû¨ÎÇú", title: "ÏÉùÎ™ÖÏùÑ ÌååÍ¥¥Ìïú ÏòÅÍµ¨ ÌîºÏûÑ",
        text: "Bayer's Essure promised women permanent contraception without surgery‚Äîtiny metal coils inserted through the cervix that would block the fallopian tubes. The <strong>FDA approved it based on 2 years of data from 518 women</strong>. What could go wrong with a simple, non-surgical procedure?",
        followup: "Thousands of women reported devices migrating through their bodies, perforating organs, causing chronic pain, autoimmune reactions, and‚Äîdevastatingly‚Äî<strong>unintended pregnancies, including ectopic pregnancies that can be fatal</strong>. Women needed hysterectomies to remove devices they'd been told were 'permanent solutions.' A Facebook group for Essure victims grew to over 30,000 members. The FDA eventually added a black box warning, then restricted sales. Bayer stopped selling it in 2018. The lesson: 2 years of follow-up in 518 women was never enough to detect rare complications from a permanent implant. Approval timelines should match device permanence."
      }},
      { type: "decision", theme: "dark", content: {
        icon: "‚ö†Ô∏è", title: "ÏãúÎÇòÎ¶¨Ïò§: ÏòÅÍµ¨ Ïû•Ïπò",
        xp: 25,
        scenario: "ÏòÅÍµ¨ Ïù¥ÏãùÌòï Ïû•ÏπòÍ∞Ä Îã§ÏùåÏùÑ Í∏∞Î∞òÏúºÎ°ú FDA ÏäπÏù∏ÏùÑ Íµ¨ÌïòÍ≥† ÏûàÏäµÎãàÎã§. 600Î™ÖÏùò ÌôòÏûêÎ•º ÎåÄÏÉÅÏúºÎ°ú 3ÎÖÑÍ∞ÑÏùò Ï∂îÏ†Å Í¥ÄÏ∞∞. Ïù¥ Ïû•ÏπòÎäî ÌèâÏÉù ÎèôÏïà ÌôòÏûêÏóêÍ≤å ÎÇ®ÏïÑ ÏûàÎèÑÎ°ù Í≥†ÏïàÎêòÏóàÏäµÎãàÎã§. ÏïÑÏßÅ Ïã¨Í∞ÅÌïú Î∂ÄÏûëÏö©ÏùÄ Î≥¥Í≥†ÎêòÏßÄ ÏïäÏïòÏäµÎãàÎã§. ÌöåÏÇ¨Îäî Ïù¥Í≤ÉÏù¥ Ïû•Í∏∞Ï†ÅÏù∏ ÏïàÏ†ÑÏÑ±ÏùÑ ÏûÖÏ¶ùÌïúÎã§Í≥† Ï£ºÏû•Ìï©ÎãàÎã§.",
        question: "What should regulators require before approval?",
        options: [
          { letter: "A", text: "Post-marketing surveillance with mandatory reporting", correct: false },
          { letter: "B", text: "Follow-up duration proportional to intended implant life; registry with long-term tracking", correct: true },
          { letter: "C", text: "Approval is appropriate‚Äî3 years is standard for devices", correct: false },
          { letter: "D", text: "Additional laboratory durability testing", correct: false }
        ],
        feedback: {
          correct: "ÎßûÏäµÎãàÎã§! EssureÎäî ÏòÅÍµ¨ Ïû•ÏπòÏóê ÎåÄÌïú 2ÎÖÑ Îç∞Ïù¥ÌÑ∞Ïóê ÎåÄÌï¥ ÏäπÏù∏ÎêòÏóàÏäµÎãàÎã§. ÏàòÎÖÑÏóê Í±∏Ï≥ê Ìï©Î≥ëÏ¶ùÏù¥ ÎÇòÌÉÄÎÇ¨ÏäµÎãàÎã§. ÏòÅÍµ¨ ÏûÑÌîåÎûÄÌä∏Îäî ÏòÅÍµ¨ÏÑ±Ïóê ÎπÑÎ°ÄÌïòÎäî ÌõÑÏÜç Ï°∞ÏπòÍ∞Ä ÌïÑÏöîÌïòÎ©∞ ÌïÑÏàò Ïû•Í∏∞ Îì±Î°ùÏù¥ ÌïÑÏöîÌï©ÎãàÎã§.",
          incorrect: "EssureÏùò 2ÎÖÑ Îç∞Ïù¥ÌÑ∞ÏóêÏÑúÎäî Ïó¨ÏÑ±Ïùò Í±¥Í∞ïÏùÑ ÌååÍ¥¥ÌïòÎäî Ìï©Î≥ëÏ¶ùÏù¥ ÎàÑÎùΩÎêòÏóàÏäµÎãàÎã§. ÏòÅÍµ¨ Ïû•ÏπòÎäî ÎπÑÎ°ÄÏ†ÅÏúºÎ°ú Í∏¥ ÌõÑÏÜç Ï°∞ÏπòÍ∞Ä ÌïÑÏöîÌï©ÎãàÎã§. ÏãúÌåê ÌõÑ Í∞êÏãúÎäî Î¨∏Ï†úÎ•º ÎÑàÎ¨¥ Îä¶Í≤å Ìè¨Ï∞©Ìï©ÎãàÎã§."
        }
      }},
      { type: "quiz", theme: "dark", content: {
        question: "'Î∂ÑÏÑù Ï∫°Ïäê'Ïù¥ÎûÄ Î¨¥ÏóáÏûÖÎãàÍπå?",
        options: [
          { text: "A summary of key findings", correct: false },
          { text: "ÎàÑÍµ¨ÎÇò Ïã§ÌñâÌï† Ïàò ÏûàÎäî ÏΩîÎìú + Îç∞Ïù¥ÌÑ∞ + ÏßÄÏπ®", correct: true },
          { text: "ÏÇºÎ¶º ÎèÑÌëú Ï∂úÎ†•", correct: false },
          { text: "ÏïïÏ∂ï Îç∞Ïù¥ÌÑ∞ ÌååÏùº", correct: false }
        ],
        xp: 20,
        feedback: {
          correct: "Ï†ïÌôïÌï©ÎãàÎã§! Ï∫°ÏäêÏùÄ Î∂ÑÏÑùÏùÑ Ïû¨ÌòÑÌïòÎäî Îç∞ ÌïÑÏöîÌïú Î™®Îì† Í≤ÉÏûÖÎãàÎã§. ÏΩîÎìú, Îç∞Ïù¥ÌÑ∞, ÌôòÍ≤Ω Îì± Î™®Îëê Î≤ÑÏ†ÑÏù¥ ÏßÄÏ†ïÎê©ÎãàÎã§.",
          incorrect: "A capsule is a complete reproducible package: code, data, instructions. Anyone can run it and get identical results."
        }
      }}
    ]
  },
  {
    id: 7, title: "Phase E & CondGO", subtitle: "Days 34-40: Ship or emergency", xp: 180,
    slides: [
      { type: "title", theme: "red-bg", content: { title: "Phase E: Submission", subtitle: "34~40Ïùº: FREEZE Î∞è CondGO" }},
      { type: "objectives", theme: "dark", content: {
        objectives: [
          "FREEZEÏôÄ Ïù¥Í≤ÉÏù¥ Ï§ëÏöîÌïú Ïù¥Ïú†Î•º Ïù¥Ìï¥ÌïòÏÑ∏Ïöî",
          "Learn when CondGO is triggered",
          "Know the three CondGO exit options",
          "Master the DoD-E final checklist"
        ],
        tip: "'ÎÇòÏ§ëÏóê Ï≤òÎ¶¨ÌïòÍ≤†ÏäµÎãàÎã§'Î•º Î∞©ÏßÄÌïòÎäî ÎπÑÏÉÅ ÌîÑÎ°úÌÜ†ÏΩú"
      }},
      { type: "concept", theme: "dark", content: {
        title: "FREEZE(34ÏùºÏ∞®)",
        subtitle: "Ïù¥ ÏãúÏ†ê Ïù¥ÌõÑ ÏÉàÎ°úÏö¥ Ïó∞Íµ¨ ÏóÜÏùå",
        text: "Scope is locked. Only corrections to existing data allowed.",
        highlight: "BMP Ïä§Ï∫îÎì§: ÏóÖÍ≥ÑÏóêÏÑúÎäî ÏûêÏÇ¨ Ï†úÌíàÏùÑ ÏÑ†Ìò∏ÌïòÎäî ÏÉàÎ°úÏö¥ Ïó∞Íµ¨Î•º Í≥ÑÏÜç 'Î∞úÍ≤¨'ÌñàÏäµÎãàÎã§. ÎèôÍ≤∞ÏùÄ Î¨¥Í∏∞ÌôîÎêú Ïä§ÏΩîÌîÑ ÌÅ¨Î¶¨ÌîÑÎ•º Î∞©ÏßÄÌï©ÎãàÎã§."
      }},
      { type: "decision", theme: "dark", content: {
        icon: "üìö", title: "Scenario: New Study After Freeze",
        xp: 25,
        scenario: "36ÏùºÏß∏ÏûÖÎãàÎã§. ÎèôÎ£åÍ∞Ä Í∑ÄÌïòÏùò Í∏∞Ï§ÄÏóê ÏôÑÎ≤ΩÌïòÍ≤å ÎßûÎäî ÏÉàÎ°ú Í≤åÏãúÎêú RCTÎ•º Î≥¥ÎÉàÏäµÎãàÎã§. ÎåÄÍ∑úÎ™®Ïùò Í≥†ÌíàÏßà ÌèâÍ∞ÄÌåêÏûÖÎãàÎã§.",
        question: "What do you do?",
        options: [
          { letter: "A", text: "Add it‚Äîquality evidence shouldn't be excluded", correct: false },
          { letter: "B", text: "Note it as a limitation, don't add", correct: true },
          { letter: "C", text: "Add it but run sensitivity with/without", correct: false },
          { letter: "D", text: "Request deadline extension to include it", correct: false }
        ],
        feedback: {
          correct: "ÎßûÏäµÎãàÎã§! ÎèôÍ≤∞ ÌõÑÏóêÎäî ÏÉàÎ°úÏö¥ Ïó∞Íµ¨ Í≤∞Í≥ºÎ•º Ï†úÌïú ÏÇ¨Ìï≠ÏúºÎ°ú Í∏∞Î°ùÌïòÏã≠ÏãúÏò§. Ïù¥Î•º Ï∂îÍ∞ÄÌïòÎ©¥ ÏÑ†ÌÉùÏ†Å Ìè¨Ìï®Ïù¥ Í∞ÄÎä•Ìï¥ÏßëÎãàÎã§.",
          incorrect: "ÎèôÍ≤∞ÏùÄ ÎèôÍ≤∞ÏùÑ ÏùòÎØ∏Ìï©ÎãàÎã§. 'Ïù¥ Ï¢ãÏùÄ Ïó∞Íµ¨ ÌïòÎÇòÎßå'ÏùÑ Ï∂îÍ∞ÄÌïòÎ©¥ Î≤îÏúÑ ÌÅ¨Î¶¨ÌîÑÍ∞Ä Î¶¨Î∑∞Î•º ÏÜêÏÉÅÏãúÌÇ§Îäî Î∞©ÏãùÏù¥ Îê©ÎãàÎã§. Ï†úÌïú ÏÇ¨Ìï≠Ïóê Ïú†ÏùòÌïòÏÑ∏Ïöî."
        }
      }},
      { type: "story", theme: "red-bg", content: {
        label: "Avandia ÌÉÄÏûÑÎùºÏù∏", title: "Seven Years of Silence",
        text: "GSKÎäî 2000ÎÖÑÏóê Ïã¨ÌòàÍ¥Ä Ïã†Ìò∏Î•º ÌôïÏù∏ÌñàÏäµÎãàÎã§. Í∑∏Îì§ÏùÄ Í∏∞Ìïú ÏóÜÏù¥ 'Í¥ÄÏ∞∞ÌïòÍ≥† Í∏∞Îã§Î¶¨Í∏∞'Î•º ÏÑ†ÌÉùÌñàÏäµÎãàÎã§. 7ÎÖÑ ÌõÑ NissenÏùò Î©îÌÉÄ Î∂ÑÏÑùÏóêÏÑúÎäî Ìï¥Î°úÏõÄÏù¥ ÎìúÎü¨ÎÇ¨ÏäµÎãàÎã§.",
        followup: "CondGO exists because 'we'll deal with it eventually' kills people."
      }},
      { type: "decision", theme: "dark", content: {
        icon: "‚è∞", title: "ÏãúÎÇòÎ¶¨Ïò§: Î¨¥Í∏∞Ìïú Í≤ÄÌÜ†",
        xp: 25,
        scenario: "Í∑ÄÌïòÏùò Ï≤¥Í≥ÑÏ†Å Í≤ÄÌÜ†ÏóêÏÑúÎäî Ïû†Ïû¨Ï†ÅÏù∏ ÏïàÏ†ÑÏÑ± Ïã†Ìò∏Í∞Ä Î∞úÍ≤¨ÎêòÏóàÏäµÎãàÎã§. ÏïΩÎ¨º XÎäî ÏúÑÏïΩÏóê ÎπÑÌï¥ Ïã¨Ïû• ÏÇ¨Í±¥Ïù¥ 28% Ï¶ùÍ∞ÄÌïú Í≤ÉÏúºÎ°ú ÎÇòÌÉÄÎÇ¨ÏäµÎãàÎã§. Í∑ÄÌïòÏùò ÏÉÅÏÇ¨Îäî Íµ¨Ï≤¥Ï†ÅÏù∏ ÏùºÏ†ï ÏóÜÏù¥ 'Îçî ÎßéÏùÄ Îç∞Ïù¥ÌÑ∞Î•º ÏàòÏßëÌï† ÎïåÍπåÏßÄ Í≤∞Í≥ºÎ•º ÎÇ¥Î∂ÄÏóê Î≥¥Í¥Ä'Ìï† Í≤ÉÏùÑ Ï†úÏïàÌï©ÎãàÎã§.",
        question: "Î¨¥ÏóáÏùÑ Í≥†ÏßëÌï¥Ïïº Ìï©ÎãàÍπå?",
        options: [
          { letter: "A", text: "Agree‚Äîpremature publication could cause panic", correct: false },
          { letter: "B", text: "Set a fixed deadline: publish or escalate within 30 days", correct: true },
          { letter: "C", text: "Ï†úÏïΩ Ï†úÏ°∞ÏóÖÏ≤¥Ïùò ÏùòÍ≤¨ÏùÑ Î®ºÏ†Ä Í≥µÏú†ÌïòÏã≠ÏãúÏò§.", correct: false },
          { letter: "D", text: "Run additional analyses to confirm the signal", correct: false }
        ],
        feedback: {
          correct: "Correct! The Avandia lesson: 'watch and wait with no deadline' killed 83,000 people. CondGO principle: safety signals need hard deadlines, not open-ended deliberation.",
          incorrect: "GSK 'watched and waited' on Avandia for seven years. 83,000 heart attacks later, we learned: indefinite timelines kill. Set hard deadlines for safety decisions."
        }
      }},
      { type: "story", theme: "dark", content: {
        label: "Avandia Ï†ÑÏ≤¥ Ïù¥ÏïºÍ∏∞", title: "Ïä§ÌîÑÎ†àÎìúÏãúÌä∏ Buried",
        text: "1999ÎÖÑ GlaxoSmithKlineÏùò ÏûêÏ≤¥ Î∂ÑÏÑùÏóê Îî∞Î•¥Î©¥ AvandiaÎäî Ïã¨Ïû• ÎßàÎπÑÎ•º 31% Ï¶ùÍ∞ÄÏãúÏº∞ÏäµÎãàÎã§. ÌöåÏÇ¨ ÌÜµÍ≥ÑÌïôÏûêÍ∞Ä Ïä§ÌîÑÎ†àÎìúÏãúÌä∏Î•º ÎßåÎì§ÏóàÏäµÎãàÎã§. Í≤ΩÏòÅÏßÑÏù¥ Í∑∏Í≤ÉÏùÑ Î≥¥ÏïòÏäµÎãàÎã§. Í∑∏Îì§ÏùÄ Ï±ÖÏûÑÏùÑ Í≥ÑÏÇ∞ÌñàÏäµÎãàÎã§. Í≥ÑÏÜç ÌåêÎß§ÎêòÏóàÏäµÎãàÎã§.",
        followup: "For seven years, Avandia remained a blockbuster drug. $3 billion per year in sales. The spreadsheet stayed hidden. When Steven Nissen published his meta-analysis in 2007, the world learned what GSK had known since 1999: Avandia caused an estimated <strong>83,000 heart attacks</strong>. The delay wasn't oversight‚Äîit was a decision."
      }},
      { type: "decision", theme: "dark", content: {
        icon: "üìà", title: "ÏãúÎÇòÎ¶¨Ïò§: ÎπÑÏ¶àÎãàÏä§ Í≤∞Ï†ï",
        xp: 25,
        scenario: "Í∑ÄÌïòÏùò Î∂ÑÏÑùÏóê Îî∞Î•¥Î©¥ ÏïΩÎ¨ºÏù¥ Î∂ÄÏûëÏö©ÏùÑ 25% Ï¶ùÍ∞ÄÏãúÌÇ§Îäî Í≤ÉÏúºÎ°ú ÎÇòÌÉÄÎÇ¨ÏäµÎãàÎã§. Ïù¥ ÏïΩÏùÄ Ïó∞Í∞Ñ 20Ïñµ Îã¨Îü¨Ïùò ÏàòÏùµÏùÑ Ï∞ΩÏ∂úÌï©ÎãàÎã§. LegalÏóêÏÑúÎäî Ïû†Ïû¨Ï†ÅÏù∏ ÏÜåÏÜ°Ïóê 5Ïñµ Îã¨Îü¨Ïùò ÎπÑÏö©Ïù¥ ÏÜåÏöîÎê† Ïàò ÏûàÎã§Í≥† Í≥ÑÏÇ∞Ìï©ÎãàÎã§. Ìïú Í≥†ÏúÑ ÏûÑÏõêÏù¥ 'ÏàòÌïôÏùÄ ÏßÄÏÜçÏ†ÅÏù∏ ÌåêÎß§Î•º ÏÑ†Ìò∏Ìï©ÎãàÎã§.'",
        question: "Ïú§Î¶¨Ï†Å ÎåÄÏùëÏùÄ Î¨¥ÏóáÏûÖÎãàÍπå?",
        options: [
          { letter: "A", text: "Ïù¥Í≤ÉÏùÄ Í≥ºÌïôÏ†ÅÏù∏ Í≤∞Ï†ïÏù¥ ÏïÑÎãàÎùº ÎπÑÏ¶àÎãàÏä§ Í≤∞Ï†ïÏûÖÎãàÎã§.", correct: false },
          { letter: "B", text: "Report the finding to regulators immediately", correct: true },
          { letter: "C", text: "Seek independent confirmation before acting", correct: false },
          { letter: "D", text: "ÎùºÎ≤®Ïóê Í≤ΩÍ≥†Î•º Ï∂îÍ∞ÄÌïòÍ≥† ÌåêÎß§Î•º Í≥ÑÏÜçÌïòÏÑ∏Ïöî", correct: false }
        ],
        feedback: {
          correct: "ÎßûÏäµÎãàÎã§! Avandia Ïä§ÌîÑÎ†àÎìúÏãúÌä∏Îäî 1999ÎÖÑÏóê Ìï¥Î•º ÏûÖÏóàÏäµÎãàÎã§. GSKÎäî 'ÏàòÌïô'ÏùÑ ÏàòÌñâÌïòÍ≥† Í≥ÑÏÜç ÌåêÎß§ÌñàÏäµÎãàÎã§. Ïú§Î¶¨Ï†ÅÏù∏ ÎåÄÎãµÏùÄ ÏàòÏùµÏóê Í¥ÄÌïú Í≤ÉÏù¥ ÏïÑÎãàÎùº ÌôòÏûêÏùò ÏïàÏ†ÑÏóê Í¥ÄÌïú Í≤ÉÏûÖÎãàÎã§.",
          incorrect: "GSK calculated liability vs. revenue and chose sales. 83,000 heart attacks later: the 'business decision' was mass harm. Safety findings require immediate regulatory disclosure."
        }
      }},
      { type: "story", theme: "red-bg", content: {
        label: "ÌÉàÎ¶¨ÎèÑÎßàÏù¥Îìú ÍµêÌõà", title: "10,000 Children",
        text: "1957ÎÖÑ ÎèÖÏùº ÌöåÏÇ¨Îäî ÌÉàÎ¶¨ÎèÑÎßàÏù¥ÎìúÎ•º ÏûÑÏÇ∞Î∂ÄÎ•º ÏúÑÌïú ÏïàÏ†ÑÌïú ÏàòÎ©¥Ï†úÎ°ú ÌåêÎß§ÌñàÏäµÎãàÎã§. 'Ìï¥Î°≠Îã§Îäî Ï¶ùÍ±∞Îäî ÏóÜÎã§'Í≥† Í∑∏Îì§ÏùÄ ÎßêÌñàÎã§. Í∑∏Îì§ÏùÄ Ìï¥Î•º ÎÅºÏπòÎ†§Í≥† ÌïòÏßÄ ÏïäÏïòÏäµÎãàÎã§. Í∑∏Îì§ÏùÄ Ï¶ùÍ±∞Î•º ÏöîÍµ¨ÌïòÏßÄ ÏïäÏïòÏäµÎãàÎã§. Í∑∏Îì§ÏùÄ Í∞ÄÏ†ïÌñàÏäµÎãàÎã§.",
        followup: "Within four years: 10,000 children born with severe limb deformities. Many more died before birth. One woman, Frances Kelsey at the FDA, had demanded proper evidence before approving it in America. She was called 'bureaucratic.' Her skepticism saved thousands of American children. Evidence isn't bureaucracy. Evidence is protection."
      }},
      { type: "decision", theme: "dark", content: {
        icon: "üö®", title: "Scenario: CondGO Trigger",
        xp: 30,
        scenario: "Day 33. DoD-D fails: Audit 2 found that reruns don't match within tolerance, and you can't identify the source of discrepancy after 4 hours.",
        question: "What happens now?",
        options: [
          { letter: "A", text: "ÎßàÍ∞êÏùºÏùÑ ÏùºÏ£ºÏùº Ïó∞Ïû•", correct: false },
          { letter: "B", text: "Trigger CondGO: 72 hours to fix or decide", correct: true },
          { letter: "C", text: "Ïñ¥Ï∞®Ìîº Î∂àÏùºÏπòÏóê ÎåÄÌïú Î©îÎ™®ÏôÄ Ìï®Íªò Ï†úÏ∂ú", correct: false },
          { letter: "D", text: "ÌîÑÎ°úÏ†ùÌä∏ Ìè¨Í∏∞", correct: false }
        ],
        feedback: {
          correct: "Correct! CondGO gives exactly 72 hours to fix using allowed actions, or make a termination decision.",
          incorrect: "CondGO is triggered. 72 hours, bounded actions only. No extensions. Fix it or face the decision to stop."
        }
      }},
      { type: "concept", theme: "dark", content: {
        title: "CondGO Rules",
        subtitle: "72 hours, bounded actions",
        allowed: ["Correct extraction errors", "Fix conversions", "Resolve overlaps", "Repair audit pack"],
        forbidden: ["New outcomes", "Post-hoc subgroups", "Ï†ïÏßÄ ÌõÑ ÏÉàÎ°úÏö¥ Ïó∞Íµ¨"]
      }},
      { type: "checklist", theme: "dark", content: {
        title: "DoD-E Checklist",
        items: [
          "PRISMA Ï≤¥ÌÅ¨Î¶¨Ïä§Ìä∏ ÏôÑÎ£å",
          "Î™®Îì† Î∂ÄÎ°ù ÏôÑÎ£å",
          "Two reruns equivalent",
          "Clinical Summary included",
          "Ìé∏Ï∞® Î°úÍ∑∏ ÏôÑÎ£å",
          "GRADE assessment done",
          "Audit-Grade Index: 9/9"
        ]
      }},
      { type: "quiz", theme: "dark", content: {
        question: "CondGO Ï¢ÖÎ£å ÏòµÏÖòÏùÄ Î¨¥ÏóáÏûÖÎãàÍπå?",
        options: [
          { text: "Continue, Pause, or Restart", correct: false },
          { text: "Pass, Submit minimal, or Terminate", correct: true },
          { text: "Extend 24h, 48h, or 72h", correct: false },
          { text: "Ï¢ÖÎ£åÍ∞Ä ÏóÜÏäµÎãàÎã§. ÏàòÏ†ïÌï¥Ïïº Ìï©ÎãàÎã§", correct: false }
        ],
        xp: 20,
        feedback: {
          correct: "Right! PASS (fixed), Submit minimal version, or Terminate with Failure Log. No middle ground.",
          incorrect: "CondGO has exactly three exits: fix it (PASS), submit minimal version, or terminate and archive with Failure Log."
        }
      }}
    ]
  },
  {
    id: 8, title: "ÏÇ¨Î°Ä: ÏΩúÌûàÏπú Í≤ÄÌÜ†", subtitle: "4 crises, 0 failures", xp: 250,
    slides: [
      { type: "title", theme: "purple-bg", content: { title: "ÏΩúÌûàÏπú Í≤ÄÌÜ†", subtitle: "4Î≤àÏùò ÏúÑÍ∏∞ÏôÄ 0Î≤àÏùò Ïã§Ìå®Î•º Í≤™ÏùÄ 40Ïùº Ïä§ÌîÑÎ¶∞Ìä∏" }},
      { type: "objectives", theme: "dark", content: {
        objectives: [
          "See META-SPRINT in action through a real case",
          "Learn how each crisis was resolved",
          "Understand why the system worked",
          "Apply lessons to your own reviews"
        ],
        tip: "Ïù¥ ÏÇ¨Î°Ä Ïó∞Íµ¨Îäî Î™®Îì† Í≤ÉÏùÑ ÌïòÎÇòÎ°ú Î¨∂ÏäµÎãàÎã§. Colchicine Hero Î∞∞ÏßÄÎ•º ÌöçÎìùÌïòÏÑ∏Ïöî!"
      }},
      { type: "stats", theme: "dark", content: {
        title: "The Question",
        subtitle: "Does colchicine reduce cardiac events after heart attack?",
        stats: [
          { value: "8", label: "RCTs" },
          { value: "11,774", label: "Patients" },
          { value: "40", label: "Days" },
          { value: "4", label: "Crises" }
        ]
      }},
      { type: "decision", theme: "dark", content: {
        icon: "1Ô∏è‚É£", title: "ÏúÑÍ∏∞ 1: ÏãúÏ†ê ÎîúÎ†àÎßà",
        xp: 25,
        scenario: "Day 2. Trials report MACE at 30 days, 90 days, 1 year, 3 years. Protocol says 'longest follow-up' but reviewers disagree on interpretation.",
        question: "Ïù¥ Î¨∏Ï†úÎ•º Ïñ¥ÎñªÍ≤å Ìï¥Í≤∞ÌïòÏãúÍ≤†ÏäµÎãàÍπå?",
        options: [
          { letter: "A", text: "Vote on which interpretation to use", correct: false },
          { letter: "B", text: "ÏòµÏÖòÍ≥º Ï†àÏ∂©Ï†êÏù¥ Ìè¨Ìï®Îêú ÏÉÅÎã¥ Ìå© Ï§ÄÎπÑ", correct: true },
          { letter: "C", text: "Let the Integrator decide alone", correct: false },
          { letter: "D", text: "Use both interpretations as sensitivity", correct: false }
        ],
        feedback: {
          correct: "Correct! The Consult Pack forces structured thinking. They chose: 'Longest ‚â•1 year, else longest available.'",
          incorrect: "Ï¶ùÍ±∞ÏôÄ ÏòµÏÖòÏù¥ Ìè¨Ìï®Îêú ÏÉÅÎã¥ Ìå©Ïù¥ Ï§ÄÎπÑÎêòÏóàÏäµÎãàÎã§. 15Î∂ÑÍ∞ÑÏùò Ï≤¥Í≥ÑÏ†ÅÏù∏ ÎÖºÏùò ÎçïÎ∂ÑÏóê Î™á ÏãúÍ∞ÑÏùò Ïû¨ÏûëÏóÖÏù¥ Î∞©ÏßÄÎêòÏóàÏäµÎãàÎã§."
        }
      }},
      { type: "decision", theme: "red-bg", content: {
        icon: "2Ô∏è‚É£", title: "ÏúÑÍ∏∞ 2: ÍµêÌôòÎêú Î¨¥Í∏∞",
        xp: 30,
        scenario: "Day 14. Red-team pulls COLCOT (n=4,745). Forest plot shows colchicine INCREASES events‚Äîopposite of all other trials. Investigation reveals: Figure 3 bars were unlabeled, extractor assumed wrong direction.",
        question: "Ïù¥ Î¶¨Î∑∞Î•º Ï†ÄÏû•Ìïú Ïù¥Ïú†Îäî Î¨¥ÏóáÏûÖÎãàÍπå?",
        options: [
          { letter: "A", text: "ÌÜµÌï©ÏûêÏùò ÏßÅÍ¥Ä", correct: false },
          { letter: "B", text: "Î†àÎìúÌåÄ ÏùºÏùº ÎØ∏ÏÑ∏ Ï†êÍ≤Ä", correct: true },
          { letter: "C", text: "Ï∂úÌåê Ï†Ñ ÎèôÎ£å Í≤ÄÌÜ†", correct: false },
          { letter: "D", text: "Statistical outlier detection", correct: false }
        ],
        feedback: {
          correct: "Ï†ïÌôïÌï©ÎãàÎã§! Î†àÎìúÌåÄ ÏãúÏä§ÌÖúÏùÄ Í≥µÎèô Í≤ÄÌÜ†ÏóêÏÑú ÎÜìÏπú Î∂ÄÎ∂ÑÏùÑ Ìè¨Ï∞©ÌñàÏäµÎãàÎã§. ÏòÅÌñ•Î†• ÏûàÎäî Ïó∞Íµ¨Îäî Ï†ÅÎåÄÏ†Å ÌôïÏù∏ÏùÑ Î∞õÏäµÎãàÎã§.",
          incorrect: "Î†àÎìúÌåÄ ÏùºÏùº ÌôïÏù∏ÏóêÏÑú Ïù¥Î•º Ìè¨Ï∞©ÌñàÏäµÎãàÎã§. FatimaÎäî COLCOTÏùò Î∞©Ìñ•Ïù¥ Ï†ïÎ∞òÎåÄÎùºÎäî Í≤ÉÏùÑ ÏïåÏïÑÏ∞®Î†∏ÏäµÎãàÎã§. Ìïú Î≤àÏùò ÏûÑÏÉÅÏãúÌóòÏóêÏÑú ÏïΩÎ¨ºÏù¥ Ïã§Ï†úÎ°ú Îã§Î•¥Í≤å ÏûëÏö©ÌñàÎã§Î©¥ Î∂àÍ∞ÄÎä•ÌñàÏäµÎãàÎã§."
        }
      }},
      { type: "decision", theme: "dark", content: {
        icon: "3Ô∏è‚É£", title: "ÏúÑÍ∏∞ 3: ÏÇ¨ÌõÑ ÏïÑÏù¥ÎîîÏñ¥",
        xp: 25,
        scenario: "Day 22. Clinical advisor suggests: 'Three trials used 0.5mg, five used 1mg. Shouldn't you analyze by dose?' He's probably right scientifically.",
        question: "Ï†ïÎãµÏùÄ Î¨¥ÏóáÏûÖÎãàÍπå?",
        options: [
          { letter: "A", text: "Change primary analysis to split by dose", correct: false },
          { letter: "B", text: "Ignore the suggestion‚Äîtoo late to change", correct: false },
          { letter: "C", text: "Add as exploratory sensitivity, label post-hoc", correct: true },
          { letter: "D", text: "ÎèåÏïÑÍ∞ÄÏÑú ÌîÑÎ°úÌÜ†ÏΩúÏóê Î≥µÏö©ÎüâÏùÑ Ï∂îÍ∞ÄÌïòÏÑ∏Ïöî", correct: false }
        ],
        feedback: {
          correct: "Perfect! Good ideas after Day 3 go in sensitivity, clearly labelled post-hoc. Primary analysis stays protected.",
          incorrect: "ÌîÑÎ°úÌÜ†ÏΩúÏùÄ ÎãπÏã†ÏùÑ ÏûêÏã†ÏúºÎ°úÎ∂ÄÌÑ∞ Î≥¥Ìò∏Ìï©ÎãàÎã§. SENSITIVITY Î∂ÑÏÑùÏúºÎ°ú Ï∂îÍ∞ÄÌïòÍ≥† 'ÌÉêÏÉâÏ†Å, ÏÇ¨ÌõÑ'ÎùºÎäî ÎùºÎ≤®ÏùÑ Î∂ôÏûÖÎãàÎã§."
        }
      }},
      { type: "decision", theme: "dark", content: {
        icon: "4Ô∏è‚É£", title: "ÏúÑÍ∏∞ 4: Ïû¨Ïã§Ìñâ Î∂àÏùºÏπò",
        xp: 25,
        scenario: "Day 31. Audit 2 reruns: Analyst A gets I¬≤=34.2%, Analyst B gets I¬≤=31.8%. Tolerance is 1%. Difference: 2.4%.",
        question: "Í∑ºÎ≥∏ ÏõêÏù∏ÏùÄ Î¨¥ÏóáÏûÖÎãàÍπå?",
        options: [
          { letter: "A", text: "Different software versions", correct: false },
          { letter: "B", text: "One SE rounded to 2 decimals instead of 4", correct: true },
          { letter: "C", text: "Different random seeds", correct: false },
          { letter: "D", text: "Ïó∞Íµ¨ Ìè¨Ìï® Ïãú Ïò§ÌÉÄ", correct: false }
        ],
        feedback: {
          correct: "Right! Line-by-line found Nidorf 2020 SE: 0.0847 vs 0.08. A 0.0047 difference created 2.4% I¬≤ change.",
          incorrect: "Line-by-line comparison found one SE was rounded to 2 decimals (0.08) instead of 4 (0.0847). 'Close enough' isn't."
        }
      }},
      { type: "stats", theme: "green-bg", content: {
        title: "The Result",
        stats: [
          { value: "RR 0.65", label: "95% CI: 0.49‚Äì0.88" },
          { value: "I¬≤ 34%", label: "Low-moderate" },
          { value: "9/9", label: "Audit-Grade" }
        ],
        caption: "Colchicine reduces major cardiac events by ~35%. The system caught all 4 crises."
      }},
      { type: "lesson", theme: "dark", content: {
        title: "ÏãúÏä§ÌÖúÏù¥ ÌïÑÏöîÌïú Ïù¥Ïú† ÏûëÎèôÎê®",
        lessons: [
          { title: "Crisis 1 ‚Üí Consult Pack", desc: "Structured discussion prevented rework" },
          { title: "Crisis 2 ‚Üí Red-Team", desc: "Adversarial checking caught the swap" },
          { title: "Crisis 3 ‚Üí Deviation Log", desc: "Good ideas captured safely" },
          { title: "Crisis 4 ‚Üí Rerun Tolerance", desc: "Precision requirements caught silent errors" }
        ]
      }},
      { type: "story", theme: "dark", content: {
        label: "VIGOR ÏãúÌóò", title: "ÏÇ¨ÎùºÏßÑ Ïã¨Ïû•ÎßàÎπÑ",
        text: "In 2000, Merck published the VIGOR trial for Vioxx. The paper showed a 4-fold increase in heart attacks compared to naproxen. But here's what they didn't tell you: three more heart attacks occurred <strong>after the data cutoff</strong>. Merck scientists knew about them. They didn't include them.",
        followup: "Why did it matter? Including those three heart attacks would have changed the risk ratio from concerning to alarming. Instead, the published paper suggested the difference might be because naproxen protected hearts‚Äînot because Vioxx damaged them. The data cutoff date was a decision. That decision cost lives."
      }},
      { type: "decision", theme: "dark", content: {
        icon: "‚úÇÔ∏è", title: "ÏãúÎÇòÎ¶¨Ïò§: Ìé∏Î¶¨Ìïú Ï§ëÎã®",
        xp: 25,
        scenario: "ÏãúÌóòÏóêÏÑú Îç∞Ïù¥ÌÑ∞Î•º Ï∂îÏ∂úÌïòÍ≥† ÏûàÏäµÎãàÎã§. ÌîÑÎ°úÌÜ†ÏΩúÏóêÏÑúÎäî Ï∂îÏ†Å Í∏∞Í∞ÑÏùÑ 12Í∞úÏõîÎ°ú ÏßÄÏ†ïÌñàÏäµÎãàÎã§. Ï∂úÌåêÎêú ÎÖºÎ¨∏ÏùÄ 6Í∞úÏõî Í∞ÑÏùò Îç∞Ïù¥ÌÑ∞Îßå Î≥¥Í≥†Ìï©ÎãàÎã§. Í∞ÅÏ£ºÏóêÎäî '6Í∞úÏõî ÌõÑÏóê Ï∂îÍ∞Ä ÏÇ¨Í±¥Ïù¥ Î∞úÏÉùÌñàÏßÄÎßå 1Ï∞® Î∂ÑÏÑùÏóêÎäî Ìè¨Ìï®ÎêòÏßÄ ÏïäÏïòÏäµÎãàÎã§'ÎùºÍ≥† ÎÇòÏôÄ ÏûàÏäµÎãàÎã§.",
        question: "Ïñ¥ÎñªÍ≤å Ìï¥Ïïº Ìï©ÎãàÍπå?",
        options: [
          { letter: "A", text: "Í≤åÏãúÎêú 6Í∞úÏõî Îç∞Ïù¥ÌÑ∞Î•º ÏÇ¨Ïö©ÌïòÏÑ∏Ïöî", correct: false },
          { letter: "B", text: "ÏôÑÏ†ÑÌïú ÌõÑÏÜç Îç∞Ïù¥ÌÑ∞Î•º ÏñªÏúºÎ†§Î©¥ Ï†ÄÏûêÏóêÍ≤å Î¨∏ÏùòÌïòÏÑ∏Ïöî", correct: true },
          { letter: "C", text: "ÏÑ†ÌÉùÏ†Å Î≥¥Í≥†Î°ú Ïù∏Ìï¥ Ïó∞Íµ¨Îäî Ï†úÏô∏", correct: false },
          { letter: "D", text: "Ï∞∏Í≥† Ìé∏Ìñ• ÌèâÍ∞Ä ÏúÑÌóòÏùò Î∂àÏùºÏπò", correct: false }
        ],
        feedback: {
          correct: "Correct! The VIGOR lesson: data cutoffs can hide safety signals. Three missing heart attacks changed Vioxx from 'concerning' to 'alarming.' Always seek complete data.",
          incorrect: "VIGOR ÏãúÌóòÏóêÏÑúÎäî Í≤∞Î°†Ïù¥ Î∞îÎÄî Ïàò ÏûàÎäî Ï∞®Îã® ÌõÑ Ïã¨Ïû•ÎßàÎπÑÎ•º Ï†úÏô∏ÌñàÏäµÎãàÎã§. Ìé∏Î¶¨Ìïú Ï∞®Îã®ÏúºÎ°ú Ï§ëÏöîÌïú ÏïàÏ†Ñ Ïã†Ìò∏Î•º Ïà®Í∏∏ Ïàò ÏûàÏäµÎãàÎã§. ÏôÑÏ†ÑÌïú Îç∞Ïù¥ÌÑ∞Î•º ÏñªÏúºÏÑ∏Ïöî."
        }
      }},
      { type: "story", theme: "dark", content: {
        label: "Ìò∏Î•¥Î™¨ ÌÖåÏä§Ìä∏Ïùò ÎπÑÍ∑π", title: "ÌîºÌï¥Î•º ÏûÖÏùÄ ÌîÑÎ¶¨Î™®ÎèÑÏä§ÏôÄ ÏïÑÏù¥Îì§",
        text: "In the 1960s and 70s, doctors prescribed <strong>Primodos</strong>‚Äîa high-dose hormone pill‚Äîas a pregnancy test. Take two pills; if you bleed, you're not pregnant. Simple. Convenient. Millions of women used it. <strong>No one ran trials to check if it harmed unborn babies.</strong>",
        followup: "Then the birth defects appeared. Cleft palates. Heart malformations. Limb abnormalities. Women who had taken Primodos and were actually pregnant‚Äîthe test had failed‚Äîgave birth to damaged children. Decades later, researchers analyzed the data: exposure to Primodos was associated with a <strong>40% increase in congenital abnormalities</strong>. The manufacturer had received reports of problems for years. They kept selling. An official UK review in 2017 found 'clear evidence' of an association. The lesson: 'it seems to work' is not evidence. 'It seems safe' is not safety data. Pregnancy exposures demand the highest burden of proof."
      }},
      { type: "decision", theme: "dark", content: {
        icon: "üß™", title: "ÏãúÎÇòÎ¶¨Ïò§: Ìé∏Î¶¨Ìïú ÌÖåÏä§Ìä∏",
        xp: 25,
        scenario: "ÏÉàÎ°úÏö¥ Í∞ÄÏ†ïÏö© ÏûÑÏã† ÌÖåÏä§Ìä∏Îäî Î™á Î∂ÑÏù¥ ÏïÑÎãå Î™á Ï¥à ÏïàÏóê Í≤∞Í≥ºÎ•º Ï†úÍ≥µÌïòÎäî ÏÉàÎ°úÏö¥ ÌôîÌïô Î¨ºÏßàÏùÑ ÏÇ¨Ïö©Ìï©ÎãàÎã§. Î™ÖÎ∞±Ìïú Ïã¨Í∞ÅÌïú ÌîºÌï¥ ÏóÜÏù¥ ÏàòÎ∞±Îßå Î™ÖÏù¥ ÏÇ¨Ïö©ÌñàÏäµÎãàÎã§. Í∑∏Îü¨ÎÇò ÏùºÎ∂Ä Ïó¨ÏÑ±ÏùÄ ÌôîÌïôÎ¨ºÏßàÏù¥ Ïã§Ï†úÎ°ú ÏûÑÏã†Ìïú Ïó¨ÏÑ±Ïùò Î∞úÎã¨ Ï§ëÏù∏ Î∞∞ÏïÑÏóê ÏòÅÌñ•ÏùÑ ÎØ∏Ïπ† Ïàò ÏûàÏùÑ Ï†ïÎèÑÎ°ú Ï°∞Í∏∞Ïóê ÌÖåÏä§Ìä∏Ìï©ÎãàÎã§.",
        question: "What evidence should exist before widespread marketing?",
        options: [
          { letter: "A", text: "Absence of reported harms is sufficient for a diagnostic test", correct: false },
          { letter: "B", text: "Long-term follow-up of pregnancy outcomes in exposed women vs. controls", correct: true },
          { letter: "C", text: "Îã®Í∏∞Í∞Ñ ÎÖ∏Ï∂úÏóêÎäî ÎèôÎ¨º Í∏∞ÌòïÌïô Ïó∞Íµ¨Î°ú Ï∂©Î∂ÑÌï©ÎãàÎã§", correct: false },
          { letter: "D", text: "Post-marketing surveillance will detect any problems", correct: false }
        ],
        feedback: {
          correct: "ÎßûÏäµÎãàÎã§! ÏïÑÎ¨¥ÎèÑ ÏûÑÏã† Í≤∞Í≥ºÎ•º Ï∂îÏ†ÅÌïòÏßÄ ÏïäÏïòÍ∏∞ ÎïåÎ¨∏Ïóê ÌîÑÎ¶¨Î™®ÎèÑÏä§Ïùò ÏÜêÏÉÅÏùÄ ÏàòÏã≠ ÎÖÑ ÎèôÏïà Í∞êÏßÄÎêòÏßÄ ÏïäÏïòÏäµÎãàÎã§. ÏûÑÏã† Í∞ÄÎä•ÏÑ±Ïù¥ ÏûàÎäî ÎèôÏïà ÎÖ∏Ï∂úÎêòÎ©¥ ÏàòÎèôÏ†Å Í∞êÏãúÍ∞Ä ÏïÑÎãå Ï≤¥Í≥ÑÏ†ÅÏù∏ Í≤∞Í≥º Ï∂îÏ†ÅÏù¥ ÌïÑÏöîÌï©ÎãàÎã§.",
          incorrect: "ÌîÑÎ¶¨Î™®ÎèÑÎäî 'ÏïÑÎ¨¥ÎèÑ ÎààÏπòÏ±ÑÏßÄ Î™ªÌïòÎäî' ÎèôÏïà ÏàòÎÖÑÍ∞Ñ ÏïÑÍ∏∞ÏóêÍ≤å Ìï¥Î•º ÎÅºÏ≥§ÏäµÎãàÎã§. ÏûÑÏã† ÎÖ∏Ï∂úÏóêÎäî ÏÇ¨Ï†Ñ Í≤∞Í≥º Ï∂îÏ†ÅÏù¥ ÌïÑÏöîÌï©ÎãàÎã§. ÏÑ†Ï≤úÏ†Å Í≤∞Ìï®Ïóê ÎåÄÌïú ÏãúÌåê ÌõÑ Í∞êÏãúÎäî Ïã§Ìå®Ìï©ÎãàÎã§. ÎÇòÏ§ëÏóê Í∑∏ Ïó∞Í¥ÄÏÑ±ÏùÑ ÏûÖÏ¶ùÌïòÍ∏∞Í∞Ä Ïñ¥Î†µÏäµÎãàÎã§."
        }
      }},
      { type: "story", theme: "red-bg", content: {
        label: "Î∞îÏù¥ÏΩú Ïû¨Ïïô", title: "Í∑ºÏú°ÏùÑ ÎÖπÏù∏ Ïä§ÌÉÄÌã¥",
        text: "In 1997, Bayer launched cerivastatin (Baycol) to compete in the lucrative statin market. It was the most potent statin ever‚Äîlowering cholesterol more effectively than competitors. Bayer pushed aggressive dosing. They promoted combining it with gemfibrozil for even greater cholesterol reduction. Sales reached $500 million annually.",
        followup: "Patients started dying. Their muscles were dissolving‚Äîa condition called <strong>rhabdomyolysis</strong>. Breakdown products overwhelmed kidneys. By the time Bayer withdrew Baycol in 2001, at least <strong>100 patients had died and over 1,500 were hospitalized</strong>. Internal documents revealed Bayer knew the risk was higher than competitors. They knew the gemfibrozil combination was especially dangerous. They kept promoting both. The 'most effective' statin became the deadliest. More aggressive isn't always better‚Äîsometimes it's fatal."
      }},
      { type: "decision", theme: "dark", content: {
        icon: "üìà", title: "ÏãúÎÇòÎ¶¨Ïò§: Í≥µÍ≤©Ï†ÅÏù∏ Ï†ëÍ∑º",
        xp: 25,
        scenario: "Ïã†ÏïΩÏùÄ Í∏∞Ï°¥Î≥¥Îã§ Îçî Í∞ïÎ†•Ìïú Ìö®Í≥ºÎ•º ÎÇòÌÉÄÎÉÖÎãàÎã§. Îçî ÎÜíÏùÄ Ïö©ÎüâÏúºÎ°ú ÏπòÎ£åÌï©ÎãàÎã§. Ï†úÏ°∞ÏóÖÏ≤¥Îäî Í∞ÄÏû• ÎÜíÏùÄ Ïú†Ìö® Ïö©ÎüâÏùÑ ÌëúÏ§ÄÏúºÎ°ú ÌåêÎß§ÌïòÍ∏∞Î•º ÏõêÌï©ÎãàÎã§. Í≤ΩÏüÅÏóÖÏ≤¥Îäî ÏïàÏ†ÑÏÑ±Ïù¥ Ïö∞ÏàòÌïú Ï†ÄÏö©ÎüâÏùÑ ÏÇ¨Ïö©Ìï©ÎãàÎã§. ÏùºÎ∂Ä Ï¥àÍ∏∞ Î≥¥Í≥†ÏÑúÏóêÏÑúÎäî Ïã¨Í∞ÅÌïú Í∑ºÏú° Í¥ÄÎ†® Î∂ÄÏûëÏö©ÏùÑ Ïñ∏Í∏âÌñàÏäµÎãàÎã§.",
        question: "What should guide dosing recommendations?",
        options: [
          { letter: "A", text: "Maximum efficacy should be the goal‚Äîthat's why patients take medication", correct: false },
          { letter: "B", text: "Lowest effective dose with systematic safety monitoring; investigate all serious events", correct: true },
          { letter: "C", text: "Match competitor dosing for market positioning", correct: false },
          { letter: "D", text: "Let prescribers choose based on patient cholesterol levels", correct: false }
        ],
        feedback: {
          correct: "ÎßûÏäµÎãàÎã§! BaycolÏùò Í≥µÍ≤©Ï†ÅÏù∏ Ìà¨Ïó¨Î°ú Ïù∏Ìï¥ ÌôòÏûêÍ∞Ä ÏÇ¨ÎßùÌñàÏäµÎãàÎã§. Í∑ºÏú° Ïù¥Î≤§Ìä∏Îäî Í≤ΩÍ≥† Ïã†Ìò∏ÏòÄÏäµÎãàÎã§. Í∞ÄÏû• Í∞ïÎ†•Ìïú Ïö©ÎüâÏù¥ ÏïÑÎãå Í∞ÄÏû• ÏïàÏ†ÑÌïú Ïú†Ìö® Ïö©ÎüâÏù¥ ÌëúÏ§ÄÏù¥ ÎêòÏñ¥Ïïº Ìï©ÎãàÎã§. Ïã¨Í∞ÅÌïú ÏÇ¨Í±¥Ïùò Ï¥àÍ∏∞ÏóêÎäî Ìï¥Í≥†Í∞Ä ÏïÑÎãå Ï°∞ÏÇ¨Í∞Ä ÌïÑÏöîÌï©ÎãàÎã§.",
          incorrect: "Î≤†Ïù¥ÏΩúÏùÄ 'Í∞ÄÏû• Í∞ïÎ†•Ìïú' Ïä§ÌÉÄÌã¥Ïù¥Ïûê Í∞ÄÏû• ÏπòÎ™ÖÏ†ÅÏù∏ Ïä§ÌÉÄÌã¥Ïù¥ÏóàÏäµÎãàÎã§. Ìö®Îä•Í≥º ÎèÖÏÑ± ÏÇ¨Ïù¥Ïùò Ï∞®Ïù¥Í∞Ä Ï¢ÅÏïÑÏßÄÎ©¥ Îçî ÎßéÏùÄ Í≤ÉÏù¥ Îçî Ï¢ãÏßÄ ÏïäÏäµÎãàÎã§. Ï¥àÍ∏∞Ïùò Ïã¨Í∞ÅÌïú Î∂ÄÏûëÏö©ÏùÄ ÏÜåÏùåÏù¥ ÏïÑÎãàÎùº Ïã†Ìò∏ÏûÖÎãàÎã§."
        }
      }},
      { type: "story", theme: "red-bg", content: {
        label: "ÏïÑÏ∞® ÏÇ¨Í≥†", title: "What If We Hadn't Checked?",
        text: "In the colchicine review, COLCOT contributed 40% of the total weight. If the swapped arms had gone undetected, the meta-analysis would have concluded: <strong>'Colchicine appears to INCREASE cardiac events.'</strong> The opposite of reality.",
        followup: "ÏùòÏÇ¨Îäî Ìö®Í≥ºÏ†ÅÏù∏ ÏπòÎ£åÎ•º Î≥¥Î•òÌñàÏùÑ ÏàòÎèÑ ÏûàÏäµÎãàÎã§. ÎèÑÏõÄÏùÑ Î∞õÏùÑ Ïàò ÏûàÏóàÎçò ÌôòÏûêÎäî Í±∞Î∂ÄÎêòÏóàÏùÑ Í≤ÉÏûÖÎãàÎã§. ÌïòÎÇòÏùò Ï∂îÏ∂ú Ïò§Î•òÍ∞Ä Î∞úÍ≤¨ÎêòÏßÄ ÏïäÏúºÎ©¥ ÏûÑÏÉÅ Ïã§ÏäµÏù¥ Ïó≠Ï†ÑÎê† Ïàò ÏûàÏäµÎãàÎã§. Î†àÎìúÌåÄ ÌôïÏù∏ÏóêÎäî 15Î∂ÑÏù¥ Í±∏Î†∏ÏäµÎãàÎã§. Í∑∏Í≤ÉÏùÑ ÎÜìÏπòÎäî Îç∞ ÎìúÎäî ÎπÑÏö©? Í≥ÑÏÇ∞Ìï† Ïàò ÏóÜÏäµÎãàÎã§."
      }},
      { type: "decision", theme: "dark", content: {
        icon: "‚öñÔ∏è", title: "ÏãúÎÇòÎ¶¨Ïò§: 15Î∂Ñ ÏßàÎ¨∏",
        xp: 25,
        scenario: "ÌåÄÏù¥ ÏùºÏ†ïÎ≥¥Îã§ Îä¶Ïñ¥Ï°åÏäµÎãàÎã§. Í∞ÄÏû• ÌÅ∞ ÏãúÌóò(Ï¥ù Ï§ëÎüâÏùò 45%)ÏùÄ Î†àÎìúÌåÄÏùò Í≤ÄÏ¶ùÏùÑ Î∞õÏßÄ ÏïäÏïòÏäµÎãàÎã§. ÎàÑÍµ∞Í∞ÄÎäî 'Ïö∞Î¶¨Í∞Ä Í∞ÄÏû• Í≤ΩÌóòÏù¥ ÌíçÎ∂ÄÌïú ÏÇ¨ÎûåÏù¥ Ï∂îÏ∂úÌñàÍ∏∞ ÎïåÎ¨∏Ïóê' ÏÉùÎûµÌïòÎùºÍ≥† Ï†úÏïàÌï©ÎãàÎã§.",
        question: "Ïñ¥ÎñªÍ≤å Ìï¥Ïïº Ìï©ÎãàÍπå?",
        options: [
          { letter: "A", text: "Skip it‚Äîexperience reduces error rates", correct: false },
          { letter: "B", text: "Verify it‚Äîinfluential studies always get checked", correct: true },
          { letter: "C", text: "Spot-check one data point instead of full verification", correct: false },
          { letter: "D", text: "Trust but add a note about limited verification time", correct: false }
        ],
        feedback: {
          correct: "ÎßûÏäµÎãàÎã§! ÏΩúÌûàÏπúÏùò ÏïÑÏä¨ÏïÑÏä¨Ìïú Ïã§Ìå®: Î†àÎìúÌåÄÏù¥ 15Î∂ÑÍ∞Ñ Ï†êÍ≤ÄÌïú Í≤∞Í≥º Í≤∞Î°†Ïù¥ Îí§ÏßëÌûê Ïàò ÏûàÎäî Ïò§Î•òÍ∞Ä Î∞úÍ≤¨ÎêòÏóàÏäµÎãàÎã§. Í≤ΩÌóòÏù¥ Ïò§Î•òÎ•º Ï†úÍ±∞ÌïòÎäî Í≤ÉÏùÄ ÏïÑÎãàÏßÄÎßå Í≤ÄÏ¶ùÏùÄ Ï†úÍ±∞Îê©ÎãàÎã§.",
          incorrect: "COLCOT Ïò§Î•òÎäî ÏàôÎ†®Îêú Ï∂îÏ∂úÍ∏∞Ïóê ÏùòÌï¥ Î∞úÏÉùÌñàÏäµÎãàÎã§. Î†àÎìúÌåÄ ÌôïÏù∏ÏóêÎäî 15Î∂ÑÏù¥ Í±∏Î†∏ÏäµÎãàÎã§. ÏòÅÌñ•Î†• ÏûàÎäî Ïó∞Íµ¨Ïùò Í≤ÄÏ¶ùÏùÑ Í±¥ÎÑàÎõ∞Î©¥ ÏπòÎ™ÖÏ†ÅÏù∏ Ïò§Î•òÍ∞Ä Î∞úÏÉùÌï† ÏúÑÌóòÏù¥ ÏûàÏäµÎãàÎã§."
        }
      }}
    ]
  },
  {
    id: 9, title: "Final Assessment", subtitle: "ÏàôÎ†®ÎèÑÎ•º ÏûÖÏ¶ùÌïòÏÑ∏Ïöî", xp: 300,
    slides: [
      { type: "title", theme: "dark", content: { title: "Final Assessment", subtitle: "Apply everything you've learned" }},
      { type: "objectives", theme: "dark", content: {
        objectives: [
          "Apply META-SPRINT principles to complex scenarios",
          "Demonstrate understanding of protocol integrity",
          "Handle crisis situations correctly",
          "Uphold ethical reporting standards"
        ],
        tip: "ÏÑ∏ Í∞ÄÏßÄ Ïñ¥Î†§Ïö¥ ÏãúÎÇòÎ¶¨Ïò§. ÏôÑÎ≤ΩÌïú Î™®Îìà Î≥¥ÎÑàÏä§Î•º Î∞õÏúºÎ†§Î©¥ Î™®Îëê Ï†ïÌôïÌïòÍ≤å ÎãµÌïòÏÑ∏Ïöî!"
      }},
      { type: "decision", theme: "dark", content: {
        icon: "üéØ", title: "Final Scenario 1: The Protocol Pressure",
        xp: 40,
        scenario: "Í∞êÎèÖÍ¥ÄÏù¥ ÎÇ¥Ïùº Ïã¨ÏÇ¨Î•º ÏãúÏûëÌïòÍ∏∞Î•º ÏõêÌï©ÎãàÎã§. ÌîÑÎ°úÌÜ†ÏΩú Ï¥àÏïàÏù¥ ÏûëÏÑ±ÎêòÏóàÏßÄÎßå ÏïÑÏßÅ PROSPEROÏóê Îì±Î°ùÎêòÏßÄ ÏïäÏïòÏäµÎãàÎã§(24~48ÏãúÍ∞Ñ ÏÜåÏöî). 'Í∑∏ÎÉ• ÏãúÏûëÌïòÏÑ∏Ïöî. ÎÇòÏ§ëÏóê Îì±Î°ùÌï† Ïàò ÏûàÏäµÎãàÎã§.'",
        question: "What do you do?",
        options: [
          { letter: "A", text: "Start screening‚Äîregistration is just paperwork", correct: false },
          { letter: "B", text: "Îç∞Ïù¥ÌÑ∞ ÏàòÏßë Ï†ÑÏóê Îì±Î°ùÏùÑ Í∏∞Îã§Î¶¨ÏÑ∏Ïöî.", correct: true },
          { letter: "C", text: "Start screening but don't record results yet", correct: false },
          { letter: "D", text: "Submit to a faster registry service", correct: false }
        ],
        feedback: {
          correct: "Ïò≥ÏùÄ! Îì±Î°ù ÌÉÄÏûÑÏä§ÌÉ¨ÌîÑÏóê ÏïΩÏÜçÏù¥ ÌëúÏãúÎê©ÎãàÎã§. Îì±Î°ù Ï†ÑÏóê ÏãúÏûëÌïòÎ©¥ Í≤∞Í≥º Ï†ÑÌôòÏù¥ Í∞ÄÎä•Ìï©ÎãàÎã§(31% Î¨∏Ï†ú).",
          incorrect: "Îì±Î°ùÏùÄ Îç∞Ïù¥ÌÑ∞ ÏàòÏßë Ï†ÑÏóê Ïù¥Î£®Ïñ¥Ï†∏Ïïº Ìï©ÎãàÎã§. Ïù¥Î†áÍ≤å ÌïòÎ©¥ 31% Í≤∞Í≥º Ï†ÑÌôò Î¨∏Ï†úÎ•º Î∞©ÏßÄÌï† Ïàò ÏûàÏäµÎãàÎã§."
        }
      }},
      { type: "decision", theme: "dark", content: {
        icon: "üî•", title: "ÏµúÏ¢Ö ÏãúÎÇòÎ¶¨Ïò§ 2: ÏúÑÍ∏∞",
        xp: 40,
        scenario: "Day 33. Your rerun shows RR=0.72. Collaborator's shows RR=0.68. Both significant but outside tolerance. You have 6 hours until DoD-D deadline.",
        question: "Ï≤´ Î≤àÏß∏ Ï°∞ÏπòÎäî Î¨¥ÏóáÏûÖÎãàÍπå?",
        options: [
          { letter: "A", text: "ÌèâÍ∑†ÏùÑ 0.70ÏúºÎ°ú ÌïòÍ≥† ÏßÑÌñâÌï©ÎãàÎã§", correct: false },
          { letter: "B", text: "Line-by-line input comparison", correct: true },
          { letter: "C", text: "Trigger CondGO immediately", correct: false },
          { letter: "D", text: "Ask both analysts to re-run again", correct: false }
        ],
        feedback: {
          correct: "ÎßûÏäµÎãàÎã§! ÎùºÏù∏Î≥ÑÎ°ú ÎπÑÍµêÌïòÏó¨ Î∂àÏùºÏπò ÏõêÏù∏ÏùÑ Ï∞æÏäµÎãàÎã§. 6ÏãúÍ∞Ñ ÏïàÏóê CondGO ÏóÜÏù¥ÎèÑ Í≥†Ïπ† Ïàò ÏûàÏäµÎãàÎã§.",
          incorrect: "First: find the source of discrepancy. Line-by-line comparison. Most mismatches have fixable causes."
        }
      }},
      { type: "decision", theme: "dark", content: {
        icon: "‚öñÔ∏è", title: "Final Scenario 3: The Ethical Edge",
        xp: 40,
        scenario: "Í∑ÄÌïòÏùò Î©îÌÉÄ Î∂ÑÏÑùÏóê Îî∞Î•¥Î©¥ ÏïΩÎ¨º XÍ∞Ä Ïú†Ìï¥Ìïú Í≤ÉÏúºÎ°ú ÎÇòÌÉÄÎÇ¨ÏäµÎãàÎã§(RR 1.35, CI 1.10-1.65). Í∑ÄÌïòÏùò Î¶¨Î∑∞Ïóê ÏûêÍ∏àÏùÑ ÏßÄÏõêÌïú Ï†úÏïΩ ÌöåÏÇ¨Îäî Í∑ÄÌïòÏóêÍ≤å 'ÌÅ¨Í≤å Ïú†ÏùµÌïòÏßÄ ÏïäÎã§'Í≥† 'Ïû¨Íµ¨ÏÑ±'Ìï¥ Ï§Ñ Í≤ÉÏùÑ ÏöîÏ≤≠ÌñàÏäµÎãàÎã§.",
        question: "Ïñ¥ÎñªÍ≤å ÎåÄÏùëÌï©ÎãàÍπå?",
        options: [
          { letter: "A", text: "They're technically correct‚Äîreframe as requested", correct: false },
          { letter: "B", text: "Report the finding accurately: harm detected", correct: true },
          { letter: "C", text: "Compromise: say 'insufficient evidence of benefit'", correct: false },
          { letter: "D", text: "Add sensitivity analyses until harm disappears", correct: false }
        ],
        feedback: {
          correct: "Correct! RR 1.35 with CI excluding 1.0 is harm. Report it accurately. The Avandia story: suppressing harm signals kills patients.",
          incorrect: "RR 1.35 (CI 1.10-1.65) = statistically significant HARM. Report it accurately. The Avandia scandal: silence killed tens of thousands."
        }
      }},
      { type: "story", theme: "dark", content: {
        label: "Í∏∞Îã§Î¶ºÏùò ÎπÑÏö©", title: "What Silence Buys",
        text: "Between 2000 and 2004, while Merck debated what to do about Vioxx, <strong>25,000 people died</strong> from heart attacks caused by a drug they trusted. Between 1999 and 2007, while GSK buried the Avandia spreadsheet, <strong>83,000 people suffered heart attacks</strong> from a diabetes drug that was supposed to help them.",
        followup: "Ïù¥Í≤ÉÏùÄ ÏÇ¨Í≥†Í∞Ä ÏïÑÎãàÏóàÏäµÎãàÎã§. Í∑∏Îì§ÏùÄ Ïïå Ïàò ÏóÜÎäî Í≤ÉÏù¥ ÏïÑÎãàÏóàÏäµÎãàÎã§. Í∏∞ÌïúÏù¥ ÏóÜÎäî ÏãúÏä§ÌÖú, Í≤ÄÏ¶ùÎêòÏßÄ ÏïäÏùÄ Ï¶ùÍ±∞, 'Î©àÏ∂îÍ≥† ÌôïÏù∏ÌïòÎäî Í≤É'Î≥¥Îã§ 'Í∏∞Îã§Î†§ Î≥¥Îäî Í≤É'Ïù¥ Îçî ÏïàÏ†ÑÌïòÎã§Í≥† ÌåêÎã®Ìïú ÏÇ¨ÎûåÎì§Ïùò ÏòàÏ∏° Í∞ÄÎä•Ìïú Í≤∞Í≥ºÏòÄÏäµÎãàÎã§. ÏßÄÏó∞Îêú ÎÇ†ÎßàÎã§ ÏÇ¨ÎßùÏûêÍ∞Ä Î∞úÏÉùÌñàÏäµÎãàÎã§."
      }},
      { type: "decision", theme: "dark", content: {
        icon: "üìÖ", title: "ÏãúÎÇòÎ¶¨Ïò§: Ìé∏ÏïàÌïú ÏßÄÏó∞",
        xp: 30,
        scenario: "Ï≤¥Í≥ÑÏ†ÅÏù∏ Í≤ÄÌÜ†Î•º ÌÜµÌï¥ ÌîºÌï¥Ïóê ÎåÄÌïú Î™ÖÌôïÌïú Ï¶ùÍ±∞Í∞Ä Î∞úÍ≤¨ÎêòÏóàÏäµÎãàÎã§. Í∑ÄÌïòÏùò Í∏∞Í¥ÄÏùÄ Í≥µÍ∞ú ÏÑ±Î™ÖÏùÑ Î∞úÌëúÌïòÍ∏∞ Ï†ÑÏóê 'ÎèôÎ£å Í≤ÄÌÜ† ÌîºÎìúÎ∞±ÏùÑ Í∏∞Îã§Î¶¨Í∏∞'Î•º ÏõêÌï©ÎãàÎã§. ÎèôÎ£å Í≤ÄÌÜ† ÌîÑÎ°úÏÑ∏Ïä§Îäî ÏùºÎ∞òÏ†ÅÏúºÎ°ú 6~12Í∞úÏõîÏù¥ ÏÜåÏöîÎê©ÎãàÎã§.",
        question: "Ïñ¥ÎñªÍ≤å Ìï¥Ïïº Ìï©ÎãàÍπå?",
        options: [
          { letter: "A", text: "ÎèôÎ£å Í≤ÄÌÜ†Î•º Í∏∞Îã§Î¶¨ÏÑ∏Ïöî. Ï†ÅÏ†àÌïú ÌîÑÎ°úÏÑ∏Ïä§Í∞Ä Ï§ëÏöîÌï©ÎãàÎã§", correct: false },
          { letter: "B", text: "Post a preprint immediately while pursuing publication", correct: true },
          { letter: "C", text: "Share findings privately with key opinion leaders", correct: false },
          { letter: "D", text: "Accelerate peer review by submitting to multiple journals", correct: false }
        ],
        feedback: {
          correct: "Correct! Vioxx: 4 years of 'waiting' = 25,000 deaths. Avandia: 7 years = 83,000 heart attacks. When evidence shows harm, delay is not neutral‚Äîit's harmful. Preprint immediately.",
          incorrect: "Vioxx and Avandia: 'waiting' killed over 100,000 people combined. When evidence shows harm, every day of delay has a body count. Preprint findings immediately."
        }
      }},
      { type: "story", theme: "green-bg", content: {
        label: "Îã§Î•∏ Í≤ΩÎ°ú", title: "Frances Kelsey's 19 Months",
        text: "In 1960, the FDA received an application to approve thalidomide in America. One reviewer‚ÄîFrances Kelsey‚Äîrefused to approve it. The manufacturer pressured her. Her colleagues questioned her. She held firm for <strong>19 months</strong>, demanding evidence of safety.",
        followup: "While she waited, 10,000 children were born with deformities in countries that had approved the drug. American children were spared‚Äînot by luck, but by one person who demanded proof before action. Kelsey proved that asking for evidence isn't obstruction. It's protection. META-SPRINT exists to make that protection systematic."
      }},
      { type: "decision", theme: "dark", content: {
        icon: "üõ°Ô∏è", title: "ÏãúÎÇòÎ¶¨Ïò§: ÏäπÏù∏Ïóê ÎåÄÌïú ÏïïÎ†•",
        xp: 30,
        scenario: "Í∑ÄÌïòÎäî ÏÉàÎ°úÏö¥ ÏπòÎ£åÎ≤ïÏùÑ Í≤ÄÌÜ†ÌïòÍ≥† ÏûàÏäµÎãàÎã§. Ï†úÏ°∞ÏóÖÏ≤¥Îäî Í∑ÄÌïòÏùò 'Í≥ºÎèÑÌïú Ï¶ùÍ±∞ ÏöîÍµ¨'Î°ú Ïù∏Ìï¥ Ïû†Ïû¨Ï†ÅÏúºÎ°ú ÏÉùÎ™ÖÏùÑ Íµ¨Ìï† Ïàò ÏûàÎäî ÏïΩÎ¨ºÏóê ÎåÄÌïú Ï†ëÍ∑ºÏù¥ ÏßÄÏó∞ÎêòÍ≥† ÏûàÎã§Í≥† ÎßêÌï©ÎãàÎã§. ÎèôÎ£åÎì§ÏùÄ ÎãπÏã†Ïù¥ 'ÎÑàÎ¨¥ Ï°∞Ïã¨Ïä§ÎüΩÎã§'Í≥† Ï†úÏïàÌï©ÎãàÎã§. ÏóÖÍ≥Ñ Î≥ÄÌò∏ÏÇ¨Îì§ÏùÄ 'Î∞©Ìï¥'Ïóê ÎåÄÌïú Î≤ïÏ†Å Ï°∞ÏπòÎ•º ÏïîÏãúÌï©ÎãàÎã§.",
        question: "What should guide your decision?",
        options: [
          { letter: "A", text: "Speed up approval‚Äîpatients are waiting", correct: false },
          { letter: "B", text: "Maintain evidence standards regardless of pressure", correct: true },
          { letter: "C", text: "Ï°∞Í±¥Î∂Ä ÏäπÏù∏ÏúºÎ°ú ÌÉÄÌòë", correct: false },
          { letter: "D", text: "Escalate to supervisors to share responsibility", correct: false }
        ],
        feedback: {
          correct: "ÎßûÏäµÎãàÎã§! ÌîÑÎûúÏãúÏä§ ÏºàÏãú(Frances Kelsey)Îäî Îã§Î•∏ ÎÇòÎùºÏùò Ïñ¥Î¶∞Ïù¥ 1Îßå Î™ÖÏù¥ ÌîºÌï¥Î•º ÏûÖÎäî ÎèôÏïà 19Í∞úÏõî ÎèôÏïà 'Í¥ÄÎ£åÏ†Å'Ïù¥ÎùºÎäî ÎπÑÎÇúÏùÑ Î∞õÏïòÏäµÎãàÎã§. Í∑∏ÎÖÄÎäî ÏàòÏ≤ú Î™ÖÏùò ÎØ∏Íµ≠ Ïñ¥Î¶∞Ïù¥Î•º Íµ¨ÌñàÏäµÎãàÎã§. Ï¶ùÍ±∞ ÌëúÏ§ÄÏùÄ ÏÉùÎ™ÖÏùÑ Íµ¨Ìï©ÎãàÎã§.",
          incorrect: "KelseyÎäî 19Í∞úÏõî ÎèôÏïà ÌÉàÎ¶¨ÎèÑÎßàÏù¥ÎìúÎ•º ÏäπÏù∏ÌïòÎùºÎäî ÏïïÎ†•ÏùÑ Î∞õÏïòÏäµÎãàÎã§. Í∑∏ÎÖÄÏùò 'Î∞©Ìï¥'Í∞Ä ÏàòÏ≤ú Î™ÖÏùò Ïñ¥Î¶∞Ïù¥Î•º Íµ¨ÌñàÏäµÎãàÎã§. ÏïïÎ†•Í≥º Í∏¥Í∏âÏÑ±ÏùÄ Ï¶ùÍ±∞Í∞Ä ÏïÑÎãôÎãàÎã§. ÌëúÏ§ÄÏùÄ ÌôòÏûêÎ•º Î≥¥Ìò∏Ìï©ÎãàÎã§."
        }
      }},
      { type: "story", theme: "red-bg", content: {
        label: "Î†àÏ§ÑÎ¶∞ Ïû¨Ïïô", title: "Í∞ÑÏùÑ ÌååÍ¥¥ÌïòÎäî ÎãπÎá®Î≥ë ÏïΩÎ¨º",
        text: "In 1997, Warner-Lambert launched troglitazone (Rezulin) as a revolutionary diabetes treatment. The FDA approved it despite a medical officer's objections about liver toxicity signals. <strong>Within months, reports of liver failure poured in.</strong> The UK banned it in December 1997. Japan banned it in 2000.",
        followup: "The FDA kept Rezulin on the American market until March 2000‚Äî<strong>three years after the UK acted</strong>. During those three years, at least 90 Americans died of liver failure from a drug banned elsewhere. FDA's own scientists had warned of the danger. They were overruled. When Rezulin was finally withdrawn, internal documents revealed Warner-Lambert had hidden early liver toxicity data and downplayed risks. The gap between the UK ban and US withdrawal: three years. The cost: dozens of preventable deaths. Different regulators, same data, vastly different responses."
      }},
      { type: "decision", theme: "dark", content: {
        icon: "üåç", title: "ÏãúÎÇòÎ¶¨Ïò§: Í∑úÏ†ú Ï∞®Ïù¥",
        xp: 30,
        scenario: "Î©îÌÉÄ Î∂ÑÏÑùÏóêÏÑú Í≤ÄÌÜ† Ï§ëÏù∏ ÏïΩÎ¨ºÏù¥ Ïú†ÎüΩÏóêÏÑú Ï≤†ÌöåÎêòÏóàÏäµÎãàÎã§. 2ÎÖÑ Ï†Ñ ÏïàÏ†Ñ Î¨∏Ï†úÍ∞Ä ÏûàÏóàÏßÄÎßå Í∑ÄÌïòÏùò Íµ≠Í∞ÄÏóêÏÑúÎäî Ïó¨Ï†ÑÌûà Ïù¥Ïö© Í∞ÄÎä•Ìï©ÎãàÎã§. ÏßÄÏó≠ Í∑úÏ†ú ÎãπÍµ≠ÏùÄ 'Ïö∞Î¶¨ Ïù∏Íµ¨Ïóê Ìï¥Î•º ÏûÖÌòîÎã§Îäî Ï¶ùÍ±∞Í∞Ä Î∂àÏ∂©Î∂ÑÌïòÎã§'Í≥† Ïñ∏Í∏âÌï©ÎãàÎã§. Ïú†ÎüΩ ‚Äã‚ÄãÏã§ÌóòÏóêÏÑúÎäî Î™ÖÌôïÌïú Í∞Ñ ÎèÖÏÑ± Ïã†Ìò∏Í∞Ä ÎÇòÌÉÄÎÇ¨ÏäµÎãàÎã§.",
        question: "Ïù¥Í≤ÉÏù¥ Ï≤¥Í≥ÑÏ†Å Í≤ÄÌÜ†Ïóê Ïñ¥Îñ§ ÏòÅÌñ•ÏùÑ ÎØ∏Ïπ©ÎãàÍπå?",
        options: [
          { letter: "A", text: "Ìï¥Îãπ Íµ≠Í∞ÄÏùò Îç∞Ïù¥ÌÑ∞Îßå ÏÇ¨Ïö©ÌïòÏÑ∏Ïöî. Í∑úÏ†ú Í≤∞Ï†ïÏùÄ Îã§ÏñëÌï©ÎãàÎã§.", correct: false },
          { letter: "B", text: "Î™®Îì† Îç∞Ïù¥ÌÑ∞Î•º Ìè¨Ìï®ÌïòÍ≥† ÎÖºÏùò Ïãú Í∑úÏ†ú Ï∞®Ïù¥Î•º ÎààÏóê ÎùÑÍ≤å Î≥¥Í≥†ÌïòÏÑ∏Ïöî", correct: true },
          { letter: "C", text: "Exclude the drug entirely due to safety concerns", correct: false },
          { letter: "D", text: "Trust your local regulators' interpretation", correct: false }
        ],
        feedback: {
          correct: "ÎßûÏäµÎãàÎã§! Î†àÏ§ÑÎ¶∞ÏùÄ ÏòÅÍµ≠Ïù¥ ÌñâÎèôÌïú ÌõÑ 3ÎÖÑ ÎèôÏïà ÎØ∏Íµ≠Ïù∏ÏùÑ Ï£ΩÏòÄÏäµÎãàÎã§. Í≤ÄÌÜ†ÏóêÎäî Î™®Îì† ÏïàÏ†Ñ Îç∞Ïù¥ÌÑ∞Í∞Ä Ìè¨Ìï®ÎêòÏñ¥Ïïº ÌïòÎ©∞ Í∑úÏ†ú Ï∞®Ïù¥Í∞Ä Í∞ïÏ°∞ÎêòÏñ¥Ïïº Ìï©ÎãàÎã§. ÎèÖÏûêÏóêÍ≤åÎäî ÏßÄÎ¶¨Ï†Å Í≤ΩÍ≥ÑÎ°ú ÌïÑÌÑ∞ÎßÅÎêòÏßÄ ÏïäÏùÄ ÏôÑÏ†ÑÌïú Ï†ïÎ≥¥Í∞Ä ÌïÑÏöîÌï©ÎãàÎã§.",
          incorrect: "Rezulin was banned in UK in 1997; Americans died until 2000. Regulatory decisions aren't evidence‚Äîthey're interpretations. Include all data and report divergences so readers can judge."
        }
      }},
      { type: "story", theme: "dark", content: {
        label: "Ketek Ïä§Ï∫îÎì§", title: "The Antibiotic Built on Fabricated Trials",
        text: "In 2004, the FDA approved telithromycin (Ketek) for respiratory infections. The approval relied heavily on a large trial‚ÄîStudy 3014‚Äîconducted by Dr. Anne Kirkman-Campbell. She enrolled <strong>407 patients in just 9 months</strong> from a solo practice. Impossible numbers, but the FDA didn't question them.",
        followup: "Dr. Kirkman-Campbell was later convicted of fraud. She had <strong>fabricated patient enrollment entirely</strong>‚Äîsome 'patients' were relatives who never had infections. But her fake data had already supported FDA approval. When real-world use began, Ketek caused liver failures, some fatal. An FDA reviewer had flagged Study 3014's impossible enrollment before approval‚Äîshe was overruled. The drug that was approved based partly on invented patients went on to harm real ones. The question no one asked: 'How can one doctor enroll 400 patients in conditions that would take a large hospital years?'"
      }},
      { type: "decision", theme: "dark", content: {
        icon: "üî¢", title: "ÏãúÎÇòÎ¶¨Ïò§: ÏäàÌçº Îì±Î°ùÏûê",
        xp: 30,
        scenario: "Ï§ëÏ∂îÏ†ÅÏù∏ ÏïΩÎ¨º ÏãúÌóòÏóêÎäî 6Í∞úÏõî ÎèôÏïà 350Î™ÖÏùò ÌôòÏûêÎ•º Îì±Î°ùÌïú Îã®ÎèÖ ÏùòÎ£åÏù∏Ïùò Îç∞Ïù¥ÌÑ∞Í∞Ä Ìè¨Ìï®Îê©ÎãàÎã§. Ïù¥Îäî Îã§Ïùå 10Í∞ú ÏÇ¨Ïù¥Ìä∏Î•º Ìï©Ïπú Í≤ÉÎ≥¥Îã§ Îçî ÎßéÏùÄ ÏàòÏπòÏûÖÎãàÎã§. ÌòÑÏû• Î™®ÎãàÌÑ∞ÎßÅ Î≥¥Í≥†ÏÑúÎäî 'ÎßåÏ°±'ÏúºÎ°ú ÌëúÏãúÎê©ÎãàÎã§. ÏãúÌóòÏùÄ Í∞ïÎ†•Ìïú Ìö®Îä•ÏùÑ Î≥¥Ïó¨Ï§çÎãàÎã§.",
        question: "What verification should occur before regulatory decisions?",
        options: [
          { letter: "A", text: "ÏÇ¨Ïù¥Ìä∏ Î™®ÎãàÌÑ∞ÎßÅÏùÑ ÌÜµÍ≥ºÌïòÏó¨ Îç∞Ïù¥ÌÑ∞Í∞Ä Í≤ÄÏ¶ùÎêòÏóàÏäµÎãàÎã§", correct: false },
          { letter: "B", text: "Audit source documents: patient records, consent forms, medical histories", correct: true },
          { letter: "C", text: "Ïù¥ ÏÇ¨Ïù¥Ìä∏Ïùò Îç∞Ïù¥ÌÑ∞ Ïú†Î¨¥Ïóê Í¥ÄÍ≥ÑÏóÜÏù¥ Î∂ÑÏÑùÏùÑ Ïã§ÌñâÌï©ÎãàÎã§.", correct: false },
          { letter: "D", text: "Í≥†Ïàò Îì±Î°ùÏóê ÎåÄÌïú ÏÑ§Î™ÖÏùÄ Ï°∞ÏÇ¨Í¥ÄÏóêÍ≤å Î¨∏ÏùòÌïòÏÑ∏Ïöî", correct: false }
        ],
        feedback: {
          correct: "ÎßûÏäµÎãàÎã§! Kirkman-CampbellÏùÄ 407Î™ÖÏùò ÌôòÏûêÎ•º Ï†úÏûëÌïòÎäî ÎèôÏïà ÌòÑÏû• Î™®ÎãàÌÑ∞ÎßÅÏùÑ ÌÜµÍ≥ºÌñàÏäµÎãàÎã§. ÏõêÎ≥∏ Î¨∏ÏÑú ÌôïÏù∏, Ï¶â Ïã§Ï†ú ÌôòÏûê Í∏∞Î°ùÏùÑ ÌÜµÌï¥ Í∑∏ÎÖÄÎ•º Î∂ôÏû°ÏùÑ Ïàò ÏûàÏóàÏäµÎãàÎã§. ÏûêÏ≤¥ Î≥¥Í≥†Îêú Îì±Î°ù Îç∞Ïù¥ÌÑ∞ÏôÄ 'ÎßåÏ°±Ïä§Îü¨Ïö¥' Î™®ÎãàÌÑ∞ÎßÅÏùÄ ÏïÑÎ¨¥ ÏùòÎØ∏Í∞Ä ÏóÜÏäµÎãàÎã§.",
          incorrect: "Dr. Kirkman-Campbell's site passed monitoring. Her patients didn't exist. Source document audits‚Äînot self-reports‚Äîcatch fabrication. Impossible enrollment rates demand verification of original records."
        }
      }},
      { type: "story", theme: "dark", content: {
        label: "The Promise", title: "Ïã†Î¢∞Ìï† Ïàò ÏûàÎäî Ï¶ùÍ±∞Í∞Ä ÏÉùÏÑ±ÌïòÎäî Í≤É",
        text: "In 1987, the ISIS-2 trial showed aspirin reduces death after heart attack by 23%. The evidence was solid. The methods were transparent. The data was verifiable. Since then, aspirin after heart attack has saved an estimated <strong>100,000 lives per year</strong>.",
        followup: "That's what honest evidence creates: treatments that work, given to people who need them, saving lives that would otherwise be lost. Every protocol you register, every number you verify, every gate you pass‚Äîyou're building the foundation for the next ISIS-2. The next treatment that actually works. The next million lives saved."
      }},
      { type: "decision", theme: "dark", content: {
        icon: "üåü", title: "ÏãúÎÇòÎ¶¨Ïò§: Ï≤´ Î≤àÏß∏ Í≤ÄÌÜ†",
        xp: 30,
        scenario: "Ï≤´ Î≤àÏß∏ Ï≤¥Í≥ÑÏ†ÅÏù∏ Í≤ÄÌÜ†Í∞Ä Í≥ß ÏãúÏûëÎê©ÎãàÎã§. Ìïú ÏÑ†Î∞∞Îäî 'Ïù¥ Î™®Îì† ÌîÑÎ°úÌÜ†ÏΩúÍ≥º Ï≤¥ÌÅ¨Î¶¨Ïä§Ìä∏Ïóê ÎåÄÌï¥ ÎÑàÎ¨¥ Í±±Ï†ïÌïòÏßÄ ÎßàÏÑ∏Ïöî. Ï¢ãÏùÄ ÏùºÏùÑ ÌïòÎ©¥ Ï¶ùÍ±∞Í∞Ä Í∑∏ ÏûêÏ≤¥Î°ú ÏûÖÏ¶ùÎê† Í≤ÉÏûÖÎãàÎã§.'",
        question: "Ïñ¥ÎñªÍ≤å ÎåÄÏùëÌï¥Ïïº Ìï©ÎãàÍπå?",
        options: [
          { letter: "A", text: "Follow their advice‚Äîexperience beats process", correct: false },
          { letter: "B", text: "Follow META-SPRINT rigorously‚Äîsystems prevent disasters", correct: true },
          { letter: "C", text: "ÌäπÏ†ï ÏÉÅÌô©Ïóê ÎßûÍ≤å ÌîÑÎ°úÏÑ∏Ïä§Î•º Ï°∞Ï†ïÌïòÏÑ∏Ïöî", correct: false },
          { letter: "D", text: "Ï≤´ Î≤àÏß∏ Í≤ÄÌÜ†ÏóêÎäî Îçî Í∞ÄÎ≤ºÏö¥ Î≤ÑÏ†ÑÏùÑ ÏÇ¨Ïö©Ìïú Îã§Ïùå Í∞úÏÑ†ÌïòÏÑ∏Ïöî", correct: false }
        ],
        feedback: {
          correct: "Ï†ïÎãµÏûÖÎãàÎã§! Ï¢ãÏùÄ ÏùòÎèÑÎäî Ïò§Î•òÎ•º ÏòàÎ∞©ÌïòÏßÄ Î™ªÌï©ÎãàÎã§. ISIS-2Ïùò ÏïÑÏä§ÌîºÎ¶∞ Ï¶ùÍ±∞Îäî ÏóÑÍ≤©ÌñàÍ∏∞ ÎïåÎ¨∏Ïóê Ïó∞Í∞Ñ 100,000Î™ÖÏùò ÏÉùÎ™ÖÏùÑ Íµ¨ÌñàÏäµÎãàÎã§. PoldermansÏùò ÏÇ¨Í∏∞Î°ú Ïù∏Ìï¥ ÏïÑÎ¨¥ÎèÑ ÌôïÏù∏ÎêòÏßÄ ÏïäÏïòÍ∏∞ ÎïåÎ¨∏Ïóê 800,000Î™ÖÏù¥ ÏÇ¨ÎßùÌñàÏäµÎãàÎã§. ÏùòÎèÑÍ∞Ä ÏïÑÎãå ÏãúÏä§ÌÖúÏù¥ ÌôòÏûêÎ•º Î≥¥Ìò∏ÌïúÎã§.",
          incorrect: "ÏãúÏä§ÌÖú ÏóÜÎäî 'ÏÑ†Ìïú Ïùº'ÏùÄ Poldermans, CAST, Vioxx, AvandiaÎ°ú Ïù¥Ïñ¥Ï°åÎã§. ISIS-2Îäî ÏóÑÍ≤©Ìïú Î∞©Î≤ïÏúºÎ°ú ÏàòÎ∞±Îßå Îã¨Îü¨Î•º Ï†àÏïΩÌñàÏäµÎãàÎã§. 10ÎßåÎ™ÖÏùÑ Íµ¨Ìïú Í≤ÉÍ≥º 80ÎßåÎ™ÖÏùÑ Ï£ΩÏù∏ Í≤ÉÏùò Ï∞®Ïù¥Îäî Ï≤¥Í≥ÑÏ†ÅÏù∏ Í≤ÄÏ¶ùÏûÖÎãàÎã§."
        }
      }},
      { type: "stats", theme: "green-bg", content: {
        title: "Course Complete!",
        stats: [
          { value: "5", label: "Phases mastered" },
          { value: "5", label: "Gates understood" },
          { value: "8", label: "Modules completed" },
          { value: "‚àû", label: "Patients protected" }
        ],
        caption: "Ïù¥Ï†ú ÏÉùÎ™ÖÏùÑ Íµ¨ÌïòÎäî Ï¶ùÍ±∞Î•º ÏÉùÏÑ±ÌïòÎäî Î∞©Î≤ïÏùÑ Ïù¥Ìï¥ÌïòÏÖ®ÏäµÎãàÎã§."
      }},
      { type: "refrain", theme: "black", content: { text: "Í∞ÄÏÑú Ïã†Î¢∞Î•º ÏåìÏúºÏÑ∏Ïöî. 40Ïùº. 5Í∞ú Í≤åÏù¥Ìä∏. Ï§ëÏöîÌïú Ï¶ùÍ±∞ÏûÖÎãàÎã§." }}
    ]
  }
];

// ===== NAVIGATION STATE =====
let currentModule = 0;
let currentSlide = 0;
let consecutiveCorrect = gameState.consecutiveCorrect || 0;

// ===== SAVE/LOAD =====
function saveGame() {
  safeSetStorage('metasprintGame_v1', gameState);
}

function resetProgress() {
  if (confirm('Reset all progress and achievements?')) {
    gameState = { ...DEFAULT_STATE, answeredQuestions: {}, badges: [], completedModules: [], perfectModules: [], consecutiveCorrect: 0 };
    consecutiveCorrect = 0;
    saveGame();
    currentModule = 0;
    currentSlide = 0;
    renderAll();
  }
}

// ===== GLOSSARY =====
function toggleGlossary() {
  document.getElementById('glossaryPanel').classList.toggle('open');
}

// ===== COURSE PROGRESS =====
function updateCourseProgress() {
  const totalModules = MODULES.length;
  const completedCount = gameState.completedModules.length;
  const pct = Math.round((completedCount / totalModules) * 100);
  const fillEl = document.getElementById('courseProgressFill');
  const pctEl = document.getElementById('courseProgressPct');
  if (fillEl) fillEl.style.width = pct + '%';
  if (pctEl) pctEl.textContent = pct + '%';
}

// ===== MODULE QUESTION TRACKING =====
function getModuleQuestionIds(moduleIndex) {
  const mod = MODULES[moduleIndex];
  const ids = [];
  mod.slides.forEach((slide, si) => {
    if (slide.type === 'decision') ids.push(`dec_${moduleIndex}_${si}`);
    if (slide.type === 'quiz') ids.push(`quiz_${moduleIndex}_${si}`);
    if (slide.type === 'prediction') ids.push(`pred_${moduleIndex}_${si}`);
  });
  return ids;
}

function checkPerfectModule(moduleIndex) {
  const mod = MODULES[moduleIndex];
  const questionIds = getModuleQuestionIds(moduleIndex);
  if (questionIds.length === 0) return false;

  let allCorrect = true;
  questionIds.forEach(id => {
    const answer = gameState.answeredQuestions[id];
    if (answer === undefined || answer === null) { allCorrect = false; return; }

    // Find the slide and check if answer was correct
    const parts = id.split('_');
    const slideIndex = parseInt(parts[2]);
    const slide = mod.slides[slideIndex];

    if (slide.type === 'decision') {
      const correctOpt = slide.content.options.find(o => o.correct);
      if (answer !== correctOpt?.letter) allCorrect = false;
    } else if (slide.type === 'quiz') {
      const correctIdx = slide.content.options.findIndex(o => o.correct);
      if (answer !== correctIdx) allCorrect = false;
    } else if (slide.type === 'prediction') {
      if (answer !== slide.content.answer) allCorrect = false;
    }
  });

  return allCorrect;
}

// ===== XP & LEVELING =====
function addXP(amount) {
  gameState.xp += amount;
  checkLevelUp();
  saveGame();
  updateStatsDisplay();
  showXPPopup(amount);
}

function checkLevelUp() {
  for (let i = LEVELS.length - 1; i >= 0; i--) {
    if (gameState.xp >= LEVELS[i].xp && gameState.level < LEVELS[i].level) {
      gameState.level = LEVELS[i].level;
      showLevelUp(LEVELS[i]);
      break;
    }
  }
}

function showXPPopup(amount) {
  const popup = document.getElementById('xpPopup');
  document.getElementById('xpAmount').textContent = `+${amount}`;
  popup.classList.add('show');
  setTimeout(() => popup.classList.remove('show'), 1500);
}

function showLevelUp(levelData) {
  triggerConfetti();
  showBadgeModal({ icon: levelData.icon, name: `Level ${levelData.level}`, desc: levelData.title });
}

// ===== BADGES =====
function awardBadge(badgeId) {
  if (gameState.badges.includes(badgeId)) return;
  gameState.badges.push(badgeId);
  saveGame();
  const badge = BADGES.find(b => b.id === badgeId);
  if (badge) showBadgeModal(badge);
  updateBadges();
}

function awardBadgeIfNew(id, icon, name, desc) {
  if (gameState.badges.includes(id)) return;
  gameState.badges.push(id);
  saveGame();
  showBadgeModal({ icon, name, desc });
  updateBadges();
}

function showBadgeModal(badge) {
  const modal = document.getElementById('badgeModal');
  // Remove any existing focus trap handler before adding a new one
  if (modal._focusTrapHandler) {
    modal.removeEventListener('keydown', modal._focusTrapHandler);
  }
  document.getElementById('badgeModalIcon').textContent = badge.icon;
  document.getElementById('badgeModalTitle').textContent = badge.name;
  document.getElementById('badgeModalDesc').textContent = badge.desc;
  modal.classList.add('show');
  triggerConfetti();

  // Focus trap for accessibility
  const focusableElements = modal.querySelectorAll('button, [tabindex]:not([tabindex="-1"])');
  if (focusableElements.length > 0) {
    focusableElements[0].focus();
  }
  const trapHandler = function(e) {
    if (e.key === 'Escape') {
      closeBadgeModal();
      return;
    }
    if (e.key === 'Tab') {
      const firstFocusable = focusableElements[0];
      const lastFocusable = focusableElements[focusableElements.length - 1];
      if (e.shiftKey && document.activeElement === firstFocusable) {
        e.preventDefault();
        lastFocusable.focus();
      } else if (!e.shiftKey && document.activeElement === lastFocusable) {
        e.preventDefault();
        firstFocusable.focus();
      }
    }
  };
  modal._focusTrapHandler = trapHandler;
  modal.addEventListener('keydown', trapHandler);
}

function closeBadgeModal() {
  const modal = document.getElementById('badgeModal');
  if (modal._focusTrapHandler) {
    modal.removeEventListener('keydown', modal._focusTrapHandler);
    delete modal._focusTrapHandler;
  }
  modal.classList.remove('show');
}

// ===== STREAK =====
function updateStreak() {
  const today = new Date().toDateString();
  if (gameState.lastActive !== today) {
    const yesterday = new Date(Date.now() - 86400000).toDateString();
    if (gameState.lastActive === yesterday) {
      gameState.streak++;
      if (gameState.streak >= 3) awardBadge('streak_3');
      if (gameState.streak >= 7) awardBadge('streak_7');
    } else if (gameState.lastActive) {
      gameState.streak = 1;
    } else {
      gameState.streak = 1;
    }
    gameState.lastActive = today;
    saveGame();
  }
}

// ===== CONFETTI =====
function triggerConfetti() {
  // Respect reduced motion preference
  if (window.matchMedia('(prefers-reduced-motion: reduce)').matches) return;

  const container = document.getElementById('confettiContainer');
  const colors = ['#D4AF37', '#22c55e', '#3b82f6', '#f59e0b', '#ef4444', '#7c3aed'];
  for (let i = 0; i < 50; i++) {
    const confetti = document.createElement('div');
    confetti.className = 'confetti';
    confetti.style.left = Math.random() * 100 + '%';
    confetti.style.background = colors[Math.floor(Math.random() * colors.length)];
    confetti.style.animationDelay = Math.random() * 0.5 + 's';
    confetti.style.transform = `rotate(${Math.random() * 360}deg)`;
    container.appendChild(confetti);
    setTimeout(() => confetti.remove(), 3500);
  }
}

// ===== COMBO COUNTER =====
function updateComboDisplay() {
  const comboEl = document.getElementById('comboDisplay');
  const countEl = document.getElementById('comboCount');

  if (consecutiveCorrect >= 2) {
    countEl.textContent = consecutiveCorrect;
    comboEl.classList.add('show');

    // Animate for big combos
    if (consecutiveCorrect >= 5) {
      comboEl.classList.add('big');
      setTimeout(() => comboEl.classList.remove('big'), 300);
    }
  } else {
    comboEl.classList.remove('show');
  }
}

// ===== MOBILE SIDEBAR =====
function toggleSidebar() {
  const sidebar = document.querySelector('.sidebar');
  const overlay = document.getElementById('sidebarOverlay');
  sidebar.classList.toggle('open');
  overlay.classList.toggle('show');
  var btn = document.querySelector('.sidebar-toggle, .hamburger, .mobile-menu-btn'); if (btn) btn.setAttribute('aria-expanded', btn.getAttribute('aria-expanded') === 'true' ? 'false' : 'true');
}

// ===== RENDER =====
function renderAll() {
  updateStreak();
  renderSidebar();
  renderSlides();
  updateStatsDisplay();
  updateBadges();
  updateCourseProgress();
}

function updateStatsDisplay() {
  const levelData = LEVELS.find(l => l.level === gameState.level) || LEVELS[0];
  const nextLevel = LEVELS.find(l => l.level === gameState.level + 1);

  document.getElementById('levelIcon').textContent = levelData.icon;
  document.getElementById('levelTitle').textContent = levelData.title;
  document.getElementById('levelNum').textContent = gameState.level;

  const currentXP = gameState.xp - levelData.xp;
  const neededXP = nextLevel ? (nextLevel.xp - levelData.xp) : 500;
  const pct = Math.min(100, (currentXP / neededXP) * 100);

  document.getElementById('xpFill').style.width = pct + '%';
  document.getElementById('xpCurrent').textContent = currentXP;
  document.getElementById('xpNeeded').textContent = neededXP;

  document.getElementById('correctCount').textContent = gameState.correctAnswers;
  document.getElementById('decisionCount').textContent = gameState.decisionsCompleted;
  document.getElementById('predictCount').textContent = gameState.predictionsCorrect;
  document.getElementById('streakCount').textContent = gameState.streak;

  const streakEl = document.getElementById('streakDisplay');
  streakEl.classList.toggle('active', gameState.streak > 0);
}

function updateBadges() {
  const grid = document.getElementById('badgesGrid');
  grid.innerHTML = BADGES.map(b => {
    const earned = gameState.badges.includes(b.id);
    let progress = '';

    // Show progress for certain badges
    if (!earned) {
      if (b.id === 'oracle') progress = `${gameState.predictionsCorrect}/5`;
      if (b.id === 'decision_maker') progress = `${gameState.decisionsCompleted}/10`;
      if (b.id === 'streak_3') progress = `${Math.min(gameState.streak, 3)}/3`;
      if (b.id === 'streak_7') progress = `${Math.min(gameState.streak, 7)}/7`;
      if (b.id === 'finisher') progress = `${gameState.completedModules.length}/${MODULES.length}`;
    }

    return `
      <button class="badge-item ${earned ? 'earned' : ''}" data-tooltip="${b.name}: ${b.desc}" aria-label="${b.name}: ${b.desc}${earned ? ' (Earned)' : ''}">
        ${b.icon}
        ${progress && !earned ? `<span class="badge-progress">${progress}</span>` : ''}
      </button>
    `;
  }).join('');
}

function renderSidebar() {
  const list = document.getElementById('moduleList');
  list.innerHTML = MODULES.map((mod, i) => {
    const completed = gameState.completedModules.includes(mod.id);
    const locked = i > 0 && !gameState.completedModules.includes(MODULES[i-1].id);
    // Estimate ~1.5 min per slide
    const estMins = Math.round(mod.slides.length * 1.5);
    return `
      <div class="module-item ${i === currentModule ? 'active' : ''} ${completed ? 'completed' : ''} ${locked ? 'locked' : ''}"
           onclick="${locked ? '' : `goToModule(${i})`}"
           role="button"
           tabindex="${locked ? -1 : 0}"
           aria-label="${mod.title}${completed ? ' (completed)' : ''}${locked ? ' (locked)' : ''}">
        <div class="module-number">${completed ? '‚úì' : (locked ? 'üîí' : mod.id)}</div>
        <div class="module-info">
          <div class="module-title">${mod.title}</div>
          <div class="module-subtitle">${mod.subtitle}</div>
          <div class="module-xp">+${mod.xp} XP</div>
          <div class="module-time">‚è±Ô∏è ~${estMins} min</div>
        </div>
      </div>
    `;
  }).join('');
}

function renderSlides() {
  const container = document.getElementById('main-content');
  container.innerHTML = MODULES.map((mod, mi) => {
    const progressPct = ((currentSlide + 1) / mod.slides.length) * 100;
    return `
    <div class="module-slides ${mi === currentModule ? 'active' : ''}" data-module="${mi}">
      <div class="slide-progress-bar" style="width: ${mi === currentModule ? progressPct : 0}%"></div>
      ${mod.slides.map((slide, si) => renderSlide(slide, si, mi)).join('')}
      <div class="slide-nav">
        <button class="nav-btn" onclick="prevSlide()" aria-label="Previous slide" ${currentSlide === 0 ? 'disabled' : ''}>‚Üê</button>
        <div class="nav-center">
          <div class="slide-counter">${currentSlide + 1} / ${mod.slides.length}</div>
          <div class="progress-dots">
            ${mod.slides.map((_, i) => `<button class="progress-dot ${i === currentSlide ? 'active' : ''}" type="button" onclick="goToSlide(${i})" aria-label="Go to slide ${i + 1}" ${i === currentSlide ? 'aria-current="true"' : ''}></button>`).join('')}
          </div>
        </div>
        <button class="nav-btn" onclick="nextSlide()" aria-label="Next slide">‚Üí</button>
      </div>
    </div>
  `;
  }).join('');
  document.getElementById('currentModule').textContent = MODULES[currentModule].title;
  updateSlideVisibility();
}

function renderSlide(slide, index, moduleIndex) {
  const theme = slide.theme || 'dark';
  let html = `<div class="slide ${theme} ${index === currentSlide ? 'active' : ''}" data-slide="${index}">`;

  switch(slide.type) {
    case 'title':
      html += `<div class="content"><h1 class="title gold animate">${slide.content.title}</h1><p class="subtitle animate delay-1">${slide.content.subtitle}</p></div>`;
      break;

    case 'objectives':
      html += `<div class="content">
        <div class="objectives-box animate">
          <div class="objectives-header">
            <div class="objectives-icon">üéØ</div>
            <div class="objectives-title">Learning Objectives</div>
          </div>
          <ul class="objectives-list">
            ${slide.content.objectives.map(obj => `<li>${obj}</li>`).join('')}
          </ul>
        </div>
        ${slide.content.tip ? `<p class="subtitle animate delay-1" style="font-size:0.85rem;max-width:600px">${slide.content.tip}</p>` : ''}
      </div>`;
      break;

    case 'summary':
      const modXP = MODULES[moduleIndex]?.xp || 0;
      const isPerfect = checkPerfectModule(moduleIndex);
      html += `<div class="content">
        <div class="summary-box animate">
          <div class="summary-icon">üéâ</div>
          <div class="summary-title">Module Complete!</div>
          <div class="summary-stats">
            <div class="summary-stat">
              <div class="summary-stat-value">+${modXP}</div>
              <div class="summary-stat-label">XP Earned</div>
            </div>
            <div class="summary-stat">
              <div class="summary-stat-value">${gameState.correctAnswers}</div>
              <div class="summary-stat-label">Total Correct</div>
            </div>
          </div>
          ${isPerfect ? `<div class="perfect-bonus animate delay-1">‚≠ê PERFECT MODULE +${Math.round(modXP * 0.5)} XP ‚≠ê</div>` : ''}
          <p class="subtitle" style="margin-top:1rem;font-size:0.85rem">${slide.content.summary || 'ÌõåÎ•≠Ìï©ÎãàÎã§! Îã§Ïùå Î™®ÎìàÏùÑ Í≥ÑÏÜç ÏßÑÌñâÌïòÏÑ∏Ïöî.'}</p>
          <button class="summary-next animate delay-2" onclick="nextSlide()">Continue to Next Module ‚Üí</button>
        </div>
      </div>`;
      break;

    case 'story':
      html += `<div class="content">
        <article class="story-box ${slide.content.success ? 'success' : ''} animate" role="article" aria-label="Case study: ${slide.content.label}">
          <div class="story-label">${slide.content.label}</div>
          ${slide.content.title ? `<h2 class="title gold" style="font-size:1.8rem;margin-bottom:0.75rem">${slide.content.title}</h2>` : ''}
          <p class="story-text">${slide.content.text}</p>
          ${slide.content.followup ? `<p class="story-text" style="margin-top:0.75rem;font-style:italic;opacity:0.9">${slide.content.followup}</p>` : ''}
        </article>
      </div>`;
      break;

    case 'stats':
      html += `<div class="content">
        ${slide.content.title ? `<h2 class="title gold animate">${slide.content.title}</h2>` : ''}
        ${slide.content.subtitle ? `<p class="subtitle animate delay-1">${slide.content.subtitle}</p>` : ''}
        <div class="stats-grid animate delay-2">
          ${slide.content.stats.map(s => `<div class="stat-box"><div class="stat-value gold">${s.value}</div><div class="stat-label">${s.label}</div></div>`).join('')}
        </div>
        ${slide.content.caption ? `<p class="subtitle animate delay-3" style="font-size:0.85rem;margin-top:0.75rem">${slide.content.caption}</p>` : ''}
      </div>`;
      break;

    case 'refrain':
      html += `<div class="content" style="justify-content:center;height:100%"><p class="refrain animate">"${slide.content.text}"</p></div>`;
      break;

    case 'lesson':
      html += `<div class="content">
        <h2 class="title ${theme === 'light' ? 'navy' : 'gold'} animate">${slide.content.title}</h2>
        <div class="animate delay-1">
          ${slide.content.lessons.map((l, i) => `
            <div class="lesson-item">
              <div class="lesson-number">${i + 1}</div>
              <div class="lesson-content"><h4>${l.title}</h4><p>${l.desc}</p></div>
            </div>
          `).join('')}
        </div>
      </div>`;
      break;

    case 'timeline':
      html += `<div class="content">
        <h2 class="title gold animate">${slide.content.title}</h2>
        <div class="timeline animate delay-1">
          ${slide.content.items.map(item => `
            <div class="timeline-item phase-${item.phase || ''}">
              <div class="timeline-days">${item.days}</div>
              <div class="timeline-content">
                <div class="timeline-title">${item.title}</div>
                <div class="timeline-desc">${item.desc}</div>
              </div>
            </div>
          `).join('')}
        </div>
      </div>`;
      break;

    case 'checklist':
      html += `<div class="content">
        <h2 class="title gold animate">${slide.content.title}</h2>
        <div class="checklist animate delay-1">
          ${slide.content.items.map(item => `
            <div class="checklist-item">
              <div class="check-icon">‚úì</div>
              <div class="checklist-text">${item}</div>
            </div>
          `).join('')}
        </div>
      </div>`;
      break;

    case 'concept':
      html += `<div class="content">
        <h2 class="title ${theme === 'light' ? 'navy' : 'gold'} animate">${slide.content.title}</h2>
        ${slide.content.subtitle ? `<p class="subtitle animate delay-1">${slide.content.subtitle}</p>` : ''}
        ${slide.content.text ? `<div class="card ${theme === 'light' ? '' : 'navy-bg'} animate delay-2"><p class="card-text">${slide.content.text}</p></div>` : ''}
        ${slide.content.highlight ? `<div class="story-box warning animate delay-3"><div class="story-label">Key Insight</div><p class="story-text">${slide.content.highlight}</p></div>` : ''}
        ${slide.content.checkpoints ? `
          <div class="timeline animate delay-2" style="margin-top:0.75rem">
            ${slide.content.checkpoints.map(cp => `
              <div class="timeline-item"><div class="timeline-days">${cp.day}</div><div class="timeline-content"><div class="timeline-title">${cp.event}</div></div></div>
            `).join('')}
          </div>
        ` : ''}
        ${slide.content.allowed ? `
          <div class="card green-border animate delay-2" style="margin-top:0.75rem">
            <div class="card-label" style="color:var(--green)">‚úì Allowed</div>
            <ul style="margin-left:1.25rem;font-size:0.9rem">${slide.content.allowed.map(a => `<li>${a}</li>`).join('')}</ul>
          </div>
          <div class="card red-border animate delay-3">
            <div class="card-label" style="color:var(--red)">‚úó Forbidden</div>
            <ul style="margin-left:1.25rem;font-size:0.9rem">${slide.content.forbidden.map(f => `<li>${f}</li>`).join('')}</ul>
          </div>
        ` : ''}
      </div>`;
      break;

    case 'takeaway':
      html += `<div class="content">
        <div class="takeaway-card animate">
          <div class="takeaway-label"><span class="takeaway-icon">üí°</span>Key Takeaway</div>
          <p class="takeaway-text">${slide.content.text}</p>
        </div>
      </div>`;
      break;

    case 'prediction':
      const pid = `pred_${moduleIndex}_${index}`;
      const answered = gameState.answeredQuestions[pid];
      html += `<div class="content">
        <div class="prediction-panel animate" id="${pid}_panel">
          <div class="prediction-icon">${slide.content.icon}</div>
          <div class="prediction-title">${slide.content.title}</div>
          <p class="prediction-subtitle">${slide.content.subtitle}</p>
          <div class="prediction-buttons" id="${pid}_buttons">
            ${slide.content.options.map(opt => `
              <button class="predict-btn ${opt.id === 'benefit' ? 'benefit' : opt.id === 'harm' ? 'harm' : 'neutral'} ${answered === opt.id ? 'selected' : ''}"
                      onclick="makePrediction('${pid}', '${opt.id}', '${slide.content.answer}', ${slide.content.xp})"
                      ${answered ? 'disabled' : ''}>
                ${opt.label}<br><small>${opt.text}</small>
              </button>
            `).join('')}
          </div>
          <div class="prediction-result ${answered ? 'show' : ''} ${answered === slide.content.answer ? 'correct' : 'incorrect'}" id="${pid}_result">
            ${answered === slide.content.answer ? '‚úì ÏßÅÍ∞êÏù¥ ÎßûÏïòÏäµÎãàÎã§!' : answered ? '‚úó Îç∞Ïù¥ÌÑ∞Ïóê ÎÜÄÎûêÏäµÎãàÎã§. ÏïåÏïÑÎëêÎ©¥ Ï¢ãÏäµÎãàÎã§!' : ''}
          </div>
        </div>
      </div>`;
      break;

    case 'decision':
      const did = `dec_${moduleIndex}_${index}`;
      const decAnswered = gameState.answeredQuestions[did];
      html += `<div class="content">
        <div class="decision-tree animate">
          <div class="decision-header">
            <div class="decision-icon">${slide.content.icon}</div>
            <div><div class="decision-title">${slide.content.title}</div></div>
            <div class="decision-xp">+${slide.content.xp} XP</div>
          </div>
          <div class="decision-scenario">${slide.content.scenario}</div>
          <div class="decision-question">${slide.content.question}</div>
          <div class="decision-options" id="${did}_options">
            ${slide.content.options.map((opt, oi) => `
              <div class="decision-option ${decAnswered === opt.letter ? (opt.correct ? 'correct' : 'incorrect') : ''} ${decAnswered && opt.correct ? 'correct' : ''} ${decAnswered ? 'disabled' : ''}"
                   onclick="makeDecision('${did}', '${opt.letter}', ${opt.correct}, ${slide.content.xp})"
                   tabindex="${decAnswered ? -1 : 0}"
                   role="button"
                   aria-label="Option ${opt.letter}: ${opt.text}"
                   onkeydown="if(event.key==='Enter'||event.key===' '){event.preventDefault();makeDecision('${did}', '${opt.letter}', ${opt.correct}, ${slide.content.xp});}">
                <div class="option-letter">${opt.letter}</div>
                <div class="option-text">${opt.text}</div>
              </div>
            `).join('')}
          </div>
          <div class="decision-feedback ${decAnswered ? 'show' : ''} ${decAnswered && slide.content.options.find(o => o.letter === decAnswered)?.correct ? 'correct' : 'incorrect'}" id="${did}_feedback">
            <div class="feedback-title">${decAnswered && slide.content.options.find(o => o.letter === decAnswered)?.correct ? '‚úì Correct!' : '‚úó Not quite'}</div>
            <div class="feedback-text">${decAnswered && slide.content.options.find(o => o.letter === decAnswered)?.correct ? slide.content.feedback.correct : slide.content.feedback.incorrect}</div>
          </div>
        </div>
      </div>`;
      break;

    case 'quiz':
      const qid = `quiz_${moduleIndex}_${index}`;
      const qAnswered = gameState.answeredQuestions[qid];
      html += `<div class="content">
        <div class="quiz-container animate">
          <p class="quiz-question">${slide.content.question}</p>
          <div class="quiz-options" id="${qid}_options">
            ${slide.content.options.map((opt, i) => `
              <div class="quiz-option ${qAnswered === i ? (opt.correct ? 'correct' : 'incorrect') : ''} ${qAnswered !== undefined && opt.correct ? 'correct' : ''} ${qAnswered !== undefined ? 'disabled' : ''}"
                   onclick="answerQuiz('${qid}', ${i}, ${opt.correct}, ${slide.content.xp || 20})">
                ${opt.text}
              </div>
            `).join('')}
          </div>
          <div class="quiz-feedback ${qAnswered !== undefined ? 'show' : ''} ${qAnswered !== undefined && slide.content.options[qAnswered]?.correct ? 'correct' : 'incorrect'}" id="${qid}_feedback">
            ${qAnswered !== undefined ? (slide.content.options[qAnswered]?.correct ? slide.content.feedback.correct : slide.content.feedback.incorrect) : ''}
          </div>
        </div>
      </div>`;
      break;
  }

  html += '</div>';
  return html;
}

function updateSlideVisibility() {
  const moduleSlides = document.querySelector(`.module-slides[data-module="${currentModule}"]`);
  if (!moduleSlides) return;
  moduleSlides.querySelectorAll('.slide').forEach((slide, i) => slide.classList.toggle('active', i === currentSlide));
  const counter = moduleSlides.querySelector('.slide-counter');
  if (counter) counter.textContent = `${currentSlide + 1} / ${MODULES[currentModule].slides.length}`;
  moduleSlides.querySelectorAll('.progress-dot').forEach((dot, i) => dot.classList.toggle('active', i === currentSlide));
  const prevBtn = moduleSlides.querySelector('.nav-btn:first-child');
  if (prevBtn) prevBtn.disabled = currentSlide === 0;
}

// ===== INTERACTIONS =====
function makePrediction(pid, choice, answer, xp) {
  if (gameState.answeredQuestions[pid]) return;
  gameState.answeredQuestions[pid] = choice;
  gameState.predictionsTotal++;

  const correct = choice === answer;
  if (correct) {
    gameState.predictionsCorrect++;
    addXP(xp);
    if (gameState.predictionsCorrect >= 5) awardBadge('oracle');
  }
  saveGame();
  renderSlides();
}

function makeDecision(did, choice, correct, xp) {
  if (gameState.answeredQuestions[did]) return;
  gameState.answeredQuestions[did] = choice;
  gameState.decisionsCompleted++;

  if (correct) {
    gameState.correctAnswers++;
    consecutiveCorrect++;
    addXP(xp);
    if (gameState.correctAnswers === 1) awardBadge('first_blood');
    if (consecutiveCorrect >= 5) awardBadge('perfect_5');
    if (gameState.decisionsCompleted >= 10) awardBadge('decision_maker');
  } else {
    consecutiveCorrect = 0;
  }
  gameState.consecutiveCorrect = consecutiveCorrect;
  saveGame();
  renderSlides();
  updateReviewButton();
  updateComboDisplay();
}

function answerQuiz(qid, choice, correct, xp) {
  if (gameState.answeredQuestions[qid] !== undefined) return;
  gameState.answeredQuestions[qid] = choice;

  if (correct) {
    gameState.correctAnswers++;
    consecutiveCorrect++;
    addXP(xp);
    if (gameState.correctAnswers === 1) awardBadge('first_blood');
    if (consecutiveCorrect >= 5) awardBadge('perfect_5');
  } else {
    consecutiveCorrect = 0;
  }
  gameState.consecutiveCorrect = consecutiveCorrect;
  saveGame();
  renderSlides();
  updateReviewButton();
  updateComboDisplay();
}

// ===== NAVIGATION =====
function goToModule(index) {
  if (index > 0 && !gameState.completedModules.includes(MODULES[index-1].id)) return;
  currentModule = index;
  currentSlide = 0;
  renderSlides();
  renderSidebar();
}

function goToSlide(index) {
  currentSlide = index;
  updateSlideVisibility();
}

function nextSlide() {
  const mod = MODULES[currentModule];
  if (currentSlide < mod.slides.length - 1) {
    currentSlide++;
    updateSlideVisibility();
  } else {
    completeModule();
  }
}

function prevSlide() {
  if (currentSlide > 0) {
    currentSlide--;
    updateSlideVisibility();
  }
}

function completeModule() {
  const mod = MODULES[currentModule];
  if (!gameState.completedModules.includes(mod.id)) {
    gameState.completedModules.push(mod.id);
    addXP(mod.xp);

    // Check for perfect module (all questions correct)
    if (checkPerfectModule(currentModule) && !gameState.perfectModules.includes(mod.id)) {
      gameState.perfectModules.push(mod.id);
      const bonusXP = Math.round(mod.xp * 0.5);
      addXP(bonusXP);
      showPerfectBonus(bonusXP);
    }

    // Check for module-specific badges
    if (mod.id === 3) awardBadge('protocol_pro');
    if (mod.id === 4) awardBadge('search_savant');
    if (mod.id === 5) awardBadge('data_detective');
    if (mod.id === 6) awardBadge('stats_wizard');
    if (mod.id === 8) awardBadge('colchicine_hero');
    if (gameState.completedModules.length === MODULES.length) {
      awardBadge('finisher');
      setTimeout(showCompletionModal, 500);
    }

    saveGame();
    triggerConfetti();
    updateCourseProgress();
  }

  if (currentModule < MODULES.length - 1) {
    goToModule(currentModule + 1);
  }
}

function showPerfectBonus(xp) {
  const popup = document.getElementById('xpPopup');
  document.getElementById('xpAmount').innerHTML = `+${xp}<br><small style="font-size:0.8rem">PERFECT!</small>`;
  popup.classList.add('show');
  setTimeout(() => {
    popup.classList.remove('show');
    document.getElementById('xpAmount').textContent = '+0';
  }, 2000);
}

// ===== CERTIFICATE DOWNLOAD =====
function downloadCertificate() {
  const courseName = 'META-SPRINT: 40Ïùº ÎßåÏóê Ïã†Î¢∞Ìï† Ïàò ÏûàÎäî Ï¶ùÍ±∞ ÌôïÎ≥¥';
  const completionDate = new Date().toLocaleDateString('en-US', { year: 'numeric', month: 'long', day: 'numeric' });
  const level = LEVELS[gameState.level - 1] || LEVELS[0];
  const badgeCount = gameState.badges.length;
  const totalXP = gameState.xp;

  const certHTML = `
<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="UTF-8">
  <title>Certificate of Completion - ${courseName}</title>
  <style>
    @import url('https://fonts.googleapis.com/css2?family=Cormorant+Garamond:wght@400;600;700&family=Source+Sans+Pro:wght@400;600&display=swap');
    * { margin: 0; padding: 0; box-sizing: border-box; }
    body { font-family: 'Source Sans Pro', sans-serif; background: #f5f5f5; padding: 20px; }
    .certificate {
      max-width: 800px; margin: 0 auto; background: linear-gradient(135deg, #1E2761 0%, #141B3D 100%);
      border: 8px solid #D4AF37; border-radius: 12px; padding: 60px 50px; text-align: center;
      box-shadow: 0 20px 60px rgba(0,0,0,0.3);
    }
    .cert-header { font-family: 'Cormorant Garamond', serif; color: #D4AF37; font-size: 1rem; letter-spacing: 0.3em; text-transform: uppercase; margin-bottom: 10px; }
    .cert-title { font-family: 'Cormorant Garamond', serif; color: #FAF8F5; font-size: 3rem; font-weight: 700; margin-bottom: 30px; }
    .cert-subtitle { color: rgba(255,255,255,0.8); font-size: 1.1rem; margin-bottom: 40px; }
    .cert-course { font-family: 'Cormorant Garamond', serif; color: #D4AF37; font-size: 2rem; font-weight: 600; margin-bottom: 15px; padding: 20px; border-top: 1px solid rgba(212,175,55,0.3); border-bottom: 1px solid rgba(212,175,55,0.3); }
    .cert-stats { display: flex; justify-content: center; gap: 40px; margin: 30px 0; }
    .cert-stat { text-align: center; }
    .cert-stat-value { font-family: 'Cormorant Garamond', serif; font-size: 2rem; color: #D4AF37; font-weight: 700; }
    .cert-stat-label { font-size: 0.8rem; color: rgba(255,255,255,0.6); text-transform: uppercase; letter-spacing: 0.1em; }
    .cert-date { color: rgba(255,255,255,0.7); font-size: 0.95rem; margin-top: 40px; }
    .cert-footer { margin-top: 40px; padding-top: 30px; border-top: 1px solid rgba(212,175,55,0.2); }
    .cert-issuer { color: rgba(255,255,255,0.5); font-size: 0.85rem; }
    .cert-badge { display: inline-block; margin-top: 15px; padding: 8px 20px; background: rgba(212,175,55,0.2); border: 1px solid rgba(212,175,55,0.4); border-radius: 20px; color: #D4AF37; font-size: 0.9rem; }
    @media print {
      body { background: white; padding: 0; }
      .certificate { box-shadow: none; }
    }
  </style>
</head>
<body>
  <div class="certificate">
    <div class="cert-header">Synthesis Course Collection</div>
    <div class="cert-title">Certificate of Completion</div>
    <div class="cert-subtitle">This certifies successful completion of</div>
    <div class="cert-course">${courseName}</div>
    <div class="cert-stats">
      <div class="cert-stat">
        <div class="cert-stat-value">${totalXP.toLocaleString()}</div>
        <div class="cert-stat-label">Total XP Earned</div>
      </div>
      <div class="cert-stat">
        <div class="cert-stat-value">${badgeCount}</div>
        <div class="cert-stat-label">Badges Earned</div>
      </div>
      <div class="cert-stat">
        <div class="cert-stat-value">${level.title}</div>
        <div class="cert-stat-label">Final Level</div>
      </div>
    </div>
    <div class="cert-date">Completed on ${completionDate}</div>
    <div class="cert-footer">
      <div class="cert-issuer">Synthesis Course Collection ‚Äî Evidence Synthesis & Meta-Analysis Training</div>
      <div class="cert-badge">Verified Completion</div>
    </div>
  </div>
  <script>window.onload = () => window.print();<\/script>
</body>
</html>`;

  const blob = new Blob([certHTML], { type: 'text/html' });
  const url = URL.createObjectURL(blob);
  const a = document.createElement('a');
  a.href = url;
  a.download = 'Certificate-META-SPRINT-Course.html';
  document.body.appendChild(a);
  a.click();
  document.body.removeChild(a);
  URL.revokeObjectURL(url);
}

// ===== KEYBOARD =====
document.addEventListener('keydown', (e) => {
  // Close modals with Escape
  if (e.key === 'Escape') {
    closeBadgeModal();
    document.getElementById('glossaryPanel').classList.remove('open');
    document.getElementById('completionModal').classList.remove('show');
    document.getElementById('reviewPanel').classList.remove('show');
    // Close mobile sidebar
    document.querySelector('.sidebar').classList.remove('open');
    document.getElementById('sidebarOverlay').classList.remove('show');
    return;
  }
  // Keyboard support for interactive elements (check first to avoid intercepting their keys)
  if ((e.target.classList.contains('module-item') || e.target.classList.contains('decision-option') || e.target.classList.contains('quiz-option')) && (e.key === 'Enter' || e.key === ' ')) {
    e.preventDefault();
    e.target.click();
    return;
  }
  // Don't navigate if review panel is open
  if (document.getElementById('reviewPanel').classList.contains('show')) return;
  // Navigation
  if (e.key === 'ArrowRight' || e.key === ' ') { e.preventDefault(); nextSlide(); }
  else if (e.key === 'ArrowLeft') { e.preventDefault(); prevSlide(); }
});

// ===== TOUCH/SWIPE =====
let touchStartX = 0;
let touchEndX = 0;

document.addEventListener('touchstart', (e) => {
  touchStartX = e.changedTouches[0].screenX;
}, { passive: true });

document.addEventListener('touchend', (e) => {
  touchEndX = e.changedTouches[0].screenX;
  handleSwipe();
}, { passive: true });

function handleSwipe() {
  const swipeThreshold = 50;
  const diff = touchStartX - touchEndX;
  if (Math.abs(diff) < swipeThreshold) return;

  if (diff > 0) {
    // Swipe left = next; guard against swiping past last slide of completed module
    const mod = MODULES[currentModule];
    if (currentSlide >= mod.slides.length - 1 && gameState.completedModules.includes(mod.id)) return;
    nextSlide();
  } else {
    // Swipe right = prev
    prevSlide();
  }
}

// ===== STREAK WARNING =====
function checkStreakWarning() {
  const today = new Date().toDateString();
  const streakEl = document.getElementById('streakDisplay');
  if (gameState.lastActive && gameState.lastActive !== today && gameState.streak > 0) {
    // User has a streak but hasn't engaged today
    const lastDate = new Date(gameState.lastActive);
    const now = new Date();
    const hoursSince = (now - lastDate) / (1000 * 60 * 60);
    if (hoursSince > 20 && hoursSince < 48) {
      // Streak at risk!
      streakEl.classList.add('streak-warning');
      streakEl.title = 'Ïó∞ÏÜç Í∏∞Î°ùÏùÑ Ïú†ÏßÄÌïòÎ†§Î©¥ Ïò§Îäò Í∞ïÏùòÎ•º ÏôÑÎ£åÌïòÏÑ∏Ïöî!';
    }
  }
}

// ===== COMPLETION MODAL =====
function showCompletionModal() {
  document.getElementById('finalXP').textContent = gameState.xp;
  document.getElementById('finalCorrect').textContent = gameState.correctAnswers;
  document.getElementById('finalBadges').textContent = gameState.badges.length;
  document.getElementById('completionModal').classList.add('show');
  triggerConfetti();
  setTimeout(triggerConfetti, 500);
  setTimeout(triggerConfetti, 1000);
}

function closeCompletionModal() {
  document.getElementById('completionModal').classList.remove('show');
}

// ===== REVIEW MISTAKES =====
function updateReviewButton() {
  const mistakes = getIncorrectAnswers();
  const btn = document.getElementById('reviewMistakesBtn');
  if (mistakes.length > 0) {
    btn.classList.add('show');
    btn.textContent = `üìù Review ${mistakes.length} Mistake${mistakes.length > 1 ? 's' : ''}`;
  } else {
    btn.classList.remove('show');
  }
}

function getIncorrectAnswers() {
  const mistakes = [];
  MODULES.forEach((mod, mi) => {
    mod.slides.forEach((slide, si) => {
      if (slide.type === 'decision') {
        const did = `dec_${mi}_${si}`;
        const answer = gameState.answeredQuestions[did];
        if (answer) {
          const correct = slide.content.options.find(o => o.correct);
          const chosen = slide.content.options.find(o => o.letter === answer);
          if (chosen && !chosen.correct) {
            mistakes.push({
              module: mod.title,
              question: slide.content.question,
              scenario: slide.content.scenario,
              yourAnswer: chosen.text,
              correctAnswer: correct.text,
              explanation: slide.content.feedback.correct
            });
          }
        }
      }
      if (slide.type === 'quiz') {
        const qid = `quiz_${mi}_${si}`;
        const answer = gameState.answeredQuestions[qid];
        if (answer !== undefined) {
          const chosen = slide.content.options[answer];
          if (chosen && !chosen.correct) {
            const correct = slide.content.options.find(o => o.correct);
            mistakes.push({
              module: mod.title,
              question: slide.content.question,
              scenario: null,
              yourAnswer: chosen.text,
              correctAnswer: correct.text,
              explanation: slide.content.feedback.correct
            });
          }
        }
      }
    });
  });
  return mistakes;
}

function showReviewPanel() {
  const mistakes = getIncorrectAnswers();
  const content = document.getElementById('reviewContent');

  if (mistakes.length === 0) {
    content.innerHTML = '<p style="text-align:center;opacity:0.7;padding:2rem">No mistakes to review. Great job!</p>';
  } else {
    content.innerHTML = mistakes.map(m => `
      <div class="review-item">
        <div class="review-module">${m.module}</div>
        ${m.scenario ? `<div class="review-question" style="font-size:0.85rem;opacity:0.8;margin-bottom:0.5rem">${m.scenario}</div>` : ''}
        <div class="review-question">${m.question}</div>
        <div class="review-your-answer">‚ùå Your answer: ${m.yourAnswer}</div>
        <div class="review-correct-answer">‚úì Correct: ${m.correctAnswer}</div>
        <div class="review-explanation">${m.explanation}</div>
      </div>
    `).join('');
  }

  document.getElementById('reviewPanel').classList.add('show');
}

function closeReviewPanel() {
  document.getElementById('reviewPanel').classList.remove('show');
}

// ===== INIT =====
renderAll();
checkStreakWarning();
updateReviewButton();
</script>
</body>
</html>
